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Abstract 
Dynamic regulation of cell-cell contact formation during epithelial tissue biogenesis is 
critical for many developmental processes, which, when recapitulated in adult tissue, can 
disrupt cell-cell adhesion and contribute to tumourigenesis. During de novo adherens 
junction assembly, Rho small GTPases drive a multitude of diverse cellular processes to 
build strong, functional cell-cell contacts. How E-cadherin signalling is transduced to 
specify Rho protein signalling is not well characterised. It is thought to involve spatio-
temporal activation of Rho family members by their GEFs, but which Rho GEFs contribute 
to the initial stages of epithelial biogenesis remains to be elucidated.   Here I identify 
activators of Rac and RhoA GTPases that contribute to assembly and stabilisation of 
cadherin contacts. 
I find that junction-induction modulates EGFR phosphorylation in a profile distinct from the 
canonical ligand-dependent pattern to activate Rac. Functionally, EGFR but not the GEFs 
DOCK180 or Trio, is required for junction-induced actin reorganisation, a Rac1-dependent 
cellular process. RNAi screening shows that multiple Rho GEFs regulate the distribution of 
E-cadherin and/or F-actin at nascent contacts by two modes of action: negative E-cadherin 
regulation is correlated with, but positive regulation is independent of, F-actin re-
distribution.  
Furthermore, I find that junction formation induces an early transient wave of RhoA 
activation, which is attenuated by depletion of the GEFs, ARHGEF10 or Trio. ARHGEF10 
and Trio negatively regulate the distinct cellular processes of E-cadherin availability and 
stability. Finally, I find that, loss of ARHGEF10 leads to increased incorporation of unstable 
E-cadherin into junctions resulting in global destabilisation of newly-formed contacts.  This 
suggests a fine balance between the amount of cadherin present at junctions and their 
ability to engage with the cortical cytoskeleton. These results are surprising and suggest 
that the amount of cadherin at junctions may not directly correlate with stability and they 
may be regulated by distinct pathways.  
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SUMO Small ubiquitin-like modifier 
SW480 Scott and White clinic, cell line 480 
t Half-time to recovery 1/2 
TBS Tris-buffered saline 
TBS-T TBS-Tween20 
TARA Trio-associated repeat on actin 
Tbx3 T-box transcription factor 3 
TCA Tricholoroacetic acid 
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T-cadherin Truncated-cadherin 
TCR T-cell receptor 
TGF-β Transforming growth factor -β 
Tiam-1 T-cell lymphoma invasion and metastisis 1 
TJ Tight junction 
Toca-1 Transducer of Cdc42-dependent actin assembly 
Trio Triple function domain protein 
UNC Uncoordinated 
Vav Sixth letter of the hebrew alphabet 
VE-cadherin Vascular-endothelial-cadherin 
VEGFR Vascular-endothelial growth factor receptor 
VH Vinculin Homology 
WASP Wiskott-Aldrich syndrome protein 
WAVE WASP family Verprolin-homologous protein  
WB Western blot 
WD40 40 amino acid repeat terminating Tryptophan-aspartic 
acid dipeptide 
WIP WASP interacting protein 
Wnt Wingless-Integrated 
WT Wild type 
ZO Zona Occludens 
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1 Introduction 
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1.1 Cell-cell adhesion in epithelial tissue biogenesis 
1.1.1 Structure-function relationship of epithelial tissues 
The capacity for cells to come together and communicate with each other to form  
specialised tissues and organs is fundamental to the development of a properly functioning 
multicellular organism (Gumbiner, 1996). Many organs with specialised functions are 
composed of epithelial tissue.  Throughout the body, a diverse range of epithelial tissues 
function as a barrier to keep the external environment outside (Powell, 1981). The variety 
of epithelial tissue types, conferred by the architecture of the tissue and the properties of 
the cells of which it is composed, is indicative of the distinct function each specialised 
tissue performs (Fig. 1.1). Key to this tissue structure-function relationship is the ability of 
cells to form strong, yet adaptable cell-cell contacts with one another.  
Flexible and dynamic intercellular adhesions define and refine tissue architecture in 
response to environmental changes (Baum & Georgiou, 2011; Ivanov et al, 2005b). 
Regulation of intercellular connections is not only vital for the maintenance of adult tissue 
homeostasis (Baum & Georgiou, 2011), but is also an important aspect of tissue 
remodeling in wound repair (Takeichi, 1995). Perhaps even more significant is the 
fundamental role for cell-cell adhesion in epithelial tissue biogenesis during organism 
development (Edelman, 1984; Nishimura & Takeichi, 2009).   
As epithelial tissues form, the cells undergo a process of polarisation, whereby the three-
dimensional structure of the cell becomes asymmetric. When cells make initial cell-cell 
contacts a cascade of intracellular signalling events occur to drive cell shape changes. 
These include localisation of specific membrane bound proteins to distinct surfaces on the 
cell, rearrangement of the cytoskeleton to dictate the cellular architecture, and re-
distribution of intracellular organelles in order to create the asymmetrical epithelial 
phenotype (Braga, 2000) (Fig. 1.2A). The earliest example of cell-cell contact formation 
during morphogenesis is the compaction of the unstructured ball of blastomere cells at the 
8-cell stage into the compartmentalised blastocyst (De Vries et al, 2004; Kemler et al, 
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Figure 1.1 Diversity of mammalian epithelial tissues. Schematic representations of the different 
types of epithelial cells and tissue organisations found in mammals. There are three types of 
epithelial cell classified depending on their shape: squamous (flat), cuboidal (width and height are 
similar) and columnar (tall). The three cell types can arrange into single layers (simple) or multiple 
layers (stratified) to make up eight distinct categories. Each epithelial tissue has structural and 
functional properties suited to the function of the organ they comprise. Annotations give examples 
of the functional properties and the type of organ in which each epithelial tissue type is found. 
Images based on www.cancerresearchuk.org and www.antranik.org.   
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Figure 1.2 Epithelial biogenesis. Simplified schematic representations of biogenesis of epithelial 
morphology. A) Principles of polarisation in epithelial sheets: i) Adjacent cells in the absence of 
cell-cell adhesions; ii) Epithelialisation begins when adjacent cells make intercellular contacts that 
strengthen the epithelial sheet structure and provide the cell with spatial cues to trigger polarisation 
processes; iii) Rearrangement of the cytoskeleton drives cell shape changes and reinforces 
intercellular interactions, whilst membranes and organelles are compartmentalised to define a 
classical polarised phenotype. B) An example of the generation of epithelial phenotype in the 
developing embryo is compaction: i) At the eight cell stage the morula is a ‘loose’ ball of cells; ii) 
These cells rearrange and compact; iii) Blastocyst consists of a ring of outer tightly packed, 
polarised epithelial cells. 
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1977; Sefton et al, 1992; Vestweber et al, 1987) (Fig. 1.2B). Other examples include 
neural tube formation, gastrulation and formation of the vasculature (Stepniak et al, 2009). 
Underpinning these processes is the formation of strong bonds between opposing cells, 
and the expansion of tight intercellular connections.   
1.1.2 Cell-cell adhesion complexes 
The localisation and function of cell-cell adhesion complexes to the intercellular interface 
provide the structural and mechanical platform for strong cell-cell connections (Fig. 1.3A). 
The main components of mammalian epithelial cell-cell contacts are the Ig-like Nectins 
and core components of the desmosome, adherens junction (AJ) and tight junction (TJ) 
(Fig. 1.3A). Nectins initiate cell-cell contacts in a way that is thought to bring apposing 
membranes into close proximity and specify basolateral adhesion sites so that 
components of the AJ can engage in intercellular interactions (Takai et al, 2008). 
Desmosomes form strong intercellular adhesions required for maintaining the structural 
and adhesive strength necessary for epithelial tissue integrity (Delva et al, 2009). Apical to 
AJs lie the TJ structures. The function of TJs is to provide a barrier system that can 
modulate its permeability in response to cellular cues (Terry et al, 2010). Each of these 
adhesion complexes consists of a core set of components (Fig. 1.3A) that, together with 
the cytoskeleton, provide structural integrity and mechanisms of communication between a 
population of polarised epithelial cells in a tissue.  
1.2 AJs and classical cadherins 
1.2.1 Cadherin family of cell-cell adhesion proteins 
One of the most important adhesion complexes is the AJs, which are crucial for many 
developmental processes (Stepniak et al, 2009). Loss of cell-cell adhesion through dis-
regulation of AJs components is a key step in the generation of an invasive phenotype in 
many epithelial cancers (Berx & van Roy, 2009). Cadherins are the principle component of 
AJs. They are single pass transmembrane glycoproteins that undergo calcium-dependent 
homophilic binding in trans with cadherins on adjacent cells (Takeichi, 1988). Cadherins 
are present throughout metazoa (Nollet et al, 2000), and since they were first 
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Figure 1.3 Arrangement and composition of intercellular adhesion complexes. A) Schematic 
representation of the architecture of cell-cell adhesion complexes and their key intracellular 
components. i) Desmosomes are the basal-most of the cell-cell adhesion complexes. Single pass 
trans-membrane desmosomal cadherins span the intercellular space and mediate adhesion. Major 
intracellular components of the desmosome are plakophilin and plakoglobin catenins and 
desmoplakin scaffold proteins which mediate attachment to intermediate filaments. ii) Adherens 
junctions are composed of the major single pass trans-membrane cadherin proteins. The 
intracellular domain of cadherin associates with p120ctn and β-catenin, which in turn interacts with 
α-catenin to mediate attachment of the cadherin-catenin complex to the actin cytoskeleton. iii) 
Apical to adherens junctions lie the tight junction complexes. Amongst other components the four-
pass transmembrane proteins Claudins and Occludin mediate the barrier properties of tight 
junctions. They interact with the Zona Occludens (ZO) family proteins and components of the 
polarity complex which govern interactions with the actin cytoskeleton. Note that a large number of 
proteins have been localised to adhesion complexes but are not depicted here for simplicity. B) 
Diagram of the classical cadherin-catenin complex with the ectodomain consisting of five 
extracellular cadherin (EC) domains. EC1 mediates trans-interactions in the presence of calcium. 
The intracellular domain of classical cadherins have a juxtamembrane p120ctn binding domain 
followed by a C-terminal β-catenin binding region. Interaction with underlying actin filaments is 
mediated by α-catenin and a number of actin-binding proteins. 
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discovered over 100 mammalian cadherins have been identified.  
The cadherins are classified into a number of subfamilies to include classical cadherins, 
desmosomal cadherins, Fat, Fat-like, Dachsous, Flamingo, and Protocadherins (Nollet et 
al, 2000).  The subfamilies are based on the composition of the extracellular domain and 
the conservation of the intracellular domain. In vertebrate classical cadherins the 
ectodomains are composed of internal repeats called ‘extracellular cadherin’ (EC) domains   
(Fig. 1.3B) (Nollet et al, 2000; Overduin et al, 1995; Shapiro et al, 1995). Further sub-
divisions of classical cadherins into subfamilies are based on amino acid similarities and 
expression profiles. For example, type I classical cadherins, such as epithelial cadherin (E-
cadherin) and neural cadherin (N-cadherin), are widely expressed. On the other hand type 
II classical cadherins (i.e. vascular endothelial cadherin (VE-cadherin)), have a tissue-type 
specific distribution (Oda & Takeichi, 2011). 
1.2.2 Structural insights into cadherin-mediated cell-cell adhesion  
1.2.2.1 Calcium binding mechanism 
Cadherin-based cell-cell adhesion is a calcium-dependent process (Hyafil et al, 1980; 
Kemler et al, 1977; Peyriéras et al, 1983; Peyriéras et al, 1985; Takeichi, 1977; Takeichi et 
al, 1988; Urushihara et al, 1979; Yoshida & Takeichi, 1982).  In the absence of calcium, 
cadherin redistributes away from the cell-cell boundaries (Hirano et al, 1987) and leads to 
disruption of cell-cell adhesion (Volk & Geiger, 1986). Upon re-addition of calcium, 
localisation of cadherin at cell-cell boundaries is restored (Hirano et al, 1987). The role of 
calcium binding in cadherin function is now well established.  Three calcium ions 
coordinate in the linker regions between tandem EC domains generating the rigid 
conformation required for cadherins on opposing cells to undergo trans-interactions 
(Harrison et al, 2011; Nagar et al, 1996; Pokutta et al, 1994). In low calcium conditions, 
trans-interactions are lost and E-cadherin molecules dimerise with their neighbours on the 
same cell (in cis) using the same adhesive interface as they do in trans-dimerisation 
(Troyanovsky et al, 2003). This demonstrates that calcium is required to generate the 
geometrical organisation of E-cadherin molecules in order to form the adhesive trans-
dimers. 
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1.2.2.2 Structural mechanism of homophilic binding of cadherins  
Trans-interaction of E-cadherin molecules is mediated by the membrane-distal EC1 
domain. This has been demonstrated using a variety of techniques. In experiments using 
chimeric cadherins the specificity of cadherin-cadherin binding is switched depending on 
the cadherin type from which the EC1 domain is derived (Klingelhöfer et al, 2000; Nose et 
al, 1988; Patel et al, 2006; Shan et al, 1999; Shan et al, 2000). Site-specific crosslinking 
coupled with mutagenesis of E-cadherin also shows the adhesive interface is in the EC1 
domain (Troyanovsky et al, 2003).  
EC domains are composed of seven β-stands (Overduin et al, 1995; Shapiro et al, 1995). 
Structural studies show that in type I classical cadherins the side-chain of a conserved 
tryptophan positioned at the N-terminus (Trp2) of the EC1 domain of one E-cadherin binds 
into a hydrophobic pocket in the EC1 domain of the opposing E-cadherin (Boggon et al, 
2002; Brasch et al, 2011; Harrison et al, 2011; Häussinger et al, 2002; Shapiro et al, 
1995). Loss of adhesive function is associated with mutations in Trp2, which underscores 
the physiological relevance of the Trp2 residue (Harrison et al, 2005; May et al, 2005; 
Patel et al, 2003; Tamura et al, 1998; Troyanovsky et al, 2003). Mechanistically, a 3D 
strand swap mechanism is used (Bennett et al, 1995; Shapiro & Weis, 2009) whereby the 
β-stand containing the Trp2 residue (the A-stand) is connected to the rest of the EC1 
domain by a hinge region. The A-strand of EC1 domains is short and anchored at both 
ends and therefore is under tension. The strain destabilises the EC1 domain resulting in 
an energetically favorable strand swap configuration (Posy et al, 2008; Vendome et al, 
2011; Vunnam & Pedigo, 2011). Because the A-strand can exist in complex with its own 
EC1 domain (resulting in an E-cadherin monomer) but also with neighbouring EC1 
domains (in the dimerised form) the binding is competitive and is proposed to contribute to 
the low affinity interactions seen in adhesive studies (Chen et al, 2005a).  
The strand swap mechanism is facilitated by the formation of a lower energy intermediate 
called the X-dimer (Harrison et al, 2011). The EC1-EC2 linker regions of two opposing E-
cadherin molecules interact in an X-shaped configuration which serves to bring the strand 
swap interfaces into closer proximity and thus reduce the energy requirements for strand 
swap formation (Miloushev et al, 2008). These X-dimers are still able to form in the 
absence of the ability of strand-swap dimers to form (Sivasankar et al, 2009). Conversely, 
Natalie Welsh   PhD Thesis  
  33 
in mutated dimers that cannot form the X-intermediate, strand-swap dimers still form but 
are much weaker (Sivasankar et al, 2009), suggesting the X-dimer is important for strand-
swapping to proceed efficiently.    
Trans-dimerisation is sufficient to mediate functional adhesion as E-cadherin molecules 
rendered unable to bind to cytoplasmic proteins can still form adhesive structures 
(Harrison et al, 2011; Hong et al, 2010; Ozaki et al, 2010).  Moreover, E-cadherin 
ectodomains on liposomes are able to form adherens-type structures (Harrison et al, 
2011). The assembly of trans-dimers into adherens structures is aided by further 
extracellular cis-interactions that occur between neighbouring E-cadherin molecules on the 
same cell. The calcium-induced arched conformation of strand-swapped dimers not only 
facilitates trans-interactions, but also reveals a second homophilic binding site distinct to 
the trans-interaction region. Cis-binding occurs between the concave face of one E-
cadherin and convex face of the neighbouring E-cadherin by interactions between the 
lower portion of the first EC1 domain with the upper portion of the EC2 domain on the 
adjacent E-cadherin molecule (Boggon et al, 2002; Harrison et al, 2011) (Fig. 1.4A-C). In 
cells with wild-type and cis-binding mutant cadherins, both species are incorporated into 
junctions but the resulting structure is unstable (Harrison et al, 2011). Moreover, in cells 
devoid of wild-type cadherin, cis-mutants are unable to cluster (Harrison et al, 2011), 
suggesting the clustering of trans-dimers is biologically important. The current model 
proposes that trans-dimers form when initial membrane apposition occurs, with cis-
clustering promoted by interaction with the underlying cytoskeleton and the action of 
intracellular proteins such as the catenins (Brasch et al, 2012).  
1.2.3 Contribution of intracellular catenin proteins to cadherin-based adhesion 
The molecular architecture of AJs is central to its role in cell-cell adhesion. Cadherins 
interact (directly and indirectly) with catenins and the cortical cytoskeleton (Aberle et al, 
1996; Hartsock & Nelson, 2008) (Fig. 1.3B). The cadherin-catenin complex is not only 
structurally important, but also acts as a signalling node to control intracellular processes 
in response to external cues (Behrens, 1999). 
The 150 amino acid cytoplasmic tail of classical cadherins is highly conserved (Nollet et al, 
2000). The juxtamembrane region of the E-cadherin tail provides the binding site for 
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Figure 1.4 Extracellular structure of adherens junctions formed through cis and trans 
ectodomain interactions. A) Selected region of the N-cadherin EC1–5 crystal lattice (blue ribbon 
presentation; Research Collaboratory for Structural Bioinformatics (RCSB) protein data bank (pdb)-
ID: 3Q2W) showing an array of N-cadherin molecules oriented as if emanating from the same cell 
membrane and connected by a cis interface formed between the EC1 and EC2 domains of 
neighbouring molecules. B) Strand-swapped trans dimers form together with cis interactions in the 
same crystal lattice. Trans interactions orient opposing cis arrays approximately perpendicularly 
such that each cis array (blue) forms trans interactions with multiple opposing cis arrays (orange). 
C) The combination of cis and trans interactions enables cadherin ectodomains to form an ordered 
network that is thought to be the basis for the extracellular architecture of adherens junction. Taken 
from Brasch et al. 2012 (previously adapted from Harrison et al. 2011). 
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p120 catenin (p120ctn
The nine structurally related catenins are divided into three subfamilies: the β-catenins 
including β-catenin and plakoglobin (γ-catenin); the plakophilins (1, 2 and 3); and the 
p120
), whilst the C-terminus binds to β-catenin (Yap et al, 2007). The 
catenins were first described in cadherin-interaction experiments (Ozawa et al, 1989) and 
consist of a family of nine armadillo containing proteins (McCrea & Gu, 2010).  An 
additional, but structural unrelated catenin implicated in cadherin-mediated adhesion is α-
catenin (Ozawa et al, 1989).  
ctn subfamily to include p120ctn, p00071, δ-catenin and Armadillo repeat gene deleted 
in velocardiofacial syndrome (ARVCF) (McCrea & Gu, 2010). These proteins all contain a 
central domain of Armadillo (Arm) repeats (β-catenin family has 12, Plakophilins and 
p120ctns
1.2.3.1 Beta-catenin 
 have nine) (Choi & Weis, 2005).  Each Arm repeat forms a helix so together the 
Arm domain forms a suprahelical structure containing a positively charged groove (Huber 
et al, 1997) which composes the cadherin binding site (Huber et al, 1997). This is also the 
binding site for several other proteins (Bienz, 2005; McCrea & Gu, 2010). The Arm domain 
is flanked by N- and C-terminal regions. Plakophilin proteins utilise the N-terminal region to 
interact with desmosomal cadherins rather than the Arm domain and several catenins can 
bind to multiple cadherins (Calkins et al, 2003; Hatzfeld et al, 2003; Kanno et al, 2008). 
The function of catenins is largely to provide indirect linkage of cadherins with the 
underlying actin cytoskeleton at AJs (Hartsock & Nelson, 2008) and intermediate filaments 
at desmosomes (Garrod & Chidgey, 2008), although some catenins can regulate other 
process at cell-cell contacts or in the cytoplasm, as discussed below.  
Beta-catenin is implicated in two major cell-signalling processes. In addition to cadherin-
adhesion, β-catenin is a major player in the regulation of transcription in the canonical 
Wingless-Integrated (Wnt) signalling pathway involved in many aspects of embryogenesis 
(Clevers, 2006). Interplay between these two pathways coordinated by β-catenin is crucial 
for regulated proliferation and gene transcription during development. This is exemplified 
by the loss of cell adhesion and deregulation of Wnt target genes in the development of 
cancer (Brembeck et al, 2006). Ablation of β-catenin in developing embryos is embryonic 
lethal.  However, phenotypes given by conditional knockout of β-catenin are due to 
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perturbation of Wnt signalling as in cell-cell adhesion-dependent processes loss of β-
catenin is compensated for by upregulation of plakoglobin (Stepniak et al, 2009). 
Structurally, the Arm domain of β-catenin is approximately 520 amino acids, with flanking 
N- and C-terminal regions of 150 and 100 amino acids, respectively (Aberle et al, 1996). 
The interaction of β-catenin and E-cadherin utilises the whole of the Arm domain and 
involves several direct binding interactions (Aberle et al, 1994; Shapiro & Weis, 2009; Yap 
et al, 1998).  E-cadherin and β-catenin bind in the endoplasmic reticulum (ER) and traffic 
to the cell surface together (Hinck et al, 1994). The binding of β-catenin to E-cadherin 
serves to prevent proteasomal degradation of E-cadherin (Chen et al, 1999) by blocking a 
peptide sequence rich in Proline (P), Glutamic acid (E), Serine (S) and Threonine (T) 
(PEST) proteolytic signal located in the E-cadherin cytoplasmic tail (Huber et al, 2001). 
Phosphorylation of E-cadherin enhances the interaction with β-catenin (Choi et al, 2006), 
and cell-cell adhesion is lost when this phosphorylation is perturbed (Lickert et al, 2000). 
Additionally, phosphorylation of β-catenin at cell-cell contacts can be detrimental for 
adhesion (Daniel & Reynolds, 1997; Lilien & Balsamo, 2005; Roura et al, 1999; Wheelock 
& Johnson, 2003). The N-terminal domain of β-catenin binds to α-catenin (Pokutta & Weis, 
2000), which serves to indirectly link cadherins to the actin cytoskeleton. The implications 
of this interaction are discussed below.  
1.2.3.2 p120
Another member of the catenin family, p120
ctn 
ctn has been implicated in a variety of 
junctional and extra-junctional processes (Anastasiadis & Reynolds, 2000; Shapiro & 
Weis, 2009). Like β-catenin, p120ctn can also shuttle to the nucleus where it displaces the 
transcriptional repressor Kaiso (Daniel, 2007). It can also co-operate with β-catenin in 
transcriptional regulation of Wnt signalling (Kim et al, 2004; Park et al, 2005; Park et al, 
2006). At junctions, p120ctn binding to E-cadherin (Hinck et al, 1994) inhibits E-cadherin 
endocytosis, leading to E-cadherin stabilisation (see below) (Bryant & Stow, 2004; Davis et 
al, 2003; Ireton et al, 2002; Kowalczyk & Reynolds, 2004; Reynolds & Carnahan, 2004; 
Xiao et al, 2003; Xiao et al, 2005; Xiao et al, 2007). Lateral clustering of cadherins is 
thought to be mediated in part by p120ctn, as the juxtamembrane region of cadherin can 
cluster independently of the ectodomain or β-catenin binding region (Yap et al, 1998). This 
may be due to its role in stabilizing E-cadherin (Ishiyama et al, 2010) or by regulating the 
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actin cytoskeleton via regulation of Rho family GTPase activation (discussed below) 
(Anastasiadis, 2007).  
In addition to actin modulation, p120ctn is able to bind to tubulin (Franz & Ridley, 2004; Ichii 
& Takeichi, 2007; Roczniak-Ferguson & Reynolds, 2003; Yanagisawa et al, 2004) and 
modulate microtubule stability and dynamics. Moreover p120ctn can bind to kinesin, a plus-
end microtubule motor protein, and affect the targeting of N-cadherin to the cell periphery 
(Chen et al, 2003; Yanagisawa et al, 2004). One role of p120ctn in this context is to 
participate in microtubule plus-end capture at AJs (Bellett et al, 2009). Complementing this 
function, p120ctn can also bind to proteins at the minus-end of microtubules and contribute 
to AJ organisation and minus-end capture (Ichii & Takeichi, 2007; Meng & Takeichi, 2009).  
These diverse roles place p120ctn
1.2.3.3 Alpha-catenin 
 at the center of the regulation of AJ homeostasis. 
Structurally unrelated to the other catenin proteins, α-catenin is a homologue of the actin-
binding protein vinculin (Herrenknecht et al, 1991; Nagafuchi et al, 1991). Alpha-catenin is 
900 amino acids long and composed of three distinct domains, the dimerisation/ β-catenin 
binding domain (Vinculin Homology (VH) domain 1 (VH1)), the M-domain (VH2) and the 
actin-binding domain (VH3) (Rüdiger, 1998; Yang et al, 2001). In addition to actin, several 
proteins are thought to associate with α-catenin (Kobielak & Fuchs, 2004).  
Alpha-catenin can exist in a monomeric form, as a homodimer or as a heterodimer with β-
catenin (Koslov et al, 1997; Pokutta & Weis, 2000). Dimerisation occurs via residues 55-
264 in the N-terminal region (Pokutta & Weis, 2000). In cell lysates monomeric α-catenin is 
thought to be the dominant form, although homo- and heterodimers do exist (Drees et al, 
2005). When α- and β-catenin are mixed (in vitro) heterodimers prevail (Koslov et al, 
1997). This is thought to be due to the increased binding interface of the hetero- compared 
to the homo-interaction (Pokutta & Weis, 2000; Shapiro & Weis, 2009). 
The central M-domain portion of α-catenin consists of two helical bundles in a flexible 
configuration (Pokutta et al, 2002; Yang et al, 2001). The M-domain binds to the actin-
binding protein I-afadin and also to vinculin (Takai et al, 2008; Weiss et al, 1998). Vinculin 
binding is only possible when α-catenin is under tension which unmasks the vinculin 
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binding site (Yonemura et al, 2010).  This suggests α-catenin participates in tension-
sensing mechanisms in cell-cell adhesion (Yonemura et al, 2010).  
Direct interactions of α-catenin with filamentous (F)-actin can also occur via the actin-
binding domain of α-catenin. Actin-binding is constitutive and requires the C-terminal 
region of α-catenin (Bakolitsa et al, 1999; Pokutta et al, 2002). Monomeric α-catenin binds 
more strongly to F-actin than the homodimer (Drees et al, 2005), whilst interaction with β-
catenin abolishes α-catenin-F-actin interaction (Abe & Takeichi, 2008; Yamada et al, 
2005). The significance of the α-catenin-F-actin relationship is seen in depletion studies. 
Loss of α-catenin leads to loss of cell-cell adhesion, but also to a migratory phenotype 
(Vasioukhin et al, 2001). Moreover, α-catenin is not required to stabilise immobile E-
cadherin at the AJ, rather to ensure dynamic mobility of a mobile fraction of E-cadherin 
during clustering (Cavey et al, 2008).  
1.2.4 Regulation of E-cadherin turnover 
Once trafficked to the surface upon biosynthesis, E-cadherin turnover is regulated by a 
number of processes that drive its internalisation and recycling back to the plasma 
membrane (Niessen et al, 2011). These include both clathrin-mediated endocytosis which 
can occur in confluent epithelial cells (Chiasson et al, 2009; Ivanov et al, 2004; Izumi et al, 
2004; Le et al, 1999) and clathrin-independent mechanisms in sub-confluent cultures 
(Akhtar & Hotchin, 2001; Paterson et al, 2003).  
p120ctn seems to be a major player in the regulation of E-cadherin internalisation and 
targeting for degradation. Indeed, phosphorylation of N-terminal Ser/Thr residues of 
p120ctn upon E-cadherin ligation stabilises cell-cell adhesions (Petrova et al, 2012). 
Interaction with p120ctn blocks a dileucine motif on E-cadherin, conserved acidic residues 
and tyrosine residues that are required for clathrin-mediated endocytosis and binding of 
the E3 ubiquitin-ligase Cbl-like protein Hakai, respectively. Hakai ubiquitinates the E-
cadherin tail (Fujita et al, 2002). p120ctn binding thus prevents both the lysosomal 
degradation of E-cadherin and targeting for proteasomal degradation and is necessary for 
the stability of E-cadherin on the cell surface (Davis et al, 2003; Hong et al, 2010; Ishiyama 
et al, 2010; Ireton et al, 2002; Miyashita & Ozawa, 2007; Nanes et al, 2012; Xiao et al, 
2003; Xiao et al, 2005). 
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1.2.5 Cytoskeletal contribution to AJs 
1.2.5.1 Functional implications of cadherin-F-actin interplay 
AJs function in fundamental morphogenesis events that require the dynamic 
rearrangement of cellular architecture via remodelling of the cytoskeleton (Gumbiner, 
1996). Sites of cadherin adhesion were initially identified to associate with thin bundle 
structures (Hirano et al, 1987).  Functionally, F-actin is required for AJ structural integrity 
as disassembly of F-actin with drug treatment disrupts cell-cell adhesion (Angres et al, 
1996; Jaffe et al, 1990). During the establishment of cadherin-based adhesion, branched 
F-actin coalesces with cadherin-catenin puncta to form a detergent-insoluble pool of E-
cadherin (Adams et al, 1996; Adams et al, 1998; Ayalon et al, 1994). Therefore, structural 
organisation and the dynamics of F-actin are central to AJ architecture. 
There are several distinct pools of F-actin associated with AJs: cortical actin bundles 
underlying the AJ region and a less well characterised pool of F-actin that is found in the 
locale of the cytoplasmic face of the cell membrane in the vicinity of the cadherin-catenin 
complex (Scott et al, 2006; Yonemura et al, 1995; Zhang et al, 2005). F-actin at junctions 
is dynamic as demonstrated by fluorescence recovery after photobleaching (Kovacs et al, 
2002b; Yamada et al, 2005) and the separate pools of F-actin have distinct dynamic 
properties (Fig. 1.5) (Yonemura et al, 1995; Zhang et al, 2005). Moreover, as 
demonstrated in Drosophila, the functionally distinct F-actin populations can stabilise 
immobile cadherin, but can also regulate the dynamics of mobile cadherin leading to 
clustering of cadherin (Cavey et al, 2008) and strengthen newly forming junctions by 
promoting cis ectodomain interactions (Angres et al, 1996; Harrison et al, 2011; Yap et al, 
1997; Yap et al, 1998).  This process is also catenin-dependent (Hong 2010).  
Functionally, coupling of cadherins with the cytoskeleton is thought to act as a 
mechanotransduction mechanism, for example in morphogenic processes such as apical 
constriction in the gastrulating embryo (Martin et al, 2009). Other studies have shown a 
requirement for an intact cytoskeleton and cadherin-actin coupling in order to transmit 
tensional forces at cell-cell adhesions (Ladoux et al, 2010; le Duc et al, 2010; Liu et al, 
2010). Evidence using a novel intramolecular stress sensor, confirms the cadherin-actin 
interaction as a force transducer (Borghi et al, 2012). This interaction serves to both 
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mechanically couple sheets of epithelial cells and to sense changes in extracellular forces 
which drive appropriate signalling responses during morphogenic events. 
1.2.5.2 Cadherin signalling to the cytoskeleton 
Cadherin engagement directly influences the dynamics of F-actin at AJs. Trans-interaction 
of cadherins triggers the recruitment of F-actin to the sites of adhesion (Braga et al, 1997; 
Hara et al, 2004; Helwani et al, 2004; Kovacs et al, 2002b; Lambert et al, 2002). Cadherins 
can actively direct F-actin remodelling and cadherin adhesions are sites of actin nucleation 
and polymerisation (Braga et al, 1997; Kovacs et al, 2002b; Vasioukhin et al, 2000; Verma 
et al, 2004; Yamada et al, 2005). 
 
 
 
Figure 1.5 Two populations of F-actin at cell-cell contacts. As epithelial cells establish de novo 
adherens junctions two spatially and distinct populations of F-actin are observed. The micrograph 
shows a cell-cell contact region in primary human keratinocytes after 30 minutes junction initiation. 
Full arrow and line arrow show peri-junctional thin bundles of F-actin and a distinct population of F-
actin that colocalises with E-cadherin at the junction, respectively. E-cadherin is pink. As junctions 
mature the two populations of F-actin coelese at junctions and become indistinct. 
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The Actin-related protein-2/3 (Arp2/3) complex is an actin nucleator that promotes 
polymerisation of G-actin into branched networks of filamentous actin (Goley & Welch, 
2006). Arp2/3 binds to E-cadherin at AJs (Kovacs et al, 2002b; Kovacs et al, 2011) and 
regulates the junctional cytoskeleton (Bernadskaya et al, 2011; Verma et al, 2004). At AJs, 
the branching of actin networks promotes lamellipodial protrusions which contact between 
neighbouring cells (Vasioukhin et al, 2000).  The intrinsic nucleation activity of the Arp2/3 
complex is slow, but once nucleation has occurred polymerisation proceeds rapidly (Higgs 
& Pollard, 1999).  Nucleation promoting factors serve to activate the nucleation process 
and govern regulation of actin polymerisation in a context-dependent manner (Insall & 
Machesky, 2009). The nucleation promoting factors of the Wiskott-Aldrich syndrome 
protein (WASP) / WASP-family verprolin-homologous protein (WAVE) family of proteins 
are localised to junctions, where they are able to regulate cytoskeletal dynamics (Ivanov et 
al, 2005a; Kovacs et al, 2011; Yamazaki et al, 2007).  A second nucleation factor, Formin-
1, which facilitates polymerisation of actin filaments from the barbed end, has been found 
at junctions (Kobielak & Fuchs, 2004; Sahai & Marshall, 2002), so too has another Formin 
family member, mammalian Diaphanous (mDia), a member of the Diaphanous-related 
formin (DRF) family (Carramusa et al, 2007). The specificity of F-actin structures at AJs is 
thought to be dependent on the type of activators present at the junctions, which in turn is 
influenced by upstream regulatory processes.  
The contribution of the cadherin-catenin complex and F-actin to epithelial biogenesis is 
summarised in (Fig. 1.6). Initiation of cell-cell contacts is mediated by the collision of actin-
rich, cadherin-containing lamellipodia or protrusions on adjacent cells (Adams et al, 1996; 
Vasioukhin et al, 2000). Trans-dimerisation of cadherin occurs, leading to the local 
formation of cadherin puncta (Adams et al, 1996; Adams et al, 1998). Accumulation of α-
catenin leads to homodimerisation and F-actin binding in the vicinity of the nascent 
contacts. Via inhibition of Arp2/3-mediated nucleation of actin into branched networks, α-
catenin promotes the formation of actin cables to extend the newly forming contact (Drees 
et al, 2005; Yamada et al, 2005). Perhaps this is achieved directly as α-catenin is able to 
bundle F-actin (Rimm et al, 1995), or indirectly via proteins such as Formin-1 which can 
promote actin cable assembly and is known to be regulated by α-catenin (Kobielak & 
Fuchs, 2004). Regulation of dynamic F-actin rearrangements leads to the contraction of 
cortical bundles and the lateral clustering of cadherin puncta to build the functional AJ. The 
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Figure 1.6 Remodelling of F-actin during de novo adherens junction assembly. During cell-
cell contact assembly F-actin is remodelled. i) Initial membrane contacts are made by actin-rich 
protrusions containing membrane bound cadherins. ii) Trans-interactions are made between 
cadherin molecules on adjacent cells and contacts are expanded laterally by branched actin 
networks to increase the local density of cadherin. iii) This drives the accumulation of α-catenin 
(not shown) which at a certain concentration threshold is thought to homodimerise and bind to F-
actin. iv)The Arp2/3 complex (not shown) is displaced to inhibit formation of branched F-actin 
networks and promote assembly into F-actin contractile cables. v) Contraction of the actin bundles 
drives clustering of the interacting cadherin-catenin complexes and strengthens the newly formed 
adherens junction. 
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regulatory signal transduction pathways linking cadherins and the cytoskeleton are not 
fully understood. However, the Rho (Ras (Rat sarcoma) homologous) family of small 
GTPases has been identified as key regulators of F-actin dynamics in both steady-state 
AJs and in the establishment of cell-cell contacts. 
1.3 Regulation of the cytoskeleton by Rho GTPases 
1.3.1 Rho GTPases: Members of the Ras superfamily of Small GTPases 
Rho GTPases are members of the Ras superfamily of small GTPases (Macara et al, 
1996). The Ras superfamily of proteins are key regulators of intracellular signalling and are 
separated into five distinct groups (Ras, Rho, Rab, Arf and Ran) based on their sequence 
homologies (Bourne et al, 1991).  Ras-family GTPases contain a guanine nucleotide 
binding site.  The main regulatory domains are switch 1 and switch 2 and the P-loop 
(Sprang, 1997). Interactions of the GTPase with a guanine nucleotide, coordinated with 
Mg2+, are contributed to from these three regulatory regions. Phenylalanine at position 28 
(Phe28) in switch 1 stabilises binding of the guanine nucleotide. The P-loop interacts with 
the α- and β-phosphates, while the switch 2 region interacts with the γ-phosphate and 
provides part of the Mg2+ binding pocket along with the switch 2 region. The Mg2+ 
Rho proteins have around 30% sequence similarity to Ras proteins (Hall, 1990) and most 
are widely expressed (Hall, 1994). Rho was first discovered in the sea slug, Aplysia 
(Madaule & Axel, 1985). The mammalian Rho family of GTPases is now known to consist 
of 20 members sub-divided into smaller subgroups - The typical Rho GTPases: Rho 
(RhoA, RhoB and RhoC), Rac (Rac1, Rac2, Rac3 and RhoG), Cdc42 (Cdc42, TCL/RhoJ, 
TC10/RhoQ, Wrch1/RhoU, Chp/Wrch2/RhoV) and Rnd (Rnd1, Rnd2, Rnd3/RhoE, RhoD, 
stabilises 
the conformation of the nucleotide binding pocket. Energy is provided by guanosine 
triphosphate (GTP) binding which promotes conformational changes in the switch regions 
to allow effector protein binding. Upon GTP hydrolysis to guanosine diphosphate GDP, the 
interactions are disrupted and the GTPase dissociates from its effector. Thus, the ability to 
exist in either a (GDP)-bound inactive or a GTP-bound active conformation means that 
Ras family GTPases act as molecular switches within the cell. The GDP to GTP switch is 
modulated by upstream signalling and Rho family GTPases are responsible for 
transducing signals from extracellular cues to drive cellular responses (Sprang, 1997).  
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RhoF/Rif) families; and the atypical Rho-related BTB domain containing proteins 
(RhoBTB) (RhoBTB1, RhoBTB2, RhoH/TFF) which are structurally distinct and have 
different functions to the typical Rho GTPases (Burridge & Wennerberg, 2004; Bustelo et 
al, 2007).   
Newly synthesised Rho proteins undergo lipid modification in order to be correctly targeted 
to the plasma membrane (Seabra, 1998). A C-terminal CAAX motif is prenylated by the 
Geranylgeranyl Transferase – 1 (GGTase-1) enzyme, the AAX is cleaved and the C-
terminal prenylated Cysteine is further methylated.  Lipid modified proteins are then 
trafficked to the plasma membrane (Seabra, 1998). 
1.3.2 Molecular mechanisms of Rho GTPases signalling 
1.3.2.1 Rho GTPase-driven Actin-independent cellular processes 
Rho GTPases participate in a wide variety of cellular processes that mainly require 
remodelling of the actin cytoskeleton in response to external cues (Etienne-Manneville & 
Hall, 2002). The most well characterised family members are Rho, Rac and Cdc42.  These 
proteins (and other Rho GTPases) are also able to regulate actin-independent processes. 
For example, during cell cycle progression Rho, Rac and Cdc42 modulate the expression 
of cyclin D1 and cyclin E, activators of cyclin dependent kinases (Cdk), the key cell cycle 
proteins (Chou et al, 2003; Joyce et al, 1999; Mettouchi et al, 2001; Welsh et al, 2001). 
These Rho GTPases also modulate the antagonistic Cdk regulators, the Cdk inhibitors 
p21cip1 and p27kip1 
Rho, Rac and Cdc42 can also regulate gene transcription by activating upstream 
regulators of transcription c-Jun N-terminal Kinase (JNK) and p38 Mitogen-activated 
protein kinase (MAPK) signalling (Coso et al, 1995; Minden et al, 1995), and the 
transcription factors of the nuclear factor kappa-light-chain-enhancer of activated B cells 
(NFκB) family (Perona et al, 1997), and the serum response factor (SRF) (Hill et al, 1995). 
They are important activators of enzymes such as those for lipid metabolism and reactive 
oxygen species production (Jaffe & Hall, 2005). Finally, Rho, Rac and Cdc42 also 
modulate microtubule dynamics (Raftopoulou & Hall, 2004). Rho can stabilise 
microtubules, whereas Rac promotes elongation and, during cell division, Cdc42 regulates 
(Hu et al, 1999; Olson et al, 1998; Vidal et al, 2002; Weber et al, 1997), 
which demonstrates the role of Rho GTPases in fine tuning cell cycle progression.  
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the microtubule cytoskeleton to enable proper spindle orientation and chromosome 
alignment (Etienne-Manneville & Hall, 2002; Raftopoulou & Hall, 2004).  
All three proteins (Rho, Rac and Cdc42) are regulators of endocytic and exocytic 
trafficking events. Cdc42 and N-WASP play a role in Golgi to ER trafficking by modulating 
the branched actin network associated with vesicles (Luna et al, 2002). Cdc42 localises to 
the Golgi (Erickson et al, 1996; Matas et al, 2004), and inhibition of microtubule-dependent 
transport is achieved through the association of Cdc42 with the Golgi vesicle coat protein 
coatamer, which blocks the associated of Dynein, a microtubule-motor protein, with 
vesicles (Chen et al, 2005b). Cdc42 is also implicated in secretory granule exocytosis 
(Malacombe et al, 2006). Rho and Rac on the other hand have roles in both clathrin-
mediated and clathrin-independent endocytosis (Ellis & Mellor, 2000; Qualmann & Mellor, 
2003).  
1.3.2.2 Actin remodelling by Rho, Rac and Cdc42 
Processes such as the generation of cell morphology and migratory movement, which are 
mediated chiefly by regulation of F-actin polymerisation and organisation, are governed by 
co-ordination of the Rho GTPases (Etienne-Manneville & Hall, 2002). Early studies 
revealed that Rho, Rac and Cdc42 differentially affect the actin cytoskeleton to promote 
distinct actin-based structures. Activation of Rho drives focal adhesion formation and 
stress fiber formation in fibroblasts (Ridley & Hall, 1992), whilst Rac activation induces 
actin-rich lamelllipodia (Ridley et al, 1992).  Cdc42 activity leads to actin-rich filopodial 
protrusions (Kozma et al, 1995; Nobes & Hall, 1995). How activation of the three proteins 
drives distinct organisation of F-actin depends on the subset of downstream signalling 
pathways employed to nucleate, polymerise and re-model F-actin. Over 50 downstream 
targets (effector proteins) have been described for Rho, Rac and Cdc42, which highlights 
the complexity of Rho-mediated signalling (Bishop & Hall, 2000; Hall 2012). 
Activation of Rho leads to stress fiber formation via a number of mechanisms. First, Rho 
promotes stress fiber formation by inducing intrinsic tension within the cell, by activating 
myosin II, leading to contraction (Chrzanowska-Wodnicka & Burridge, 1996). Activated 
Rho can bind and activate one of its effector proteins, Rho-kinase (ROCK), which 
phosphorylates myosin light chain phosphatase (Kimura et al, 1996; Riento & Ridley, 
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2003).  This permits phosphorylation of the light chain of myosin II (MLC) leading to 
contraction of acto-myosin filaments.  ROCK can also directly phosphorylate MLC (Amano 
et al, 1996).  Secondly, ROCK is also able to phosphorylate an actin-binding kinase, LIN-
11, ISL-1 and MEC-3 (LIM)-Kinase, which is able to bind and inactivate cofilin (Maekawa 
et al, 1999). Cofilin is an actin deploymerising protein, so inactivation of cofilin promotes 
the stabilisation of actin filaments (Maekawa et al, 1999). Thirdly, active Rho is able to bind 
to the actin nucleation factor mDia (Li & Higgs, 2003). In Rho deficient cells mDia is able to 
rescue the formation of stress fibers (Riveline et al, 2001). Together, these mechanisms 
allow Rho activation to generate stress fibers, at least in fibroblasts.  
Rac and Cdc42 can influence cytoskeletal reorganisation via several signalling pathways. 
First, Rac and Cdc42 govern activation of the actin nucleating complex Arp2/3 via the 
WASP family proteins (WAVE and N-WASP respectively) (Goley & Welch, 2006; 
Machesky & Insall, 1998; Miki et al, 1998). Although activated Cdc42 can bind directly to 
N-WASP, in cells, N-WASP binds to WIP (WAS/WASL-interacting protein) which blocks 
Cdc42-mediated N-WASP activation (Ho et al, 2001; Martinez-Quiles et al, 2001). Cdc42 
activates the N-WASP/WIP complex via Transducer of Cdc42-dependent actin assembly 
(Toca-1) (Ho et al, 2004).   Rac indirectly associates with WAVE via a number of 
intermediary proteins (Eden et al, 2002; Innocenti et al, 2005). This complex of proteins 
binds and inhibits WAVE and is thought to be disassembled by Rac activation (Eden et al, 
2002). Rac and Cdc42 are also able to activate the p21-activated kinases (PAKs), which in 
turn can phosphorylate LIM-Kinase to modulate stabilisation of acto-myosin filaments 
(Edwards et al, 1999). Alternatively, Cdc42 can also regulate the assembly of actin into 
bundles, in structures such as filopodia, via the DRF proteins (Peng et al, 2003; 
Schirenbeck et al, 2005).The modulation of the same (or similar) pathway components, 
such as LIM-Kinase activity or Formins, by Rac, Cdc42 and Rho is an example of how 
small GTPase signalling pathways interact and mediate crosstalk between the multiple 
systems. 
1.3.2.3 Actin-dependent cellular functions of Rho, Rac and Cdc42 
RhoA is a key regulator of cytokinesis (Piekny et al, 2005). RhoA and its effectors ROCK, 
citron kinase and mDia are all located at the cleavage furrow (Glotzer, 2001). RhoA is 
associated with the contractile acto-myosin ring at the cleavage furrow and mediates MLC 
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phosphorylation via citron kinase and ROCK (Di Cunto et al, 2000; Kosako et al, 2000; 
Madaule et al, 1998; Yamashiro et al, 2003) in various cell types.  
Several aspects of cell shape and movement are governed by Rho, Rac and Cdc42 (as 
well as by other members of the Rho protein family). The polarised morphologies of 
specialised cells such as apical-basal polarity of epithelial cells and axon/dendrite 
morphology of neurons is controlled by Cdc42 and the polarity complex proteins 
Partitioning defective (Par) -3 and Par6 and atypical protein kinase C (PKC) (Etienne-
Manneville, 2004; Joberty et al, 2000; Lin et al, 2000), Rho and Rac (Etienne-Manneville & 
Hall, 2002). Apical-baso polarity in epithelial cells is guided by both the sensing of the 
basal lamina by integrins, which involves Rac (O'Brien et al, 2001), and the correct 
positioning of polarity complex proteins, which involves Cdc42 (Martin-Belmonte et al, 
2007). Rho, Rac and Cdc42 coordinate to form neurons via spatially restricted antagonist 
processes, whereby Rho inhibits neurite extension, whilst Rac and Cdc42 promote neurite 
outgrowth (Luo, 2002).   
Spatially-restricted Rho GTPase activity is also key to directed cell migration, which is 
governed by the activity of Rho, Rac and Cdc42. It is well established that Rac-mediated 
actin polymerisation and elongation at the front of the cell, coupled with cytoskeletal 
filament contraction at the rear, provides the driving force for directional cell migration 
(Raftopoulou & Hall, 2004).  Active Rac accumulates at the leading edge of the cell in 
response to chemotactic signals and Phosphoinositide 3-Kinase (PI3K)-mediated 
phospholipid generation (Gardiner et al, 2002; Itoh et al, 2002; Kraynov et al, 2000). Rac 
drives WAVE-mediated Arp2/3 induction of branched-actin networks that push the cell 
forwards in lamellipodia-type structures (Raftopoulou & Hall, 2004). Cdc42 acts to 
orientate the localised Rac signalling in order to maintain directed migration in response to 
the external cue (Allen et al, 1998; Etienne-Manneville & Hall, 2002). In the rear of the cell, 
Rho activation generates contractile forces via ROCK-mediated myosin II phosphorylation 
to allow the cell to move forward (Riento & Ridley, 2003). The spatio-temporal separation 
of Rho and Rac activities demonstrates a requirement for tight, regulated upstream control 
of Rho GTPase activation.  
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1.4 Regulation of Rho GTPase activation 
Rho GTPases are poor catalysts for GTP hydrolysis as the GTP•Mg2+ 
1.4.1 Regulation of Rho protein activation by post-translational modification 
interaction is 
relatively stable (Sprang, 1997). A number of upstream regulators act to facilitate rapid 
GTP hydrolysis and to regulate the active and inactive state of Rho GTPases (Fig.1.7). 
Rho protein activation state can also be regulated by a number of post-translational 
modifications which act to regulate Rho protein localisation, biochemical function and 
expression levels (de la Vega 2011, Boulter et al, 2012). 
Post-translational modifications of Rho proteins can determine where and when the Rho 
proteins are available for activation, for example regulation of localisation can be achieved 
by modifying the phosphorylation state of some Rho proteins (Boulter et al, 2012). RhoA 
can be phosphorylated by PK (protein kinase) A, PKG and SLK (Ste20-like kinase) in 
response to physiological stimuli, on Ser188 which is located between the regions in the 
C-terminus required for interaction with lipid membranes (Lang et al, 1996; Sauzeau et al, 
2000; Savoia et al, 2005; Ellerbroek et al, 2003). Phosphorylation of this residue leads to a 
reduced interaction of RhoA with the plasma membrane (Ellerbroek et al, 2003), yet an 
enhanced affinity for RhoGDI (Lang et al, 1996). The mechanism for this, however, 
remains unclear. Cdc42 can also be phosphorylated on an analogous Serine residue to 
enhance its interaction with RhoGDI (Forget et al, 2002).  RhoG is another Rho protein 
that is phosphorylated at the same position, although the signalling consequence of this 
modification is not yet established (Ellerbroek et al, 2003). 
Additional regulation of Rho protein activation can be achieved through the regulation of 
their local protein levels.  This is chiefly mediated by ubiquinating and ubiquitin-like 
proteins (de la Vega et al, 2011; Boulter et al, 2012). Inactive RhoA can be targeted for 
degradation after interaction with the ubiquitin E3 ligase Smurf1 (SMAD ubiquitin 
regulatory factor 1) which reduces levels of active RhoA at the leading edge of migrating 
cells (Wang et al, 2003; Crose et al, 2009) and in neurites of developing neurons (Cheng 
et al, 2011).  Similary, another E3 ligase CRLs (Cullin-RING E3 ligases) target inactive 
RhoA for proteasomal degradation in blunt end migrating cells (Chen et al, 2009).  The 
activated form of Rac1 can be polyubiquitinated and degraded (Visvikis et al, 2008), 
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however the binding of the SUMO (small ubiquitin-like modifier)-E3 ligase PIAS3 (protein 
inhibitor of activated STAT3), a ubiquitin-like protein to active Rac1 stabilises the protein 
and maintains active levels of Rac1 (Castillo-Lluva et al, 2010). This has been seen in 
response to HGF stimulation in epidermal cells (Castillo-Lluva et al, 2010). 
1.4.2 Rho GAPs and GDIs 
Rho GTPase activating proteins (GAPs) bind to GTP-bound Rho proteins and, by insertion 
of a conserved arginine residue into the catalytic site of the Rho GTPase, restricts a water 
molecule thus reducing the energy requirement needed for GTP hydrolysis. Overall, this 
speeds up the rate of GTP-hydrolysis resulting in the conformational change that drives 
effector dissociation, thus effectively switching off the Rho GTPase.  
Rho Guanine Dissociation Inhibitors (GDIs) regulate Rho GTPase activity by extracting the 
lipid-modified Rho proteins from lipid membranes and sequestering them in the cytosol 
(Olofsson, 1999). Rho proteins and GDIs exist in a 1:1 ratio within the cell, implying most 
Rho proteins exists in a GDI-mediated inactive state (DerMardirossian & Bokoch, 2005; 
Michaelson et al, 2001). Rho GDIs also bind to the switch 1 and switch 2 regions of Rho 
GTPases in both the GTP- and GDP-bound forms. These interactions block the binding of 
Rho guanine nucleotide exchange factors (GEFs), prevent GTP hydrolysis and block 
effector binding, serving to maintain the Rho GTPase in an inactive state. This mechanism 
provides several levels of intracellular regulation whereby promotion of GDI release serves 
to mobilise a specific pool of Rho protein upon a given stimulus (DerMardirossian & 
Bokoch, 2005). Dissociation of Rho GDI from Rho GTPase can be achieved via 
phosphorylation of either the Rho or GDI protein, or by interaction with lipids 
(DerMardirossian & Bokoch, 2005).    
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Figure 1.7 Regulation of Rho GTPases by Rho GEF proteins. Small GTPases (grey) are active 
when bound to GTP and are able to interact with their downstream effectors, but when GDP-bound 
they are inactive. These activation states are tightly governed by upstream regulator proteins. 
Guanine nucleotide exchange factors (GEF - red) bind to the GDP-bound GTPase, cause a 
conformational change which dissociates GDP and stabilises the nucleotide-free conformation 
allowing the binding of GTP which is at a higher concentration in the cytosol. The GTPase 
hydrolyses the GTP to GDP and inorganic phosphate (Pi) and can no longer exert its downstream 
effects. This intrinsic enzymatic activity is very slow and GTPase Activating Proteins (GAPs - blue) 
work to aid the process and thus govern the inactivation of the GTPase. Guanine Dissociation 
Inhibitors (GDIs – brown) work to sequester the GTPase in the nucleotide bound state thereby 
blocking the regulatory control of the GEFs and GAPs.   
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1.4.3 Rho GEFs 
Of the three classes of upstream regulator proteins, the GEFs are attractive candidates for 
facilitating spatio-temporal regulation of Rho GTPases.  Current thinking holds that Rho 
GEF proteins are important for mediating signalling from upstream extracellular stimuli to 
direct and contextualise the activity of the Rho GTPases. The Rho GEFs is a large family 
of 80 multi-domain proteins (Figs. 1.8 and 1.9) that can undergo a wide variety of protein-
protein interactions and several are able to target to lipid membranes (Cherfils & Zeghouf, 
2013; Cote & Vuori, 2007; Rossman et al, 2005). This allows GEFs to activate their 
cognate Rho GTPase/s in a spatially-regulated manner. The Rho GTPase substrate 
specificity of Rho GEFs ranges from widely promiscuous, giving versatility to the actions of 
a specific Rho GEF, to highly specific, allowing for activation of precise GEF-dependent 
signalling pathways.  
The same Rho GEF can be activated by multiple, distinct stimuli such as the Vav 
subfamily of GEFs (Fig. 1.8). Vav1 was identified as the sixth oncogene in the lab of 
Katzav and colleagues and thus designated as the sixth letter of the Hebrew alphabet 
(Katzav et al, 1989). They are downstream of many cell surface receptors including T-cell 
receptors (TCR), B-Cell receptors (BCR), growth factor receptors, cytokine receptors and 
chemokine receptors (Bustelo, 2000; Katzav, 2009; Turner & Billadeau, 2002; Tybulewicz, 
2005). This allows a small number of signalling pathways to be utilised in different 
situations. On the other hand, a number of distinct GEF proteins can be activated 
downstream of a single stimuli, such as Dedicator of cytokinesis (DOCK)180 (Fig. 1.9) and 
Triple function domain protein (Trio) (Fig. 1.8) activation by Muscle (M)-cadherin 
(Charrasse et al, 2007; Laurin et al, 2008), allowing temporal co-ordination of multiple 
signalling cascades. Furthermore, the activation of GEF proteins themselves is subject to 
upstream regulation and therefore enhances the specificity of signalling they provide 
(Cherfils & Zeghouf, 2013; Rossman et al, 2005; Schmidt & Hall, 2002). 
1.4.3.1 Two structurally distinct Rho GEF families 
The mammalian Rho GEFs are divided into two structurally distinct classes of Rho GEF 
proteins: 69 members of the Dbl (Diffuse in B-cell Lymphoma) family and 11 members of 
the DOCK family (Cote & Vuori, 2002; Meller et al, 2005; Rossman et al, 2005; Schmidt & 
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Figure 1.8 The Dbl family of GEFs. The Dbl homology (DH) domains of the 69 unique Dbl 
proteins in humans have been aligned to produce this phylogenetic tree. Dispersed around the tree 
branches are illustrations showing the domain composition and domain organization for each 
member. Black arrowheads above a guanine nucleotide-exchange factor (GEF) indicate 
truncations that are known to activate either the exchange activity or a related cellular function of 
the corresponding GEF. Black arrowheads with brackets delineate similarly active fragments. Red 
brackets indicate regions of Dbl proteins with known three-dimensional structures. The coloured 
spheres placed on the tree branches designate the reported Rho GTPase specificity of the 
corresponding Dbl-family member. Note that the specificity summary is not complete for all of the 
known human Rho GTPases, as the analyses for most Dbl-family proteins has been restricted 
primarily to RhoA, Rac1 and Cdc42. Furthermore, some Rho GTPases — for example, Rnd3/RhoE 
and TTF/RhoH — might be constitutively activated and not regulated by GEF activity. For 
descriptions of domain abbreviations and functions, the reader is referred to the text and the 
SMART website (www.smart.embl-heidelberg.de). Figure and legend reproduced from Rossman et 
al, 2005. 
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Hall, 2002a).  The two families differ considerably in their domain composition (Rossman 
et al, 2005). All Dbl family GEFs share the minimally required conserved DH (Dbl 
homology) and PH (Pleckstrin Homology) tandem domain (Eva et al, 1988; Hart et al, 
1991) necessary for GTPase binding and nucleotide exchange activity. In the DOCK 
family, these functions are conferred by the DHR (DOCK homology region)1 domain 
required for localisation and the DHR2 domain required for GTPase specificity and 
nucleotide exchange (Fig. 1.8 and 1.9).  
DOCK proteins are divided into four sub-families, DOCK-A to D, based on their sequence 
similarities (Fig. 1.9). In addition to the DHR1 and DHR2 domains, some family members 
also have a small number of protein-protein interaction domains. DOCK-A and B proteins 
have N-terminal SH3 (Sarcoma (Src) homology 3) domains and a proline-rich C-terminus, 
and DOCK-D proteins have an N-terminal PH domain, whilst the DOCK-C subfamily does 
not possess additional protein-protein interaction domains (Fig. 1.9) (Cote & Vuori, 2002). 
 
 
Figure 1.9 DOCK family GEFs. DOCK180 is the prototypical member of the DOCK family, which 
is sub-divided into 4 structurally divergent subfamilies DOCK-A to D. In addition to the DHR1 and 
DHR2 domains, DOCK-A and DOCK-B subfamilies have an N-terminal SH3 domain and a proline 
rich C-terminus, DOCK-D members contain a PH domain N-terminal to the DHR1 region, whilst 
DOCK-C proteins do not have any further specific domains (Cote & Vuori, 2007).   
Natalie Welsh   PhD Thesis  
  54 
In contrast, of the much larger Dbl family GEFs, the majority possess at least one other 
structured domain (Fig. 1.8) from a wide variety of protein-protein and protein-lipid 
interaction domains (Rossman et al, 2005). These include domains such as Coiled coils, 
SH3 domains, EH (Epidermal growth factor receptor pathway substrate 15 (Eps15) 
homology) motifs and PDZ (Post-synaptic density-90, Discs large, ZO1/2) domains, as 
well as domains that bind to tyrosine phosphorylated proteins such as BRCT (Breast 
cancer 1 (BRCA 1) C-Terminus domain) and SH2 (Src Homology 2) domains, and those 
that provide a link with the cytoskeleton such as CH (calponin homology), IQ (Calmodulin 
binding motif with conserved Ile and Gln) myosin binding domain and FERM (4.1 protein, 
Ezrin, Radixin and Moesin) domains (Fig.  1.8). The variety of different binding interactions 
signifies a role for Rho GEF proteins in many different signal transduction pathways.  
Many Rho GEFs have additional protein-lipid interaction domains which target them to 
specific membrane sites. These include BAR (Bin Amphiphysin Rvs) domains, C2 (PKC 
conserved region 2) calcium-dependent domains, DEP (Dishevelled, Egl-10, Pleckstrin) 
domains, FYVE (Fab1, YOTB, Vac1, EEA1) lipid-binding motifs and SEC14 lipid binding 
regions. These domains demonstrate that Rho GEF proteins can be spatially restricted 
within the cell (Rossman et al, 2005; Schmidt & Hall, 2002).  
A handful of Rho GEFs possess other functional domains in addition to the Rho GEF (DH-
PH/DHR2) domains, such as Ras GEF and Ran GEF domains, Rho GAP activity, 
regulator of G-protein signalling (RGS) domains to integrate G-protein coupled receptor 
(GPCR) activity with Rho signalling, and Ser/Thr Kinase domains. The domain 
composition of Rho GEF proteins can therefore enable integration of multiple signalling 
pathways, acting as nodes in larger signalling networks.  
Some domain structures, such as coiled coil regions, are found in many Rho GEFs, whilst 
others, such as FYVE motifs, are confined to a subset of closely related Rho GEFs (Fig. 
1.8). The variety within Rho GEF amino acid sequences indicates the divergent evolution 
of these proteins which enables them to participate in many distinct signal transduction 
pathways.  
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1.4.3.2 Mechanisms of nucleotide exchange   
Although the two protein families are quite different in their structures, the mechanism of 
nucleotide exchange is conceptually conserved. Crystal studies reveal that the DH domain 
mediates exchange activity in Dbl GEFs (Worthylake et al, 2000).  This ~300 amino acid 
domain consists of three conserved helical regions (CR1, CR2 and CR3). Together these 
comprise the GTPase interacting interface. Conserved residues in the CR1 and 3 regions 
bind to the switch 1 region of the Rho GTPase inducing a conformational change which 
disrupts the binding of the guanine nucleotide and co-ordinating binding pocket (Hart et al, 
1991). The CR3, along with contribution from the DH domain C-terminus α6 helix, 
sterically occludes the Mg2+ 
Nucleotide exchange is mediated by the DHR2 domain in DOCK proteins (Cote & Vuori, 
2002; Cote & Vuori, 2007). The mechanism has only recently been uncovered in studies 
using the DHR2 regions of GEFs with specificity for Cdc42 or Rac. Crystallographic data 
has been derived from the DHR2 of a Cdc42-specific GEF DOCK9 (DOCK9-DHR2) in 
complex with Cdc42 (Yang et al, 2009) and the Rac-specific GEF DOCK2 (DOCK2-DHR2) 
with Rac (Kulkarni et al, 2011), whilst biochemical data comes from interaction studies of 
the Rac-specific GEF DOCK180-DHR2 c-domain (DHR2c) with Rac (Wu et al, 2011b).  
These data show that three lobe regions (A, B and C) of the DHR2 domain contribute to 
nucleotide exchange (Yang et al, 2009).  Lobes B and C are catalytically active, whilst lobe 
A serves to stabilise the DHR2 conformation.  Lobes B and C bind to the GTPase switch 1 
domain. This causes a shift in switch 1, leading to a subsequent disruption of nucleotide 
binding. The α10 helix protrudes into the nucleotide binding site and at the same time a 
conserved Valine residue of the α10 helix excludes the Mg
binding site and stabilise the nucleotide-free binding pocket of 
the Rho GTPase (Hart et al, 1991). During this process a Cysteine residue on the P-loop 
of the Rho GTPase is moved so it can no longer interact with the α-phosphate of the 
bound guanine nucleotide (Hart et al, 1991) (Fig. 1.10C).  
2+, independently of the switch 2 
region. In Cdc42, but not in Rac, the P-loop Cys18 is also moved disrupting its interaction 
with the guanine nucleotide (Kulkarni et al, 2011; Yang et al, 2009). Binding of GTP•Mg2+ 
induces conformation changes which lead to dissociation of the active GTPase with the 
DOCK GEF (Yang et al, 2009) (Fig. 10A, B and D).  
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1.4.3.3 Rho GEF GTPase substrate specificity 
The substrate specificity of Rho GEF proteins varies among the family members. Some 
GEFs, such as the Facio-genital dysplasia (FGD) family of GEFs, that are associated with 
mental retardation pathologies (Orrico et al, 2004; Pasteris et al, 1994), promote 
nucleotide exchange specifically on a single Rho protein: Cdc42 (Zheng et al, 1996). Other 
GEFs can activate Rho GTPases found in different subfamilies such as the Vav subset of 
 
 
 
 
 
 
 
 
Figure 1.10 Schematic of GEF catalytic reaction mechanisms. A) GDP bound to nucleotide-
binding site of Rho GTPase. Switch 1 and 2 and P-loop in red, purple and blue, respectively. B) 
DOCK9DHR2-mediated release of GDP occurs via motion of Cys18C and Phe28C, disrupting 
contacts to GDP, and exclusion of Mg2+ mediated by Val1951. C) Other GEFs (for example some 
Dbl GEFs) also promote shifts of Cys18C and Phe28C, but GEF-induced motion of switch 2 
causes Ala59C to sterically occlude Mg2+ and promotes a salt bridge between Lys16C and 
Glu62C. D) Binding of GTP•Mg2+ to DOCK9DHR2-Cdc42 promotes conformational changes that 
trigger discharge of the activated GTPase. Figure reproduced and legend modified from Yang et al. 
2009.  
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Dbl GEFs that can act as RhoA, Rac, RhoG and Cdc42 exchange factors (Rapley et al, 
2008; Turner & Billadeau, 2002).  Many Rho GEFs were originally identified with multiple 
GEF functions in vitro, however subsequent analysis shows that in a cellular context not all 
the in vitro substrates are activated in vivo.  Moreover, GTPase substrate specificity can 
be cell type-specific, or even stimuli-specific, for example, Dbl’s big sister (Dbs) displays 
RhoA specificity in National Institute of Health (NIH)3T3 mouse fibroblasts (Cheng et al, 
2002), but Cdc42 specificity in Schwann cells (Yamauchi et al, 2005). These mechanisms 
demonstrate the capacity for wide-ranging regulation of Rho proteins by their GEFs.  
How some Rho GEFs can interact with a specific Rho GTPase whilst others are more 
promiscuous is not well understood.  However, it is now known that the specificity of 
interaction of Dbl and DOCK family GEFs involves the amino acid residue at position 56 in 
the Rho GTPases. In Rac, residue 56 is a Tryptophan, whilst in Cdc42 it is Phenylalanine. 
For Dbl GEFs residue 56 is sufficient to determine the specific Rho GTPase–GEF 
interaction in some cases (Karnoub et al, 2001). Mutation of Tryptophan 56 to 
Phenylalanine (Trp56Phe) in Rac abolishes activation by the Rac GEF T-cell lymphoma 
invasion and metastasis (Tiam) 1 and confers activation by the Cdc42 GEF Intersectin-
long (ITSN-L; Karnoub et al, 2001).  However, in DOCK GEF-GTPase interactions  residue 
56 is necessary but not sufficient for GTPase-GEF specificity, as Trp56Phe mutation in 
Rac abolishes activation by the Rac GEFs DOCK180-DHR2c and DOCK2-DHR2 (Kulkarni 
et al, 2011; Wu et al, 2011b), but the Cdc42-specifc GEF DOCK9 can only weakly activate 
this mutant (Kulkarni et al, 2011). Furthermore, the reciprocal mutation in Cdc42, 
Phe56Trp, does not confer activation by the Rac GEF DOCK180-DHR2c, (Wu et al, 
2011b).  
For DOCK GEFs, residue 27 (Alanine in Rac and Lysine in Cdc42) is also important for 
Rho GTPase-GEF specificity (Kulkarni et al, 2011; Kwofie & Skowronski, 2008; Wu et al, 
2011b). DOCK2-DHR2 or DOCK180-DHR2c cannot activate Rac with an Alanine to Lysine 
substitution at position 27 (Ala27Lys) (Kulkarni et al, 2011; Wu et al, 2011b) and Rac2 
Ala27Lys cannot bind to DOCK2-DHR2 (Kwofie & Skowronski, 2008). However, mutation 
of Lysine residue 27 in Cdc42 to Alanine (Lys27Ala) does not render it susceptible to 
activation by the Rac GEF DOCK180-DHR2c or DOCK2-DHR2 (Kulkarni et al, 2011; Wu 
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et al, 2011b).  Together these studies reveal that both residues 27 and 56 of the Rho 
GTPase are important for defining Rho GEF GTPase binding specificity. 
Non-conserved residues in the Rho GEF proteins themselves also contribute to Rho 
GTPase-GEF interaction specificities. In Dbl GEFs mutations in residues in the seat back 
region of the DH domain can alter Rho GTPase specificity (Cheng et al, 2002; Snyder 
2002,). However, as much of the DHR2 region in DOCK proteins is non-conserved, efforts 
to date to establish specific residues that confer specificity have not been successful due 
to the likelihood that a number of residues may contribute (Kulkarni et al, 2011).  
1.4.3.4  Cellular functions of Dbl and DOCK GEFs 
The Rho GEF proteins participate in a wide variety of cellular processes such as neuronal 
morphogenesis, phagocytosis, cytokinesis, muscle development and in the immune 
response (Miyamoto & Yamauchi, 2010; Mulinari & Häcker, 2010; Rossman et al, 2005; 
Schmidt & Hall, 2002). Several Dbl and DOCK family GEFs are key regulators of various 
stages of neural morphogenesis. The Rac GEF DOCK180, in complex with its binding 
partners the adapter protein CT10 regulator of Kinase (Crk)II and the scaffold protein 
Engulfment and cell motility 1 (ELMO-1) promotes neurite outgrowth (Katoh & Negishi, 
2003). DOCK3 (also known as modifier of cell adhesion (MOCA)), promotes neurite 
formation in response to N-cadherin cell-cell adhesions via Rac activation (Chen et al, 
2005c; Namekata et al, 2004), whilst DOCK6 activates Cdc42 to drive this process 
(Miyamoto et al, 2007). The Dbl family members Tiam1 and Tiam2 (both Rac GEFs) also 
contribute to neurite extension and, by virtue of their ability to interact with polarity complex 
proteins such as Par3, spatially localise Rac activity to a specific neurite to determine the 
future axon (Kunda et al, 2001; Leeuwen et al, 1997; Matsuo et al, 2002).  This process 
also involves the Rac GEF DOCK7 which localises to one neurite. The future axon is 
determined by DOCK7-mediated phosphorylation of a microtubule destabilising protein 
Stathmin/Op18 in a Rac-dependent fashion to block activity and maintain the microtubule 
network in the selected neurite (Watabe-Uchida et al, 2006).  
Further steps in neuronal maturation such as development of dendritic spine morphology 
and axonal outgrowth and pathfinding are governed by a distinct set of Rho GEF proteins. 
The tumour suppressor Rac GEF DOCK4 (Hiramoto et al, 2006; Yajnik et al, 2003) and 
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the Cdc42 GEF DOCK9 (also known as Zizimin-1) (Meller et al, 2002) both promote 
dendritic spine formation, via their cognate GTPases (Kuramoto et al, 2009; Ueda et al, 
2008). Axonal outgrowth and pathfinding is in response to a set of attractive and repulsive 
extracellular cues. Activation of RhoA by the RhoA GEFs PDZ-RhoGEF (Fukuhara et al, 
1999) and Ephexin (Shamah et al, 2001), in response to Eph receptor signalling, leads to 
growth cone collapse (Shamah et al, 2001; Swiercz et al, 2002). The C. elegans 
Uncoordinated (UNC)-73 family of GEFs (orthologues of the mammalian RhoG, Rac and 
RhoA GEF Trio (Blangy et al, 2000; Debant et al, 1996); and its related proteins), govern 
axon outgrowth and migration (Spencer et al, 2001; Steven et al, 1998). This subset of 
Rho GEFs, (including Duet and Kalirin), have two distinct tandem DH-PH motifs as well as 
serine/threonine kinase activity (Debant et al, 1996; Johnson et al, 2000; Kawai et al, 
1999). In response to netrin signals, mammalian Trio acts downstream of the netrin-1 
receptor, deleted in colorectal cancer (DCC), to regulate axonal outgrowth (Briançon-
Marjollet et al, 2008). Interestingly, netrin-1/DCC signalling also requires the activity of 
Tiam1 in C. elegans (Demarco et al, 2012) and DOCK180 in mammals (Li et al, 2008) to 
activate Rac and promote axon outgrowth and attraction.  
Studies in Drosophila, C. elegans and in mammals reveal that both DOCK180 and Trio are 
also both key regulators of myoblast fusion during the early stages of muscle development 
(Bach et al, 2010; Erickson et al, 1997; Laurin et al, 2008; Nolan et al, 1998). A further role 
for the DOCK180 worm orthologue Cell death abnormal (CED)-5 is in phagocytosis of 
apoptotic cells during development (Gumienny et al, 2001; Lundquist et al, 2001). The fact 
that DOCK180 participates in a range of cellular processes by activating Rac, 
demonstrates the principle that cellular/subcellular context is important for specificity of 
Rho GTPase signalling. 
Other GEFs that have multiple functions include the protein Epithelial cell transforming 
sequence 2 (Ect2), which is a RhoA, Rac and Cdc42 GEF (Tatsumoto et al, 1999).  Ect2 
participates in cytokinesis by modulating RhoA activity at the central furrow to drive acto-
myosin contraction of the contractile ring (Yüce et al, 2005). Ect2 and its Drosophila 
orthologue Pebble are positioned at the cell equator by interaction with the centralspindlin 
complex  (Somers & Saint, 2003; Yüce et al, 2005), a multi-protein unit that consists of the 
microtubule motor mitotic kinesin-like protein 1/2 (MKLP-1/2) and the Rac GAP Move germ 
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cell Rac GTPase activating protein (MgcRacGAP) (Mishima et al, 2002). Pebble and C. 
elegans Ect2 are also involved in cell migration during gastrulation (Morita et al, 2005; 
Schumacher et al, 2004; Smallhorn et al, 2004). The ability of Ect2/Pebble to participate in 
both cytokinesis and cell migration is due to the requirement of different domains of Ect2 
for each process (Morita et al, 2005). 
1.4.3.5 Regulation of Rho GEF activity 
There are a number of regulatory mechanisms that ensure Rho GEFs are activated in the 
right place at the right time. Rho GEFs can be regulated by their intracellular localisation 
which in turn is modulated by upstream regulators. For example sequestration of the RhoA 
GEF Neuroepithelial cell transforming 1 (Net1) in the nucleus blocks RhoA activation at the 
plasma membrane (Schmidt & Hall, 2002a), whilst binding to microtubules inactivates the 
RhoA GEF, GEF-H1 (also known as ARHGEF2, or Lbc), and thus RhoA activation 
(Krendel et al, 2002). Upon microtubule disassembly in response to cellular activity, GEF-
H1 is released and can activate cytoplasmic RhoA (Krendel et al, 2002). Spatio-temporal 
regulation of Ect2 also dictates its function. Ect2 localises to the cleavage furrow during 
cytokinesis (Tatsumoto et al, 1999), however, during interphase Ect2 is found in the 
nucleus but also at the AJs where it promotes contractile events associated with junction 
stability (Ratheesh et al, 2012). Another example is the translocation of Tiam1 from the 
cytoplasm to the plasma membrane in response to serum or platelet-derived growth factor 
(PDGF) stimulation where it activates Rac (Buchanan et al, 2000; Michiels et al, 1997). 
A number of GEFs are constitutively autoinhibited by intramolecular interactions (Rossman 
et al, 2005; Schmidt & Hall, 2002a). Autoinhibition is often mediated by an interaction of 
the N-terminal domain with the C-terminus. For example, as in the case of the RhoA/B/C/G 
and Cdc42 GEF Dbl, where interaction between the N-terminal portion of the protein and 
the PH domain block access to the DH domain thus preventing Rho GTPase binding (Bi et 
al, 2001; Ron et al, 1991). Relief of autoinhibition can be mediated by binding of upstream 
proteins such as adenomatous polyposis coli (APC) binding to the Rac and Cdc42 GEF 
APC-stimulated guanine nucleotide exchange factor  (ASEF, also known as ARHGEF4) to 
stimulate Rho GEF activity (Kawasaki et al, 2000; Kawasaki et al, 2003; Mitin et al, 2007).  
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Other mechanisms include modulation of the phosphorylation state of regulatory residues 
such as phosphorylation of an N-terminal Tyrosine 174 in Vav1 to activate exchange 
activity (Aghazadeh et al, 2000; Crespo et al, 1997; Han et al, 1997). Tiam1 is also 
differentially phosphorylated by the Ser/Thr kinases Ca2+
1.4.3.6 Specification of Rho GTPase subcellular signalling by Rho GEFs 
/Calmodulin-dependent protein 
kinase II (CaMKinase II) and PKC and the tyrosine-kinase Src which either activate or 
inhibit Tiam1 (Fleming et al, 1997; Fleming et al, 1999; Servitja et al, 2003). Modulation of 
these intramolecular interactions provides a mechanism to spatially and temporally 
regulate the activation of GEFs in response to upstream signals. 
Downstream signalling specificity of a given Rho GTPase can be influenced by the binding 
partners and regulation of its cognate Rho GEF. Evidence from studies on a subset of 
GEFs that are able to bind to the Rac and Cdc42 effector PAK proteins, the PAK 
interacting exchange factors (PIX), shows that Rho GEFs can complex with specific 
effector proteins to bring specific signalling components and Rho GTPases into vicinity of 
one another (Li et al, 2003; Obermeier et al, 1998; Park et al, 2004; Zhao et al, 2000). 
Upon GPCR activation the Gβγ subunit of heterotrimeric G-proteins locally bind and 
activate α-PIX. Coupling of α-PIX to PAK allows spatially restricted activation of PAK upon 
α-PIX-mediated Cdc42 activation. This serves to activate chemotactic signalling pathways 
necessary for the response to GPCR signalling in this context (Li et al, 2003). Similarly, the 
enzyme nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase-1 (NOX1), which 
is involved in the generation of reactive oxygen species (ROS) used to kill bacteria by 
phagocytes (Lambeth, 2002), is coupled to β-PIX (Park et al, 2004). This localises the 
NOX-1 Rac-specific signalling pathway (Park et al, 2004). Differential activation of Rac 
downstream signalling can also be facilitated by the ability of the Rac GEF Tiam1 to bind 
components of two distinct pathways. Binding to JNK-interacting protein 2 (JIP2) directs 
p38 MAPK pathway transcriptional programmes, whilst interaction with the scaffold protein 
spinophilin drives the translation initiator, p70 S6 Kinase, response (Buchsbaum et al, 
2002; Buchsbaum et al, 2003). This demonstrates that the combination of GEF protein and 
context-specific interacting partners is sufficient to drive specificity of Rho GTPase 
signalling.   
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Rho GEF proteins can also act as signalling nodes for cross talk between multiple 
signalling pathways.  This level of regulation is demonstrated in the regulation of the RhoA 
GEFs p115 RhoGEF, Leukaemia-associated Rho GEF (LARG), p63 RhoGEF and Trio 
that are activated downstream of GPCR activation of heterotrimeric G-proteins (Hart et al, 
1998; Kozasa et al, 1998; Rojas et al, 2007; Suzuki et al, 2003). These proteins stimulate 
Rho activity in response to GPCR activation. They also bind to and some possess GAP 
activity towards Gαq 
1.4.3.7 Rho GEFs in disease  
subunits, thus linking Rho activation and GPCR signalling (Rossman 
et al, 2005). The role of Rho GEFs as effectors of upstream activated GTPases has also 
been demonstrated for Tiam1 which mediates Ras activation of Rac (Lambert et al, 2002) 
and the RhoA/G and Cdc42 GEF Dbs which binds to active Rac and stimulates RhoA 
activation (Cheng et al, 2004).  
Rho GEF proteins have roles in a number of developmental processes such as embryonic 
development of the nervous system and musculature (Miyamoto & Yamauchi, 2010; 
Mulinari & Häcker, 2010; Rossman et al, 2005). The importance of Rho GEF proteins is 
underscored by the association of several Rho GEFs with a number of pathologies such 
as developmental disorders, neurological disorders and cancer (Rossman et al, 2005; 
Schmidt & Hall, 2002). Mutations in several Dbl family GEFs are associated with a number 
of cancers. For example, Tiam1 has been implicated in squamous cell carcinoma (Malliri 
et al, 2002), whereby mice lacking Tiam1 are overall more resistant to Ras-induced tumour 
formation, but show a large proportion of malignant tumours. Other Rho GEFs become 
oncoproteins when they are aberrantly fused to other functional proteins, such as the Rho 
GEF Breakpoint cluster region (Bcr) fusion with the tyrosine kinase Abelson (Abl) to form 
Bcr-Abl, which might mediate its oncogenic phenotype by switching GTPase specificity to 
Cdc42 (Zheng et al, 2006). Both Bcr-Abl and the fusion of the RhoA GEF LARG with a 
histone methyltransferase, mixed-lineage leukaemia (MLL), cause leukaemia (Advani & 
Pendergast, 2002; Kourlas et al, 2000).  
A handful of developmental disorders are attributed to defects in Rho GEF proteins. 
Developmental defects such as cranio-facial dimorphism, bracydactyly, urogenital 
deformities and mental retardation characteristic of FGD/Aarskog-Scott syndrome, are 
caused by a number of mutations in the FGD-1 protein. These include loss of domains 
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important for protein localisation or mutations in the GEF domain (Orrico et al, 2004). 
Juvenile onset amyotrophic lateral sclerosis, a form of motor neurons disease, is triggered 
by loss of function mutations in the Rac GEF Alsin (ALS2) protein (Eymard-Pierre et al, 
2002; Gros-Louis et al, 2003; Hadano et al, 2001). It is clear therefore that regulation of 
Rho GEF proteins has profound consequences for normal developmental and homeostatic 
processes, as mis-regulation can lead to the onset of disease. 
The variety of cellular responses exhibited by activation of the small number of Rho 
GTPase can be, to some extent, attributed to the distinct mechanisms that exist to spatially 
and temporally regulate the Rho GEFs, Rho GAPs and Rho GDI proteins. In turn, many 
mechanisms are employed by the activated regulators to add further complexity and 
dictate precise and specific downstream signalling outcomes from the small number of 
Rho GTPase family members. As described below, many of these molecular tools are put 
to use in the formation, maturation and maintenance of cell-cell adhesion. 
1.5 Rho regulation in cell-cell adhesion 
1.5.1 Activation of Rho GTPases by cadherin ligation 
Spatio-temporal regulation of Rho GTPase activation is also key to cell-cell adhesion. 
Studies using immunofluorescence labeling of Rho, Rac and Cdc42 in mammalian cells 
show that all these proteins can localise to sites of N- or E-cadherin-based adhesion 
(Charrasse et al, 2002; Kim et al, 2000; Nakagawa et al, 2001; Takaishi et al, 1997). 
Several studies use effector pull-down assays to isolate GTP-bound protein from cell 
lysates. These show that Rac is activated upon homophilic ligation of cells overexpressing 
C-cadherin spread on C-cadherin substrates (Kovacs et al, 2002a; Noren et al, 2001). In 
cell-cell contact assembly assays in epithelial cells, activation of Rac is as early as 5 
minutes after calcium induction (Betson et al, 2002) and is sustained while contacts form 
(Betson et al, 2002; Nakagawa et al, 2001). Cdc42 is activated by 30 minutes (Kim et al, 
2000). Similar studies to test RhoA activation by cadherin-ligation have yielded cell type- 
and assay- specific results. RhoA is only weakly activated by spreading of fibroblasts 
overexpressing C-cadherin onto a C-cadherin substrate (Noren et al, 2001). On the other 
hand, RhoA is activated at 30 minutes upon N-cadherin based adhesion in calcium switch 
experiments following calcium chelation by Ethyleneglycoltetraacetic acid (EGTA) in 
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C2C12 myoblasts (Charrasse et al, 2002), but not activated at this time in E-cadherin-
mediated adhesion in Madin-Darby canine kidney (MDCK)II cells (Nakagawa et al, 2001). 
Calcium-induced cell-cell adhesion in mouse keratinocytes, cultured in the absence of pre-
formed cell-cell contacts, shows activation of RhoA after 60 minutes induction (Calautti et 
al, 2002). A gap in the knowledge therefore remains:  The precise timing of RhoA 
activation and whether its requirement for appropriate junction assembly is prevalent in 
different epithelial cell types.  
Spatio-temporal studies demonstrate that GTP-bound Rho and Rac localise to the newly 
forming junction between two colliding cells (Yamada & Nelson, 2007). Time-lapse Förster 
resonance energy transfer (FRET) imaging reveals Rac to be recruited during initial cell-
cell contact and throughout contact expansion, whilst Rho localises to the periphery of the 
newly formed contact at later stages (Yamada & Nelson, 2007). In studies using confluent 
epithelial cells, active Rac localises to the cell-cell contact at 20 minutes (Nola et al, 2011). 
However the spatio-temporal activation of RhoA under these conditions has not been 
determined. In MDCKII cells active Cdc42 can be visualised by Gluthothione-s-transferase 
(GST)-WASP staining, at cell-cell contacts after 65 minutes contact initiation (Kim et al, 
2000). However, upon cadherin clustering or when junctions are induced in confluent 
keratinocytes, in the absence of prior migration or serum stimulation, Cdc42 is inactivated 
(Erasmus et al, 2010; Noren et al, 2001). Together these studies show Rac to be activated 
upon initiation of cadherin-based contacts, whereas spatio-temporal activation of RhoA 
and Cdc42 in cell-cell contact assembly is less well characterised.  
1.5.2 Role of Rho GTPases in de novo AJ formation and maturation 
Rho GTPases functionally operate downstream of cadherin-ligation to promote a variety of 
cellular processes necessary for proper epithelial biogenesis (Fig. 1.11) (Citi et al, 2011). 
However, as with other cellular processes such as migration, the contribution of Rho, Rac 
and Cdc42 to the establishment of AJs is somewhat dependent on cell type and assay 
used (Watanabe et al, 2009). In general, Rac is required for actin recruitment to AJs and 
for the subsequent clustering of cadherins in an actin-dependent manner (Braga et al, 
1997; Lambert et al, 2002). Cdc42 activation also aids the accumulation of actin to 
junctions in MDCK cells (Kodama et al, 1999) and in the Henrietta Lacks (HeLa) cancer 
cell line (Stöffler et al, 1998) and also drives polarisation of epithelial cells by interaction 
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Figure 1.11 Rho GTPase-mediated cellular processes downstream of cadherin ligation. 
Active RhoA, Rac and Cdc42 drive a number of different cellular processes necessary for 
establishment of adherens junctions. GTP-bound RhoA drives acto-myosin contractility and 
delivery of junctional components to the membrane. Rac•GTP promotes accumulation of F-actin to 
cadherin-based contacts and traffics E-cadherin, whilst the roles of active Cdc42 at adherens 
junctions are not well established but may contribute to the accumulation of F-actin and cadherin 
localisation. 
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with polarity complex proteins (Ohno, 2001). Rho is able to generate tension and drive 
contraction thus contributing to the development of epithelial cell shape (Braga, 2000; 
Clayton et al, 1999; Jou & Nelson, 1998).  
In some situations the Rho GTPases have been linked to internalisation of E-cadherin. 
Rac and Cdc42 are required to block clathrin-mediated endocytosis of trans-interacting E-
cadherin (in vitro) (Izumi et al, 2004), and in keratinocytes Rac is required for clathrin-
independent internalisation of E-cadherin (Akhtar & Hotchin, 2001). There may be 
feedback loops involved in these mechanisms as p120ctn
As each activated Rho GTPase is able to direct multiple cellular outcomes in response to 
the common upstream stimulus of cadherin ligation it is important that the molecular 
context of Rho signalling and the duration and degree of activation are tightly controlled. 
This is thought to be achieved by regulating the upstream regulatory proteins of Rho 
GTPases to define spatial populations of Rho GTPase activity in specific intracellular 
compartments.  
, a key player in E-cadherin 
endocytosis, is required for E-cadherin-induced Rac activation (Goodwin et al, 2003). In 
addition to the basal turnover of E-cadherin seen in steady-state cells, extracellular signals 
trigger E-cadherin internalisation. EGF stimulates macropinocytosis of E-cadherin (Bryant 
et al, 2007), whilst vascular endothelial growth factor (VEGF) stimulates clathrin-mediated 
endocytosis of VE-cadherin via recruitment of an internalisation promoting protein, β-
arrestin following Rac-PAK signalling (Gavard & Gutkind, 2008).  
1.5.3 Regulation by p120
Rho proteins can be regulated by p120
ctn 
ctn. Cytosolic p120ctn inhibits RhoA when uncoupled 
from E-cadherin (Anastasiadis & Reynolds, 2000; Anastasiadis et al, 2000; Noren et al, 
2000). Cytosolic p120ctn can also promote the activation of Cdc42 and Rac (Grosheva et 
al, 2001; Noren et al, 2000). It was thought the mechanism of action is through 
sequestering inactive RhoA by p120ctn and activation of Rac and Cdc42 by the GEF Vav2 
(Anastasiadis & Reynolds, 2000; Anastasiadis & Reynolds, 2001; Noren et al, 2000). 
Binding of p120ctn to cadherins at AJs would release RhoA inhibition (Anastasiadis & 
Reynolds, 2001). However, more recent evidence suggests that junctional p120ctn may 
play an indirect role in RhoA inhibition by anchoring the RhoA GAP p190RhoGAP at 
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junctions upon Rac activation (Wildenberg et al, 2006). Interestingly, p120ctn is required for 
cadherin-induced Rac activation (Goodwin et al, 2003), suggesting a complex network of 
signalling pathways utilise p120ctn
1.5.4 Regulation by Rho GAPs and GDIs  
 to build and maintain AJs.   
A number of Rho GAPs are implicated in the regulation of steady-state junctions and in the 
formation of nascent contacts. During interphase in Michigan Cancer Foundation (MCF)-7 
epithelial cells, as part of the centralspindlin complex, the Rho, Rac and Cdc42 GAP 
MgcRacGAP localises to cell-cell contacts to block Rac activity, preventing the recruitment 
of the RhoA GAP p190RhoGAP-B (Ratheesh et al, 2012). This is part of a multimeric 
complex which includes the Rho GEF Ect2. The presence of the RhoA activator (Ect2) and 
the absence of the RhoA inhibitor (p190 RhoGAP-B) facilitates junctional RhoA activation 
in epithelial cells (Ratheesh et al, 2012).  
Several Rho GAPs regulate α-catenin localisation in epithelial cells. The tumour 
suppressor activity of Deleted in liver cancer 1 (DLC1), a GAP for RhoA and Cdc42 that 
functions in cell migration and proliferation (Kim et al, 2008; Kim et al, 2009), promotes AJ 
based junctions and α-catenin junctional localisation (Tripathi et al, 2012). A second RhoA 
and Cdc42 GAP, ARHGAP21 is required to maintain junctional α-catenin levels in 
colorectal adenocarcinoma cells (Caco-2) and a human placental 
choriocarcinoma cell line, JEG cells. Low levels of α-catenin, upon ARHGAP21 depletion, 
block the uptake of Listeria monocytogenes, a process that is likely exploited by L. 
monocytogenes to facilitate cytoskeletal remodelling to gain entry into cells (Sousa et al, 
2005). Whether these proteins act via RhoA or Cdc42 activity has not been demonstrated.  
On the other hand, specific regulation of RhoA activation by Myosin 9A (MyoIXA) and the 
closely related protein Myosin 9B (MyoIXB), both RhoA GAPs containing two myosin 
head-like domains, has been demonstrated. MyoIXA is required for both expansion of de 
novo junctions in colliding cells and the maintenance of AJs and TJs in a RhoA-dependent 
manner (Abouhamed et al, 2009; Omelchenko & Hall, 2012). In contrast, inactivation of 
MyoIXB abolishes TJ formation (Chandhoke & Mooseker, 2012). Two other RhoA GAPs, 
the closely related p190RhoGAP-A and p190RhoGAP-B, are both present at epithelial 
junctions where they also act to inhibit RhoA activation. p190RhoGAP-B is recruited to 
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junctions by Rac (Bustos et al, 2008; Ratheesh et al, 2012), whereas p190RhoGAP-A is 
recruited to sites of cell-cell adhesion by p120ctn
1.5.5 Regulation by Rho GEFs 
 where it inhibits RhoA activation (Noren et 
al, 2003; Wildenberg et al, 2006). Overall, the regulation of RhoA inactivation is important 
for maturation and maintenance of epithelial cell-cell contacts.  
A number of Rho GEFs have been implicated in several stages of cell-cell adhesion (Fig. 
1.12) (McCormack et al, 2013).  In some cases, how they are localised at cell-cell contacts 
and their activation state have been elucidated. 
1.5.5.1 Cadherin-based adhesions in neuronal cells 
Some GEFs are associated with cell-cell adhesion machinery in neuronal cells, such as 
the Rac GEFs, DOCK3 and α-PIX (also known as ARHGEF7), which can regulate N-
cadherin cell-cell adhesion (Chen et al, 2005c; Sun & Bamji, 2011) to modulate junctional 
localisation of cadherin complex proteins. Exogenous DOCK3 localises to sites of cell-cell 
contacts where it colocalises with F-actin structures in PC12 pheochromocytoma cells and 
induces E- and N-cadherin and β-catenin expression in SW480 colorectal carcinoma cells 
(Caspi & Rosin-Arbesfeld, 2008; Chen et al, 2005c).  It also binds to and induces 
cytoplasmic β-catenin translocation to the plasma membrane in epithelial-like human 
embryonic kidney (HEK293) cells (Caspi & Rosin-Arbesfeld, 2008). Similarly, ARHGEF7 
interacts with β-catenin as part of the junctional complex in hippocampal neurons, where it 
modulates recruitment of synaptic vesicles to the synapse (Sun & Bamji, 2011). 
1.5.5.2 RhoA- and Cdc42-mediated regulation of tension at epithelial cell-cell 
contacts  
Other Rho GEFs are associated with cell-cell contacts in epithelial cells where RhoA 
activity is known to regulate the architecture and function of junctional complexes via the 
regulation of contractile machinery (Niessen et al, 2011; Terry et al, 2011). A number of 
RhoA GEFs manipulate the same contractile machinery for distinct purposes. The RhoA 
and Rac GEF p114 RhoGEF is known to regulate stress fibre formation, cell constriction, 
migration and invasion of tumour cells and neurite retraction in response to Wnt signalling, 
via RhoA activation (Blomquist et al, 2000; Niu et al, 2003, (Terry et al, 2012; Tsuji et al, 
2010). Another RhoA GEF, an RGS-domain containing GEF ARHGEF11 (PDZ-RhoGEF), 
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Figure 1.12 Rho GEFs in cell-cell adhesion. Summary diagram of the Rho GEF proteins that 
have been shown to localise to tight or adherens junctions either in steady-state conditions 
(where cells have mature junctions) or during de novo junction assembly (see text). Localisation 
mechanisms are shown indicating protein-protein interactions that are required for junction 
association. Activating and inhibitory processes are shown. Diagram modified with permission 
from McCormack et al, 2013. 
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is involved in integrating GPCR signalling and RhoA activation, can interact directly with 
actin, and activate RhoA downstream of the axonal guidance molecules Semaphorins and 
their Plexin-B1 receptor (Banerjee et al, 2009; Fukuhara et al, 1999; Swiercz et al, 2002). 
Both p114 RhoGEF and ARHGEF11 regulate TJ morphology by regulating acto-myosin 
contractility in a RhoA-dependent manner (Itoh et al, 2012; Nakajima & Tanoue, 2011; 
Terry et al, 2011) whilst a distinct GEF, Ect2, in addition to its roles in cytokinesis, 
(Tatsumoto et al, 1999) functions via RhoA to localise E-cadherin to AJs via the acto-
myosin cytoskeleton (Ratheesh et al, 2012).  
ARHGEF11 localises to junctions via interaction with ZO-1 (Itoh et al, 2012), whilst p114 
RhoGEF localises to maturing and steady-state contacts via interaction of the PH domain 
with cingulin and binding of the PDZ-domain to junctional polarity complex proteins Par3 
and Protein associated with C. elegans 
RhoA-mediated regulation of tension is also important for localisation of E-cadherin to the 
apical position where AJs form (Ratheesh et al, 2012). Ect2 influences RhoA activity at 
cell-cell contacts to drive E-cadherin spatial positioning (Ratheesh et al, 2012). Ect2 itself 
undergoes regulation by spatial distribution (see above). Localisation of Ect2 to cell-cell 
contacts and interaction with E-cadherin complexes depends on its interaction with the 
centralspindlin complex (Ratheesh et al, 2012). As part of the centralspindlin complex, the 
Rac GAP MgcRacGAP inhibits Rac-mediated recruitment of the RhoA GAP p190RhoGAP-
B (Ratheesh et al, 2012) whilst promoting recruitment of the RhoA GEF Ect2. This 
Lin-7 protein 1 (PALS1)-associated TJ protein 
(PatJ) (Nakajima & Tanoue, 2011, Terry et al, 2011). At junctions, p114 RhoGEF is 
activated by the FERM domain-containing protein Limulus (Lulu)2 (Nakajima & Tanoue, 
2011).  Functionally, p114RhoGEF is required for the spatial restriction of active RhoA 
distribution and the contractile machinery to TJs. Loss of either p114 RhoGEF or 
ARHGEF11 GEF activity leads to impaired maturation of TJ architecture, morphology, and 
barrier function in epithelial cells (Itoh et al, 2012; Terry et al, 2011). These defects result 
from a loss of tension at the cell-cell contact due to mislocalisation of RhoA and 
phosphorylated myosin II.  Activation of RhoA-MyosinII signalling by p114RhoGEF and 
ARHGEF11 is important to regulate contractility of the peri-junctional acto-myosin 
cytoskeleton to maintain tension at intercellular contacts (Itoh et al, 2012; Nakajima & 
Tanoue, 2011; Terry et al, 2011). 
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mechanism allows uninhibited activation of RhoA at cell-cell contacts (Ratheesh et al, 
2012). When Ect2 is lost, junction-specific RhoA activation and levels of myosin IIA are 
reduced at junctions, resulting in loss of tension in the peri-junctional cytoskeleton.  The 
consequences are perturbation in the lateral distribution of E-cadherin complexes with E-
cadherin not restricted to apically-located AJs (Ratheesh et al, 2012).  
Cdc42 activity can also play a role in correct positioning of AJs components upon 
activation by the Cdc42 GEF Tuba.  Endogenous Tuba colocalises with ZO-1 and to a 
lesser extent α-catenin and afadin, and interaction between ZO-1 and the C-terminal 
region of Tuba is required for the junctional localisation of Tuba (Otani et al, 2006). In the 
absence of Tuba in CaCo2 cells, although E-cadherin and F-actin are incorporated into 
apical AJs, both E-cadherin and F-actin are abnormally distributed in lateral regions basal 
to the apical AJ site. Additionally, both AJs and TJs have a loose morphology indicating a 
loss of tension in the junctions. This is phenocopied upon depletion of the Cdc42 effector 
N-WASP (Otani et al, 2006). In other situations, Tuba and N-WASP are also required for 
correct positioning of the central lumen in Caco2 cysts, via regulation of the mitotic spindle 
(Bryant et al, 2010; Kovacs et al, 2011; Qin et al, 2010), but they can also regulate actin 
reorganisation both directly and by binding to actin-regulatory proteins such as Dynamin-1 
(Cestra et al, 2005; Kovacs et al, 2006). The phenotype of Tuba depletion in epithelial cells 
is likely driven by the ability of Tuba and N-WASP to remodel actin. The involvement of the 
GEFs Tuba, p114RhoGEF, ARHGEF11 and Ect2 in promoting the generation of 
intracellular tension, suggests that there could be a level of interplay between the Cdc42 
and RhoA signalling pathways.  
1.5.5.3 Maintenance of the epithelial phenotype by RhoA 
Elevated levels of activated RhoA have been associated with loss of cell-cell adhesion in 
some tumour types (Karlsson et al, 2009), underscoring the importance of regulating RhoA 
activity. The spatial regulation of the Rho GEF, GEF-H1, which also plays a major role in 
linking microtubule depolymerisation to acto-myosin contractility in migrating cells (Krendel 
et al, 2002) and in cytokinesis (Birkenfeld et al, 2007), is key to tight control of  RhoA 
signalling. Localisation and the activation state of GEF-H1 are also central to the tight 
spatio-temporal control of RhoA activation in maintaining functional cell-cell connections. A 
role for negative regulation of GEF-H1 as a mechanism for reducing RhoA activity is seen 
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at steady-state contacts (Aijaz et al, 2005; Guillemot et al, 2008). Sequestration and 
inactivation of GEF-H1 at cell-cell junctions by binding to cingulin and paracingulin, serves 
to block RhoA activation at junctions (Aijaz et al, 2005; Guillemot et al, 2008).  This is likely 
to serve two purposes. First, downregulation of RhoA activity upon maturation of cell-cell 
contacts is necessary to promote contact inhibition of proliferation (Aijaz et al, 2005; 
Birkenfeld et al, 2008). Second, it maintains epithelial phenotype as RhoA activation is 
required for cell-cell adhesion disassembly, in a GEF-H1-dependent manner (Samarin et 
al, 2007). Third, overactivation of GEF-H1 increases the paracellular permeability to small 
molecular weight tracers, and loss of GEF-H1 has the opposite effect in epithelial cells 
(Benais-Pont et al, 2003). Notably, this occurs in the absence of any morphological defects 
on AJs and TJs and is presumed to be driven by alteration in RhoA activity as, in this 
context, Rac activity is not modulated by GEF-H1 (Benais-Pont et al, 2003). Similarly, in 
endothelial cells, the release of GEF-H1 from depolymerised microtubules in response to 
physiological agonists leads to RhoA activation and endothelial barrier permeability 
(Birukova et al, 2006). Subcellular localisation of GEF-H1 is therefore crucial to RhoA 
signalling outcomes. 
Both up- and down-regulation of RhoA levels and activity by transforming growth factor 
(TGF)-β signalling have been implicated in epithelial-to-mesenchymal transition (EMT), a 
key step in tumourigenesis (Moustakas & Heldin, 2005; Zhang, 2009).  Recent evidence 
has identified the RhoA GEF Net1 isoform A (Net1A) in mediating these processes (Carr 
et al, 2009; Lee et al, 2010; Papadimitriou et al, 2012; Shen et al, 2001).  In Swiss3T3 
fibroblasts and human retinal pigment epithelial (hRPE) cells, TGF-β drives Net1 activation 
of RhoA (Lee et al, 2010; Shen et al, 2001). Short term exposure of HaCat keratinocytes 
(human adult keratinocytes propagated in low calcium and elevated temperature) to TGF-β 
induces RhoA activation via the transcription factor Smad- and Extracellular signal-related 
kinase (ERK)/MAPK-induced increase in Net1A expression (Papadimitriou et al, 2012).  
Net1A silencing alone disrupts E-cadherin and ZO-1-based adhesion and upregulates 
expression of mesenchymal markers (Papadimitriou et al, 2012). This is enhanced by 
continued TGF-β exposure. However, prolonged exposure to TGF-β downregulates Net1A 
levels by proteasomal degradation and transcriptional repression via microRNA (mir)-24 
(Carr et al, 2009; Papadimitriou et al, 2012). Therefore, differential regulation of Net1A 
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levels is key to determining the level of RhoA activation and the outcome of TGF-β 
signalling on junctions. 
1.5.5.4 Rac-mediated maintenance of AJ 
Appropriately controlled levels of active Rac are also important for maintenance of AJs. In 
epithelial MDCKII cells, activated Rac (G12V mutant) promotes AJs, whilst dominant 
negative Rac (T17N mutant) reduces levels (Takaishi et al, 1997). However, in 
keratinocytes, although expression of Rac T17N reduces accumulation of E-cadherin, 
constitutive activation of Rac leads to AJ disassembly (Braga et al, 1999; Braga et al, 
2000). This suggests a tight context-dependent regulation of Rac activity levels and a 
handful of Rho GEF proteins have been implicated in these processes. 
Both of the closely related Rac exchange factors, Tiam1 and Tiam2, localise to cell-cell 
contacts in an E-cadherin-dependent manner (Kraemer et al, 2007). Whilst Tiam2 
expression promotes EMT by redistributing E-cadherin away from cell-cell contacts and 
upregulating N-cadherin in HepG2 liver cells (Chen et al, 2012), the presence of Tiam1 
protein is sufficient to induce the inverse process of  MET in mesenchymal fibroblast 
NIH3T3 cells (Sander et al, 1998). This suggests that Tiam2 is oncogenic whereas Tiam1 
can act as a tumour suppressor protein. Indeed, it appears that oncogenic signalling 
pathways manipulate levels of Tiam1 to permit disruption of cell-cell adhesion and promote 
a mesenchymal phenotype. Ras-transformation of MDCKII epithelial cells downregulates 
Tiam1 and reduces Rac activation, which correlates with EMT (Zondag et al, 2000). 
Disassembly of cell-cell contacts upon Src activation is mediated by phosphorylation of 
Tiam1 Tyr384, which targets Tiam1 for degradation (Palovuori et al, 2003; Woodcock et al, 
2009).  In support of a tumour suppressor function for Tiam1, EMT can be blocked by 
activation of Rac1 activity via expression of Tiam1 which promotes cadherin-based 
adhesions and an epitheliod phenotype (Hordijk et al, 1997; Malliri et al, 2004). Moreover, 
Tiam1 is required for maintenance of AJs in normal cells as loss of Tiam1 leads to 
disassembly of cell-cell contacts in MDCKII (Malliri et al, 2004). Localisation of Tiam1 via 
its PH domain to cadherins at cell-cell contacts is necessary for its ability to permit 
cadherin-based adhesions (Hordijk et al, 1997).   
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Maintenance of E-cadherin-based adhesions in epithelial cells is also contributed to by 
constitutive inhibition of the Rac GEF activity of Trio (Debant et al, 1996; Yano et al, 2011). 
Trio localises to junctions and interacts with E-cadherin in co-immunoprecipitation assays. 
Binding to Trio-associated repeat on Actin (TARA) inhibits Rac GEF activity of Trio (Seipel 
et al, 2001; Yano et al, 2011). Release of inhibition leads to Rac-specific reduction in E-
cadherin levels via transcriptional repression, mediated by p38 MAPK and the 
transcriptional repressor T-box transcription factor 3 (Tbx3) (Yano et al, 2011).  
1.5.5.5 De novo assembly of cell-cell adhesions   
Although a role for Tiam1 in AJ maintenance is well known, its participation in AJ formation 
is not well established. A dominant-negative Tiam1 mutant reduces the ability of E-
cadherin expressing Chinese hamster ovary (CHO) cells to spread on cadherin 
substratum, but in a Rac-independent manner (Kraemer et al, 2007). Additionally cells 
from Tiam1 knockout mice are still able to form E-cadherin adhesions (Mertens et al, 
2005).  On the other hand, generation of de novo TJs does require the spatial regulation of 
Tiam1 Rac GEF activity (Chen & Macara, 2005; Guillemot et al, 2008; Mack et al, 2012; 
Mertens et al, 2005). Activation of Tiam1 by basally located β2-syntrophin (Mack et al, 
2012) coupled with apical inactivation of Tiam1 by Par3 (Chen & Macara, 2005; Mack et 
al, 2012) establishes a Rac-activity gradient. Perturbation of the gradient of Tiam1-Rac-
activity impairs TJ assembly and apical lumen formation (Mack et al, 2012). 
Downstream signalling pathways induced by the initial stages of trans-interacting 
cadherins can be modelled by immobilisation of cadherin on culture dishes to cluster 
exogenously expressed cadherin receptors in L-fibroblasts. Using this model, E-cadherin-
based adhesion formation triggers Rac activation and lamellipodia formation. 
Mechanistically, this involves Src activation and phosphorylation of Vav2, a GEF for 
multiple Rho GTPases. Dominant-negative Vav2 reduces lamellipodia formation, a 
phenotype that is rescued by overexpression of constitutively active Rac (Fukuyama et al, 
2006). Interestingly, Vav2 interacts with cytoplasmic p120ctn but not directly with E-
cadherin in HEK293 cells and embryonic F18 rat brain cells (Chauvet et al, 2003; Noren et 
al, 2000), suggesting the recruitment of Vav2 to E-cadherin-based adhesions may be 
indirect.   
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Initiation of cell-cell contact formation can also be modelled by allowing sub-confluent cells 
to form intercellular connections as they approach confluence. In this way E-cadherin-
mediated cell-cell adhesion in MCF-7 cells stimulates binding of the PDZ-domain protein 
Discs large (Dlg) 1 to bind and stabilise the RhoA GEFs Net1 and Net1a (Carr et al, 2009; 
García-Mata et al, 2007). Stabilisation of the Net proteins permits translocation to the 
nucleus and prevents degradation (Carr et al, 2009; García-Mata et al, 2007). Cytoplasmic 
Net1 is able to activate RhoA (Schmidt & Hall, 2002b), but as the requirement for RhoA 
activation during contact formation is not well established, the significance of Net1 nuclear 
translocation is unclear. One attractive possibility is that Net1 is sequestered in the 
nucleus, thereby reducing its contribution to localised activation of RhoA in the cytoplasm 
(Carr et al, 2009; Schmidt & Hall, 2002b). This is an additional mechanism to modulate 
Net1 activity by regulating cytoplasmic levels, a concept that is demonstrated in TGF-β 
signalling described above. 
As previously mentioned, the Cdc42 GEF Tuba plays a role in maintaining spatial 
localisation of AJ components at the mature junctions (Otani et al, 2006). Similarly, Tuba 
regulates the distribution of AJ components to newly-formed cell-cell contacts in Caco2 
cells, in a Cdc42- and N-WASP-dependent manner (Otani et al, 2006). Upon Tuba 
depletion, E-cadherin and F-actin recruitment is retarded. They eventually localise at the 
apical region, but become diffuse and disorganised in the lower lateral regions of the cells.  
Tuba depletion also slows Cdc42 distribution to the membrane and blocks calcium-
induced Cdc42 activation (Otani et al, 2006). This demonstrates that temporal control of 
Tuba activation allows Tuba to function in multiple contexts.  
In spite of much progress made since Rho GTPases were first implicated in the regulation 
of cadherin adhesion, the evidence generated to date only scratches the surface of how 
they are regulated by Rho GEFs and GAPs. Firstly, it is not clear whether RhoA is 
activated by initial E-cadherin mediated cell-cell contact. Secondly, there is particularly 
limited information on the regulatory role of Rho GEFs and GAPs in de novo assembly of 
AJs specifically.  Furthermore, the signal transduction pathways that link E-cadherin to 
Rho GEFs and GAPs are very poorly understood.   
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1.6 E-cadherin-induced signal transduction 
1.6.1 E-cadherin and EGFR cross-talk at nascent AJs  
Despite the evidence to date showing that cadherin transmembrane proteins are key 
signalling nodes, they do not themselves possess any enzymatic activity in their 
cytoplasmic domains (Niessen et al, 2011). This raises the possibility that other 
membrane-bound receptors, with their own enzymatic ability, could act in concert with 
cadherins to direct downstream signalling, such as in the case of integrin-based adhesion 
(Streuli & Akhtar, 2009). Integrins are able to co-opt both cytokine and growth factor 
receptors to modulate cellular responses to external cues (Streuli & Akhtar, 2009). Indeed, 
a body of evidence also links the activity of members of the growth factor receptor (GFR) 
family of receptor tyrosine-kinases (RTKs) with cadherins in a variety of cell types. Cross-
talk has been demonstrated for E-cadherin and Truncated (T)-cadherin with epidermal 
GFR (EGFR) (Kyriakakis et al, 2012; Pece & Gutkind, 2000), VE-cadherin with vascular 
endothelial GFR (VEGFR) (Esser et al, 1998), and N-cadherin with fibroblast GFR (FGFR) 
(Williams et al, 2001). Moreover, E-cadherin and EGFR are both required for a number of 
cellular processes central to proper epithelial differentiation and maintenance during 
homeostasis. Importantly, interaction of EGFR and E-cadherin signalling has been 
implicated in disease progression including tumourigenesis and metastasis (Yasmeen et 
al, 2006).  
Not only can EGFR activation influence E-cadherin signalling, E-cadherin is also able to 
inhibit ligand-stimulated EGFR activity (Fedor-Chaiken et al, 2003; Kim et al, 2009; 
Takahashi & Suzuki, 1996). A number of regulatory mechanisms for this process have 
been proposed which include modulation of the response of EGFR to its ligand epidermal 
growth factor (EGF) or perturbations in the trafficking of EGFR (Curto et al, 2007; Damiano 
et al, 2010; Perrais et al, 2007; Qian et al, 2004; Solis et al, 2012). Intriguingly, E-cadherin 
is also able to trigger EGFR signalling in the absence of ligand in order to regulate cell-cell 
adhesion (Betson et al, 2002; Pece & Gutkind, 2000; Shen & Kramer, 2004). A dominant-
negative EGFR mutant lacking the ability to bind to EGF was unable to inhibit cadherin-
dependent EGFR activation, thus implying that a ligand-independent mechanism is at play 
(Shen & Kramer, 2004).  
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E-cadherin is clearly able to co-opt EGFR signalling to drive proper junction formation, but 
by what mechanism this occurs remains unknown. Other cell surface receptors, such as 
integrins are also able to influence RTK activity by modulating phosphorylation on tyrosine 
residues (Streuli & Akhtar, 2009). Indeed, activation of β1 
1.6.2 Regulation of Rac activity by cadherin-EGFR signalling 
integrin can lead to the 
phosphorylation of tyrosine residues in the EGFR cytoplasmic domain in a pattern distinct 
from EGF-stimulated phosphorylation (Bill et al, 2004; Moro et al, 2002).  It is not clear 
how modulation of EGFR tyrosine-phosphorylation is achieved, but it is thought that the 
physical aggregation of the different cell-surface receptors could influence the auto-
regulation of RTK (Pines et al, 2010). Similarly the likelihood of trans-phosphorylation 
events between neighbouring RTK molecules could increase upon clustering of receptors 
(Endres et al, 2011). I hypothesise therefore, that cadherin-dependent activation of EGFR 
results in a distinct pattern of tyrosine-phosphorylation designed to drive specific cell-cell 
adhesion processes (Fig. 1.13A and B) (Morandell et al, 2008).  
What processes cadherin-EGFR cross-talk mediate, and the mechanisms employed 
remain largely unknown. A key principle underpinning mechanisms of cross-talk is the 
interaction or coordinated relationship between multiple signalling pathways. Both ligand-
stimulated EGFR activation and cadherin-based adhesion strongly induce activation of 
Rac. Additionally, EGFR activation is required for cadherin-induced Rac activation, as 
pharmacological blockade of EGFR tyrosine-kinase activity abolishes junction-induced 
Rac activation (Betson et al, 2002). Similarly, unpublished data in our lab has confirmed 
the role for EGFR in this process, as RNAi-mediated depletion of EGFR protein inhibits 
junction-induced Rac activation (J. Erasmus, unpublished).  
Whereas ligand-stimulated EGFR phosphorylation is known to drive PI3K-dependent Rac 
activation (Binker et al, 2009; Dise et al, 2008), the requirement for PI3K in cell-cell 
adhesion-mediated Rac activation is less clear.  In experiments where cells are induced to 
form contacts in the presence of serum, Rac activation is PI3K-dependent (Nakagawa et 
al, 2001). However, in other studies using calcium addition alone to stimulate junction 
formation (Betson et al, 2002) or ligation of cadherin-expressing cells to immobilised 
cadherin-ectodomains (Goodwin et al, 2003), Rac activation does not require PI3K activity. 
This differential requirement for PI3K in the ligand-dependent versus -independent 
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Figure 1.13 Potential mechanisms of calcium-induced Rac activation. A) Ligand-dependent 
EGFR activation occurs upon binding of the EGFR ligand EGF (purple). EGFR (blue) is highly 
phosphorylated on residues in the cytoplasmic tail (red) and adaptor proteins (light blue) are 
recruited to the phosphorylated EGFR. Rac GEF proteins are recruited to drive Rac activation. B) 
Hypothesised model for EGFR ligand-independent activation in AJ formation. Crosstalk occurs 
between the dimerised E-cadherin receptors (pink) and EGFR (blue) to partially phosphorylate 
EGFR (red). C) Recruitment of a distinct Rac GEF protein to the E-cadherin/EGFR junctional 
complex via EGFR-mediated mechanism to activates Rac (grey). 
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mechanisms indicates the possibility that Rac activation during calcium-stimulated junction 
assembly may employ distinct signalling pathways to those downstream of ligand-
dependent EGFR activation. This alternative signalling mechanism downstream of the 
cadherin-EGFR complex may be a central driver of cell-cell adhesion specific outcomes 
following Rac activation.  
Furthermore, as GEF proteins are key regulators of context-dependent GTPase activation 
(Rossman et al, 2005; Schmidt & Hall, 2002a), it is likely that GEF proteins are recruited to 
the sites of receptor clustering upon cell-cell adhesion to activate Rac. Indeed, a small 
number of Rac GEFs are activated/recruited to the EGFR signalling complex after 
stimulation with EGF, including Son of sevenless (Sos) proteins, Vav2, Tiam1 and ASEF 
(Itoh et al, 2008; Marcoux & Vuori, 2003; Pandey et al, 2000; Ray et al, 2007; Scita et al, 
1999; Scita et al, 2000). However, because the molecular make-up associated with sites of 
cell-cell adhesion is likely to differ from the environment of ligand-bound EGFR, it may be 
that a distinct subset of Rac GEFs are recruited to nascent adhesion complexes 
(Morandell et al, 2008; Zaidel-Bar et al, 2007). The current model (Fig. 1.13) proposes E-
cadherin-mediated activation of EGFR drives recruitment and activation of a Rac GEF to 
promote Rac activation upon junction formation. This GEF may be distinct from that found 
in ligand-stimulated Rac activation. To date, the identity of a Rac GEF in ligand-
independent EGFR-mediated Rac activation remains unknown. 
1.7 Identification of AJ regulators using image-based RNAi screening 
It is well established that each Rho GTPase known to participate in AJ biogenesis is able 
to direct multiple, distinct cellular events (Fig. 1.11), however there is an unmet need to 
identify the specific regulators of the Rho GTPases that define these distinct signalling 
specificities.  It is therefore important to identify regulators of Rho activity during initiation 
and maturation of E-cadherin-mediated cell-cell adhesion, to understand the contribution 
of Rho GTPases to early stages of epithelial tissue biogenesis. RNA interference (RNAi) 
screening techniques can be used to address this issue. 
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1.7.1 Loss-of-function high throughput RNAi screening 
Forward genetics techniques have long been used to assess the genetic origin of loss-of-
function phenotypes induced by particular perturbations to a system. However, this 
approach can be time consuming and delays interpretation of experimental results. 
Technological advances over the last decade have brought the biological process of RNAi 
to the fore as a research tool, and in particular, in the development of high-throughput 
screening (Dykxhoorn & Lieberman, 2005). RNAi was first discovered in C. elegans (Fire 
et al, 1998) and has since been shown to be an ancient mechanism to defend a host cell 
against viral mRNA (Wang et al, 2006). When small interfering RNAs (siRNA) are present 
in the cell, degradation of the complementary messenger RNA (mRNA) occurs, effectively 
silencing the functional output of the gene of origin. Generation of siRNAs can be by 
introduction into cells of long double stranded RNA, viral RNA or transgenes encoding 
short hairpin RNAs (shRNA) which are processed by Drosher and Dicer, 
endoribonucleoproteins of the RNase III family, to form ~20-30 nucleotide long siRNAs.  
Alternatively, pre-produced chemically synthesised siRNAs can be introduced into cells. 
The RNA induced splicing complex (RISC) binds to the siRNA via Argonaut proteins, 
recognises the complementary mRNA sequence and directs the degradation of the target 
mRNA (Filipowicz, 2005).  When RNAi is used to silence genes in an experimental setting, 
the reverse genetics technique allows genotype-phenotype associations to be made 
immediately. 
The first high-throughput use of RNAi was again in C. elegans in morphological analysis of 
the developing organism (Fraser et al, 2000; Kamath et al, 2003; Maeda et al, 2001). 
Subsequently many RNAi screens have been performed in other organism and importantly 
the technique was extended to mammalian cell culture experiments (Brummelkamp et al, 
2004; Paddison et al, 2002). Whereas screens in whole organisms are not generally 
quantitative, advances in fluorescence microscopy techniques have allowed high-
throughput automated quantitative image analysis of mammalian cells to assess multiple 
phenotypes simultaneously (Neumann et al, 2010; Winograd-Katz et al, 2009). RNAi 
screening in mammalian cells is becoming a tool of choice for many researchers. 
RNAi screens in human primary cells and cell lines have been used to identify genes that 
are important for a number of biological processes such as cell division and proliferation 
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(Ahmed et al, 2010; Tsui et al, 2009), cell death (Vitorino & Meyer, 2008; Whitehurst et al, 
2007) and migration and motility (Lin et al, 2011; Simpson et al, 2008). Moreover, RNAi 
screens performed in C. elegans and mammalian cells have identified key regulators of 
epithelial polarity, cell-cell adhesion, and differentiation of keratinocytes (Lynch et al, 2012; 
Simpson et al, 2008; Wu et al, 2011a).  
Many RNAi screens have used libraries designed to cover the whole genome of the 
organism in question. However, depending on the biological question of interest it is often 
more insightful to screen targeted libraries of genes in particular functional families. 
Indeed, several screens have specifically assayed a subset of the genome such as the 
kinome (Ahmed et al, 2010; Arora et al, 2010; Diep et al, 2011; Simpson et al, 2008; 
Vitorino & Meyer, 2008; Yeh et al, 2011) and phosphatome (Lin et al, 2011; Simpson et al, 
2008; Yeh et al, 2011). RNAi screens of GTPases and their regulators have also been 
carried out in Drosophila cells (Nir et al, 2010; Wang et al, 2008) and mouse 
neuroblastoma cells (Tsuji et al, 2010).   
High-throughput RNAi screening generates a large amount of data and identifies RNAi 
targets as hits which can be followed up in small scale biochemical and functional studies. 
Importantly the data generated from these types of screens can yield a wealth of 
information about the interplay between the target genes. Multiparameter computational 
analysis is often performed to cluster hits with similar phenotypes in a number of 
parameters into groups (Bakal et al, 2007; Liu et al, 2009; Piano et al, 2002). Integration of 
the cluster analysis results with data mining strategies such as gene ontology annotations 
can enable the researcher to form inferences about wider signalling networks.  
1.8 Hypotheses 
EGFR is responsible for E-cadherin signal transduction to mediate Rac activation upon de 
novo cell-cell contact formation. I hypothesise that: 
o EGFR is phosphorylated in a pattern distinct to ligand-stimulated EGFR 
activation 
o EGFR mediates Rac activation via a Rac GEF 
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The ability of a single Rho GTPase family member to drive multiple and distinct cellular 
processes downstream of cadherin ligation, is likely dependent on the molecular spatial 
and temporal context of the Rho GTPase. I hypothesise that: 
 
o multiple Rho GEFs participate in determining this spatio-temporal control of Rho 
activation during establishment of AJs 
 
o Distinct Rho GEF proteins are required for different aspects of de novo AJ 
assembly 
1.9 Aims 
Using models of de novo AJ assembly I aim to: 
• Establish the phosphorylation profile of EGFR during junction formation to gain insight 
into the downstream signalling pathways that govern Rac activation 
• Elucidate the Rac GEF responsible for EGFR-mediated Rac activation during junction 
assembly  
• Identify Rho GEF proteins with novel functions in AJ formation through an RNAi 
screen 
• Characterise the molecular and cellular mechanisms of action of a Rho GEF identified 
in the screen. 
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2 Materials and methods 
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2.1 Cell culture  
2.1.1 Maintenance of keratinocyte cultures 
Primary human keratinocytes from neonatal foreskin (strain Sf, passage 3-6) were grown 
on monolayers of J2 3T3 fibroblasts treated with mitomycin-C (Sigma-Aldrich) at 37°C and 
5% CO2.  Keratinocytes were cultured in standard FAD medium (DMEM:F12, BioWittaker, 
Lonza, Germany) supplemented with 1.8mM CaCl2
For cell cultures grown in the absence of calcium-dependent cell-cell contacts, the 
standard medium formulation was used, but with 0.1mM calcium ions and serum depleted 
of divalent ions by treatment with Chelex-100 resin (BioRad, Hertforshire, UK).  Hereafter 
is referred to as low calcium
, 100units/ml penicillin, 100µg/ml 
streptomycin, 10% foetal calf serum, 5mM glutamine, 5µg/ml insulin, 10ng/ml epidermal 
growth factor (EGF), 0.5µg/ml hydrocortisone (all from Sigma) and 0.1nM cholera toxin, 
Quadratech Diagnostics Ltd, Surrey, UK)  (Rheinwald & Green, 1975).   
 
2.1.2 Induction of cell-cell contacts – calcium switch assay 
medium. 
In calcium switch experiments, keratinocytes were seeded at 3 x 104 on 2cm2 coverslips, 4 
x 104 on 11cm2 dishes and at 2-3 x 105 on 19.6cm2 dishes or 57.6cm2 dishes in standard 
medium.  After three to five days cells were switched to low calcium medium and cultured 
until confluence (Hodivala & Watt, 1994).  Cell-cell contacts were induced in confluent 
monolayers by the addition of calcium ions to a final concentration of 1.8mM CaCl2.  For 
overexpression analyses cells were transfected with cDNA when they reached confluence 
and left to express for 8-24 hours before calcium switch. For siRNA experiments cells were 
grown to 80% confluence in low calcium medium and then treated with different siRNA 
oligonucleotides for 48-72 hours before calcium switch (see section 2.2.2).  For RNAi 
screening experiments, keratinocytes were seeded onto 96 well plates at 2.2 X 103 per 
well in standard calcium medium, allowed to grow for three to five days then switched to 
low calcium media and allowed to grow to confluence.  Confluent cultures were induced to 
assemble cell-cell contacts by adding serum-depleted standard calcium medium.  
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2.2 Transfection techniques 
2.2.1 cDNA transfections 
For cDNA overexpression (constructs detailed in table 2.1), confluent monolayers of 
keratinocytes, maintained in low calcium medium, were transfected using JetPrime 
transfection reagent (Polyplus, ILLkirch, France).  For coverslips, 0.25-2µg of cDNA per 
coverslip and JetPrime transfection reagent were mixed in a 1:2 ratio of cDNA (µg) to 
JetPrime (µl) in a total of 50µl JetPrime Buffer and incubated at room temperature (RT) for 
10 minutes.  Cells were washed once in low calcium medium then replaced with 350µl low 
calcium medium per well. The transfection mix was added drop-wise around the edge of 
the well to make a total volume of 400µl.  Cells were incubated at 37˚C with 5% CO 2
For overexpression in 3cm dishes, cells were transfected using Effectene transfection 
reagent (Qiagen) as follows. Transfection mixes were made of 0.4µg cDNA at a 1:8 ratio 
with enhancer (µl) in 100µl EC buffer and incubated for 5 minutes at RT. Effectene 
transfection reagent was then added at a 1:25 ratio cDNA (µg) to Effectene (µl) and 
incubated for a further 10 minutes at RT. Low calcium medium was added to the 
transfection mix to a total volume of 600µl. Cells were washed once with medium and 
600µl added dropwise to the dish then mixed forwards and backwards. Cells were 
incubated at 37˚C with 5% CO
 for 
four hours.  Medium was changed and cells were left to express for a further four hours. 
2
2.2.2 SiRNA transfections – small scale 
 for six hours.  Medium was changed and cells were left to 
express for a further 18 hours. 
SiRNA oligonucleotides (sequences and working concentrations shown in table 2.2) were 
resuspended in 1x siRNA buffer (containing 100mM KCl, 30mM HEPES-pH7.5, 1mM 
MgCl2) in RNAse-free diethylpyrocarbonate (DEPC)-treated water (Dharmacon, Thermo 
Scientific, Colorado, USA). Cells were transfected with INTERFERin® transfection reagent 
(Polyplus). SiRNA oligonucleotides were mixed with INTERFERin® transfection reagent 
(0-10nM, 20-50nM, >50nM final concentration siRNA with 2, 3 or 5µl INTERFERin®, 
respectively) in 100µl serum free low calcium medium for 10 minutes. Cells were washed 
once and replaced with 300µl low calcium medium (containing serum).  100µl transfection 
mix was added drop-wise around the edge of the well and mixed forwards and backwards, 
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then incubated at 37˚ C with 5% CO 2
 
 for four hours. Medium was changed and cells were 
incubated for a total of 24 to 72 hours. 
Observations Construct Vector Source 
ARHGEF10 
constitutively active 
ARHGEF10 pEGFP_C2 T332I Gift, S. Inagaki 
(Graduate School of 
Medicine, Osaka 
University, Osaka, Japan.) 
ARHGEF10 
constitutively active 
construct rendered 
GEF dead   
ARHGEF10ΔDH pEGFP_C2 T332I Gift, S. Inagaki  
(Graduate School of 
Medicine, Osaka 
University, Osaka, Japan.) 
ARHGEF10 wild-type ARHGEF10-WT pEGFP_C2 Gift, S. Inagaki  
(Graduate School of 
Medicine, Osaka 
University, Osaka, Japan.) 
E-cadherin E-cadherin-GFP pCDNA.3 Gift, M. Frame (Edinburgh 
University, UK) 
EGFP control n.a pEGFP_N1 Clontech 
Trio GEFD1 dead  TRIO
(Trio
Q1368A/L1376E 
G1QA/LE
pEGFP_LL-C1 
) 
Gift, A. Debant   
(CRBM-CNRS, 
Montpellier, France.) 
Trio GEFD2 dead TRIO
(Trio
L2051E 
G2LE
pEGFP_LL_C1 
) 
Gift, A. Debant   
(CRBM-CNRS, 
Montpellier, France.) 
Trio wild-type TRIO-WT pEGFP_LL_C1 Gift, A. Debant   
(CRBM-CNRS, 
Montpellier, France.) 
Table 2.1 cDNA plasmid information. N.B. All constructs are of human origin. 
2.3 SDS-PAGE and Western blotting  
Cells were lysed in 70µl (coverslips) or 500µl (3cm dishes) buffer (50mM Tris-HCl pH 6.5, 
1% SDS, 10% Glycerol, 50mM sodium fluoride, 20mM β-glycerophosphate, 1mM sodium 
orthovanadate, 1mM sodium molybdate, ImM each of PMSF, Leupeptin, Pepstatin and  
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Oligonucleotide 
name 
Oligonucleotide sequence Amount 
transfected (nM) 
siARHGEF10#1 5’-GAACCUUACCUAAAUAAUG-3’ 20 to 60 
siARHGEF10#4 5’-GACCUAACCCGUUUAAAGG-3’ 20 
siARHGEF10#5 5’-CCAAAGAACGCCGCGUCUUUU-3’ 20 to 60 
siDOCK180#1 5’ GUACCGAGGUUACACGUUA 3’ 50 
siDOCK180#4 5’ GGCCCAAGCCUGACUAUUU 3’ 50 
siEGFR#5 5’ GAAGGAAACUGAAUUCAAAUU 3’ 5 
siEGFR#8 5’ GUAACAAGCUCACGCAGUUUU 3’ 5 
siTRIO#1 5’-GAUAAGAGGUACAGAGAUU-3’ 20 to 60 
siTRIO#2 5’-GGAAGUCGCUCCUUGACAA-3’ 20 to 60 
siTRIO#3 5’-CAACGGAGAGUCCAUGUUA-3’ 20 to 60 
siTRIO#4 5’-GAACACCAACUUCAGAUAA-3’ 20 to 60 
siRNA Non-
targetting 
control#1 
(Dharmacon) 
5’-AUGAACGUAAUUGCUCAA-3’ Corresponding to 
targeting 
concentration 
Table 2.2 SiRNA oligonucleotide sequence information and transfection details. 
Pefabloc). For SDS-PAGE, 5X sample buffer (5x stock: 0.2mM Tris pH6.8, 50% glycerol, 
5% SDS, 0.25M DTT, 250mg bromo-phenyl Blue dye) was added to lysates to 1X and 
equal amounts of total protein were loaded. Samples were separated by SDS-PAGE. For 
protein analysis gels were either stained with Coomassie Brilliant Blue (0.1% Brilliant Blue 
dye, 45% methanol, 10% acetic acid) or subjected to Western blot. 
For Western blots, gels were transferred to either polyvinylidene fluoride (PVDF) 
membrane (Millipore, equilibrated in methanol) or for Trio detection, Hybond-C 
Nitrocellulose membrane (Amersham Biosciences, equilibrated in water) using standard 
wet transfer methods and buffer (50mM Tris, 380mM glycine and 20% methanol) at 100V 
for 60 minutes or 90 minutes for detection of proteins larger than 180 kDa. After 
transferring, total protein was visualised by staining the PVDF or Hybond-C nitrocellulose 
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membranes with Amido Black solution (Sigma-Aldrich) or Ponceau Red (Sigma-Aldrich), 
respectively. 
For immunodetection, membranes were then blocked with 5% non-fat dried milk (Marvel) 
in Tris-buffered saline (TBS) pH7.5 containing 0.1% Tween-20 (Sigma-Aldrich) (TBS-T), 
with shaking for 1 hour at RT before incubating with primary antibody (see table 2.3 for 
antibody product details and working dilutions) overnight at 4°C. Membranes were washed 
three times for 5 minutes with TBS-T, then incubated with secondary antibodies (as 
indicated in table 2.4) for 1 hour at RT.  Membranes were washed three times in TBS-T 
then developed using chemiluminescence reagents ECL or ECL plus (GE Healthcare) and 
exposed to hyperfilm (Amersham Biosciences).  Repeated exposures were conducted to 
obtain a chemiluminescent signal in the linear range. Developed hyperfilms were scanned 
using an LAS-3000 scanner (Fuji Film, UK) and analysed by densitometry with ImageJ 
software.   
2.4 Immunofluorescence labelling and image acquisition  
2.4.1 Fixation 
For standard immunofluorescence processing cells were fixed with 3% paraformaldehyde 
(PFA) in phosphate-buffered saline (PBS) for 10 minutes at RT then washed 3 times in 
PBS. Cells were then simultaneously permeabilised and blocked with 0.1% Triton X-100 
(Sigma-Aldrich) diluted in 10% FCS-PBS solution, for 10 minutes at RT. Cells were then 
washed 3 times in PBS before staining. 
For pre-fixation detergent extraction experiments cells were permeabilised (10mM PIPES 
pH6.8, 50mM NaCl, 3mM MgCl2, 
 
300mM Sucrose and 0.5% Triton X-100) for 10 minutes 
at RT, washed once in fresh buffer before fixing with 3% PFA as above. Cells were then 
blocked with 10% FCS for 10 minutes at room temperature before staining.  
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Antibody Species Clone Source Dilution IF 
Dilution 
WB 
ARHGEF10 Mouse  Sigma (#SAB1400356) - 1:1000 
Beta-Actin Mouse C4 MP Biomedicals (#691000) - 1:100,000 
Cdc42 Mouse 44 Transduction laboratories (#610928) - 1:1000 
DOCK180 Rabbit H-70 Santa Cruz (#sc5625) 1:50 1:500 
E-cadherin Mouse HECD1-sup 
Gift, M. Takeichi (NCCRI, 
Tokyo, Japan) 1:000 1:1000 
E-cadherin Rat ECCD2 Invitrogen (Zymed) (#131900) 1:500 - 
EGFR Rabbit 1005 Santa Cruz (sc03) 1:500 1:500 
EGFR p992 Rabbit  Gift, H. Huitfeldt (University of Oslo, Norway) - 1:500 
EGFR p1045 Rabbit  Cell Signalling (#2237) - 1:500 
EGFR p1068 Rabbit  Cell Signalling (#2234) - 1:500 
EGFR p1086 Rabbit  Biosource (#44-790) - 1:500 
EGFR p1148 Rabbit  Cell Signalling (#4404) - 1:500 
EGFR p1173 Rabbit  Gift, H. Huitfeldt (University of Oslo, Norway) - 1:500 
GAPDH Mouse 6C5 Abcam (#ab8245) - 1:100,000 
HSP90 Mouse S88 Novus Biologicals (#NB120-1429) - 1:1000 
pMLCser19 Rabbit  Cell Signalling (#3671) - 1:500 
Rac Mouse 23A8 Millipore (Upstate) (#05389) - 1:1000 
RhoA Mouse 26C4 Santa Cruz (#sc418) 1:100 1:500 
RhoC Rabbit D40E4 Cell Signalling (#340S) - 1:3000 
Trio Rabbit  Gift, A. Debant (CRBM-CNRS, Montpellier, France.) - 1:500 
α-catenin Rabbit VB-1 V. Braga (Imperial College London, UK) - 1:2000 
β-catenin Rabbit VB-2 V. Braga (Imperial College London, UK) - 1:3000 
β-tubulin Mouse Tub 2.1 Sigma (#71-5500) - 1:100,000 
Table 2.3 Primary antibodies used for Western Blot (WB) and immunofluorescence 
labelling (IF). N.B All antibodies are against human antigens. 
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Reagent Species Supplier Dilution 
   IF WB 
Cyanine (Cy2)-conjugated 
anti-mouse IgG Goat 
Jackson Immuno 
Research 1:1000 - 
Cyanine (Cy2)-conjugated 
anti-Rabbit IgG Goat 
Jackson Immuno 
Research 1:200 - 
Cyanine (Cy2)-conjugated 
anti-Rat IgG Goat 
Jackson Immuno 
Research 1:1000 - 
DAPI - Sigma-Aldrich - 1:3000 
HRP-conjugated goat anti-
mouse IgG Goat DAKO - 1:5000 
HRP-conjugated goat anti-
Rabbit IgG Goat DAKO - 1:5000 
Indocarbocyanine (Cy3)-
conjugated anti-mouse IgG Donkey 
Jackson Immuno 
Research 1:5000 - 
Indocarbocyanine (Cy3)-
conjugated anti-Rabbit IgG Donkey 
Jackson Immuno 
Research I:3000 - 
Indodicarbocyanine (Cy5)-
conjugated anti-mouse IgG Donkey 
Jackson Immuno 
Research 1:1000 - 
Phalloidin-AlexaFluor-488 - Invitrogen - 1:1000 
Phalloidin-AlexaFuor-568 - Invitrogen - 1:1000 
Table 2.4 Secondary antibody information used for immunofluorescence (IF) and 
Western blotting (WB). 
Fixation using trichloroacetic acid (10 % TCA (Sigma-Aldrich) in PBS) was used for 
experiments requiring endogenous RhoA staining (Godsel et al, 2010; Hayashi et al, 1999; 
Piekny et al, 2005; Takaishi et al, 1995; Yonemura et al, 2004). To fix, cells were 
incubated with ice cold 10% TCA for 10 minutes on ice, quenched by washing 3 times in 
30% glycine-PBS. To permeabilise, cells were incubated with 0.2% Triton X-100 on ice for 
15mins then washed 3 times in 30% glycine-PBS. Cells were then blocked in 2% BSA-
PBS at RT for 1hr before immunofluorescence processing. 
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2.4.2 Labelling 
See tables 2.3 and 2.4 for a comprehensive list of primary and secondary antibodies used 
for immunofluorescence staining. Primary and secondary antibodies, Phalloidin and DAPI 
were diluted in 10% FCS-PBS. All staining protocols were conducted sequentially to 
minimise cross-reactivity of antibodies. All antibody incubation steps were performed for 
30 minutes in the dark at RT (unless otherwise stated) with nine PBS wash steps in 
between. Coverslips were washed three times in water and mounted in Mowiol mounting 
medium (Calbiochem, Ca, USA) on microglass slides (Fisher Scientific).   
For standard E-cadherin labelling anti-mouse E-cadherin (HECD1-sup) was routinely 
used. For DOCK180 localisation studies cells were incubated with primary rabbit-anti-
DOCK180 antibody for 1 hour. For bead assays, F-actin was detected using 568- or 565- 
conjugated Phalliodin (Invitrogen).  For detection of RhoA, cells were first labelled with 
anti-Rat-E-cadherin (ECCD2) followed by incubation with mouse-anti-RhoA diluted in 2% 
BSA-PBS overnight.   
2.4.3 Immunofluorescence image acquisition 
Confocal Z-slices of 0.2μm were taken sequentially on a Leica DCS NT confocal 11 
microscope with Leica LCS Lite software. Z-slices were summed and images were 
processed using open source ImageJ software. Epifluorescence images were acquired 
using an Olympus Provis AX70 microscope coupled to a SPOT RT monochrome camera 
using SimplePCI 6 software (Hamamatsu, Japan) or Zeiss Axiovert 200 microscope with 
Velocity software. All gain, offset, exposure times and neutral density filter settings were 
kept constant for images acquired within the same experimental repeat. Multi-channel 
images were acquired sequentially.   
 
2.4.4 Image quantification 
All images were analysed using open source ImageJ software. Several methods to assess 
the levels of E-cadherin and F-actin at the junctions and within the cells have been 
employed throughout this study. This is due to a process of development over the project 
duration.  
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Assessment of E-cadherin and F-actin were made using the intensity-based threshold 
methodology described in Figure 2.1 and Figure 2.2. DOCK180 co-localisation with 
junctional E-cadherin was detected as for junctional actin, with F-actin images being 
replaced with DOCK180 images.  For all channels, the percentage area remaining after 
thresholding was calculated by dividing the thresholded pixel area by the raw image pixel 
area. Two to four images were analysed per time-point per sample and per experiment. 
Three experiments were analysed and pooled data used for statistical analysis.  
 
Assessment of E-cadherin levels in Trio expressing cells was performed using the 
methodology described in Figure 2.3. To asses junctional E-cadherin levels in cells after 
ARHGEF10 knockdown or in ARHGEF10 transfected cells, the segmentation based 
quantification shown in Figure 2.4, developed by Kevin Kereuden (Imperial College 
London), was used. Constant junction pixel width and E-cadherin pixel intensity threshold 
were selected according to a number of control images and applied equally to all images in 
the same replicate for all experimental conditions.  For images acquired after knockdown, 
all the cells (if in focus) in the monolayer can be evaluated per image to give an image 
average. The image averages are further normalised to the mean of the controls. All 
normalised image averages from three independent experiments were pooled to find the 
condition average.  For images of overexpressing cells, a number of individual cells per 
condition are normalised to the mean of the controls per replicate then pooled from 
independent experiments to give a condition average.  
 
RhoA enrichment was calculated by measuring the average intensity of pixels in a line 
drawn over a junction to encompass the width and length of the junction, compared to that 
of pixels in a line of the same length and width drawn in the cytoplasm, immediately 
adjacent to the same junction. The fold change in average intensity from cytoplasm to 
junction was calculated and junctions scored as positive (enriched) if fold change values 
were greater than one. All other junctions were classed as negative for RhoA. Only 
junctions where enrichment of E-cadherin (calculated in the same way) was observed, 
were included in the analysis.  Raw numbers of positive and negative junctions were 
pooled from three independent experiments and analysed by the Chi-square test.  
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Figure 2.1 Intensity-based thresholding to quantify area. A) Raw 8-bit greyscale images can 
be plotted as histograms showing the number of pixels at each intensity from 0 – 225. 
Thresholding highlights pixels (red) above a chosen intensity. The number of pixels above 
threshold can be counted as the area under the curve bounded by the threshold line (red dotted 
line) and given as a percentage of the total area (e.g. all the pixels in an image) to give % Area 
values. This quantifies the amount of labelled protein in an image, above a certain intensity. B) 
When the same threshold (i.e. as chosen for a control image) is applied to histograms from images 
of varying intensities, the area values can be used to compare the amount of labelled protein, 
above the threshold intensity, in each image.   
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Figure 2.2 Quantitative image processing threshold method.  Algorithms were used to process 
the raw images to a quantitative output. E-cadherin (A), F-actin (E) and the nuclei (B) images were 
acquired per sample.  E-cadherin was thresholded to eliminate low intensity background pixels. 
The threshold value was used to create an original binary mask, which was also inverted (C). To 
segment the F-actin pool that co-localises with E-cadherin, the original E-cadherin binary mask 
was overlaid on the F-actin image and pixels removed from F-actin if they corresponded to the 
opaque region of the E-cadherin mask (F).  The resulting image is the junctional actin (Jun-A; H).  
Similarly, the inverted E-cadherin mask (C) and a nuclei mask (D) were overlaid on the F-actin 
image (G). Remaining pixels excluded from the junctions and nuclei compose the output image for 
cytoplasmic actin (Cyt-A; I). Jun-A and Cyt-A images were further thresholded to remove final low 
intensity background pixels. 
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Figure 2.3 Quantification of junctional E-cadherin upon Trio overexpression. 1. GFP 
expressing cells were intensity thresholded to remove background. Each cell is a region of interest 
(ROI). 2. Total pixel number (area) of each ROI binary was measured.  Only ROIs above a size 
threshold were measured to remove non-specific high intensity pixels in the background. 3. GFP 
masks were overlaid on the E-cadherin image. 4. Junctional E-cadherin was measured by intensity 
thresholding to remove cytoplasmic E-cadherin and the resulting thresholded pixel number (Area) 
measured. The threshold value was kept constant across images from the same replicate. 5. 
Junctional E-cadherin as a percentage of the whole GFP expressing cell was then calculated for 
each ROI.  
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Figure 2.4 Quantification of junctional E-cadherin by segmentation. 1 and 2. A constant 
junction width is set and pixel area measured for all junctions associated with a cell. 3 and 4. 
Within the constant region E-cadherin is intensity thresholded and the resulting pixel area 
measured. 5. The ratio of the two measurements give the relative amount of junctional E-cadherin 
per cell. 
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2.5 Cell fractionation  
For particulate fractionation, keratinocytes were washed once in cold PBS containing 
sodium orthovanadate and then lysed in 700μl hypotonic lysis buffer (20mM HEPES 
pH7.4, 5mM sodium pyrophosphate, 5mM EDTA, 1mM MgCl2
2.6 Bead assay 
 and 20mM NaF, 1mM 
sodium pyruvate, 1mM sodium orthovanadate, 1mM β-glycerophosphate, 1mM each of 
PMSF, Leupeptin, Pepstatin and Pefabloc). Lysates were cleared by centrifugation for 5 
minutes at 800 g at 4°C. The supernatant was collected and centrifuged at 100 000 g for 
45 minutes at 4°C using a Beckman Optima™ TL Ultracentrifuge. The particulate fraction 
was resuspended in 300μl sample buffer (as described above). 
Polystyrene beads (15μm, Polysciences) were coated with anti-E-cadherin antibody 
(1.8μg/coverslip) over night at 4°C. Control beads are coated in heat denatured BSA 
(10mg/ml) (Fluka Chemicals, Sigma-Aldrich). Beads were washed three times in PBS then 
blocked with heat inactivated BSA (10mg/ml) for 1 hour at RT, with occasional tapping. 
Beads were washed a further three times in PBS and resuspended in 50µl/coverslip warm, 
serum depleted low calcium medium. Coverslips of confluent monolayers of keratinocytes 
maintained in low calcium conditions were removed from the culture dish and placed with 
cells facing up in a humid chamber. Resuspended beads were pipetted onto each 
coverslip (50µl) then incubated for 20 minutes. Coverslips were then washed with extreme 
care by dipping in PBS to remove unbound beads, then processed for 
immunofluorescence labelling as described above. Beads were scored as positive for 
DOCK180 and F-actin if an enrichment of DOCK180 was seen around the bead or if three 
or more distinct patches of F-actin accumulation were associated with the bead in the  
of attachment. Images were quantified by calculating the percentage of positive attached 
beads per image. As controls, recruitment of DOCK180 and F-actin to BSA coated beads 
were performed.  
2.7 Protein production and purification 
GST-fusion proteins were produced in the BL21 strain of Escherichia coli (E.coli) 
(Novagen). Fresh cDNA transformants were used to produce overnight cultures (100ml) 
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grown at 37°C in LB medium. Cultures were diluted to 1 litre and grown at 37°C to an 
optical density of 0.6 (600nm) (Aquarius, Cecil Instruments, Cambridge, UK). Protein 
production was induced with 1mM IPTG for 5 hours at 30°C. A sample (1ml) was taken 
before and after induction, centrifuged and resuspended in 1x sample buffer for further 
analysis by SDS-PAGE.  
For GST-Rhotekin-RBD purification bacteria were pelleted at 2620 g for 15 minutes, 
resuspended in PBS then pelleted before resuspension in 20ml Buffer I (50mM Tris-HCl 
pH 8.0, 40mM EDTA, 25% sucrose (w/v), 1mM PMSF). Lysozyme (1mg/ml) and PMSF 
(1mM) were added and samples agitated for 20 minutes at RT. Buffer II (50mM Tris-HCl 
pH 8.0, 100mM MgCl2
2.8 Determination of RhoA activity levels in vivo 
, 0.2% Triton X-100 (w/v) and 1mM of each protease inhibitor 
PMSF, Leupeptin, Pepstatin and Pefabloc)  was added (8mls) and samples were gently 
mixed at 4°C for 20 minutes. Each sample was sonicated four times at half-maximal power 
for 30 seconds, with 20 seconds rest on ice between each round.  Bacteria were then 
centrifuged at 110000 g for 30 minutes at 4°C. The supernatant was incubated with 
glutathione sepharose 4B beads (Pharmacia), previously equilibrated in Buffer II, at a 1:1 
ratio per initial litre of bacteria, for 1 hour at 4°C. Beads were washed 4 times in wash 
buffer and resuspended in 50% glycerol in PBS with 1mM DTT. Samples of final pellet, 
supernatant, pre- and post-IPTG-bacterial pellet were analysed by SDS-PAGE.  
Confluent monolayers of keratinocytes in 9cm dishes were maintained in low calcium 
were washed twice in ice cold PBS then lysed in 1ml lysis buffer (50mM Tris-HCl pH7.5, 
1% Triton X-100, 0.5% sodium deoxycolate, 500mM NaCl, 10mM MgCl
medium and not fed for 48 hours prior to use. Cells were then subjected to calcium 
stimulation to determine the activity levels of RhoA in vivo.  After calcium stimulation cells  
2 and1mM of each 
protease inhibitor PMSF, Leupeptin, Pepstatin and Pefabloc). Lysates were cleared by 
centrifugation for 2 minutes, 14268.8 g at 4ºC, then incubated with GST-Rhotekin-RBD 
immobilised on beads for 40 minutes at 4°C. Beads were pelleted and the supernatant 
retained to evaluate total levels of Rho protein. Beads were washed three times in wash 
buffer (50mM Tris-HCl pH7.5, 1% Triton X-100, 150mM NaCl, 10mM MgCl2, and 1mM of 
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each protease inhibitor PMSF, Leupeptin, Pepstatin and Pefabloc). Samples were then 
subjected to electrophoresis and Western blotting. 
2.9 Surface biotinylation 
Confluent monolayers of keratinocytes maintained in low calcium medium were subjected 
to a calcium switch time course (no switch control, 0 minutes; 5, 15 and 30 minutes). Cells 
were washed once in PBS-Mg2+-Ca2+ (PBS supplemented with 1mM MgCl2 and 1mM 
CaCl2) and incubated with either PBS-Mg2+-Ca2+ or 0.5mg/ml Biotin NHS-E2 link (Pierce) 
dissolved in PBS-Mg2+-Ca2+ on ice for 30 minutes. Cells were washed once and the biotin 
quenched by incubating twice for 5 minutes with 15mM glycine /PBS-Mg2+-Ca2+. Cells 
were washed once in PBS-Mg2+-Ca2+
2.10  Dispase assay 
 and lysed in 500µl buffer (20mM Tris-HCl pH7.5, 
150mM NaCl, 0.1% SDS, 1% Triton X-100, 5mM EDTA, 10mM sodium fluoride, 1mM 
DTT, 1mM each PMSF, Leupeptin, Pepstatin and Pefabloc). Lysates were cleared by 
centrifugation at 14268.8 g for 2 minutes and incubated with 70µl pre-equilibrated 
streptavidin-immobilised agarose beads (Fluka) for 1 hour at 4°C with rotation. Samples 
were washed three times in lysis buffer and then analysed by SDS-PAGE and Western 
blotting. 
Following 30 minutes calcium switch confluent monolayers of keratinocytes were detached 
from 2cm2 wells by incubation with 300ul dispase II (2.4U/ml, Roche) in D-PBS (PBD, 
50mM HEPES pH7.4, 1.8mM CaCl2, 0.5mM MgCl2) for 30-50 minutes. Detached 
monolayers were transferred to a clean well and washed three times in D-PBS and imaged 
using 2.5X objective on an EVOS Xl transmitted light microscope (Advanced Microscopy 
Group (AMG), Life Technologies) with EVOS XL software. Monolayers were then agitated 
at 220rpm on an orbital shaker for 10 minutes at RT then re-imaged.  
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2.11  Fluorescence recovery after photobleaching 
2.11.1 FRAP image acquisition 
Confluent monolayers were grown in 3cm live imaging dishes (Mattek) and maintained in 
low calcium medium. Cells were transfected with E-cadherin-GFP using the Effectene 
reagent, 24 hours prior to imaging. Cells were washed once in warm sterile PBS then 
incubated in 1ml calcium switch FRAP medium (DMEM/F-12 (1:1) Gibco, UK), 
supplemented with 1.8mM CaCl2
2.11.2 FRAP analysis 
, 10% foetal calf serum, 5µg/ml insulin, 10ng/ml 
epidermal growth factor (EGF), 0.5µg/ml hydrocortisone (all from Sigma) and 0.1nM 
cholera toxin (Quadratech Diagnostics Ltd) for 20 minutes until imaging. Cells were 
imaged on a Leica SP5 inverted confocal microscope using Leica LAS AF Lite software 
FRAP module. Cells with E-cadherin-GFP expression at cell-cell contacts were chosen for 
analysis. Images were acquired from 20 minutes post switch, for 10 minutes (until 
photobleaching recovery had reached a plateau). One ROI per cell was chosen and set to 
further zoom during the bleach steps. Cells underwent four pre-bleach scans with a 488 
laser line at 10%, followed by ten bleach iterations at 100%. Five hundred subsequent 
post-bleach scans at 10% laser power, every 1.3 seconds were made to assess recovery. 
Six cells per condition were imaged per experiment.  Cells from three independent 
experiments were used for further analysis. 
The ROI of each bleach area was replicated in the background (i.e. in a non-transfected 
cell) and in an adjacent non-bleached junction.  To calculate the % recovery over time for 
each bleach region or adjacent junction, values for all time points were first normalised 
(bleach-background). Normalised bleach values were then expressed as relative to 
adjacent junction for each time point. All post-bleach % recovery reading were plotted 
against time. Graphs were analysed using GraphPad Prism software. Non-linear 
regression, using the equation f=Y0 + (plateau – Y0)(1-exp(-Kx)), was performed to find 
the half-time to recovery (t1/2) and plateau recovery value.  The immobile fraction (Fim) was 
calculated using the equation Fim = (1-(plateau – Y0)/(100-Y0))x100.  
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2.12  Statistical analysis 
All statistical analyses were performed using GraphPad Prism software. Where normalised 
data, expressed as fold change from control values that are set as 1 and have no 
variance, were used, samples were analysed using One sample t-Tests to compare 
means to the value 1. Unpaired Student’s t-Tests were used on raw data and when both 
samples and controls have been normalised to the mean of the controls then pooled.  
When multiple t-Tests were used in one analysis α values were adjusted by dividing by the 
number of times the same data set was used.  
2.13  RNAi screening 
2.13.1  RNAi screen workflow 
Immunofluoresence was used to assess the distribution of E-cadherin at junctions, and the 
two distinct populations of F-actin that have different subcellular localisations upon 
calcium-induced junction formation (Fig. 1.5). A primary RNAi screen tested 202 target 
genes with a Dharmacon SMARTPoolTM 
2.13.2  SiRNA transfections - screen 
library as chosen by a UK-wide consortium of 
scientists to include Rho proteins, Rho GEF, Rho GAP, RhoGDIs and Rho interacting 
proteins. This was previously performed and visually analysed (J. Erasmus). The library 
was spread randomly over four 96-well plates (Plates A-D) and ran in triplicate. The image 
data set was then quantitatively analysed and candidate proteins selected for a validation 
screen (J. McCormack and N. Welsh) (Fig. 2.5).  Validation screens were carried out 
separately on the different functional classes of proteins tested (Rho GTPases, Rho 
interactors, Rho GAPs and Rho GEFs).  This project focussed on validation of Rho GEF 
candidate proteins.  
For the previously performed Primary RNAi screen, 96-well plates of 80% confluent 
keratinocytes were transfected with 100nM siRNA SMARTPoolTM oligonucleotides 
(Dharmacon) containing four different targeting sequences. For the Rho GEF Validation, 
RNAi screen cells were transfected with 100nM of a single oligonucleotide (Dharmacon) 
per well.  The four different sequences from the pool were transfected separately per  
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Figure 2.5 RNAi screen workflow.  The screen was initiated using a SMARTpoolTM of 4 
oligonucleotides per target. Targets were previously selected by a UK-wide consortium of 
scientists. The cell culture and siRNA transfections were performed for 72 hours on 96-well plates 
followed by calcium induction of cell-cell contacts for 30 minutes (1).  Cells were then fixed and 
labelled to detect E-cadherin and F-actin and images acquired (2). Analysis was two-fold, whereby 
images were visually scored for perturbations in the normal junctional morphology (3a) and then 
quantitatively analysed using computer-based image processing (3b). Using the data generated by 
quantitative analysis a set of candidate proteins were selected (4).  These were then subjected to a 
validation siRNA screen using four single oligonucleotides per target. The screening process was 
repeated (1-3) and following quantitative analysis a number of hits were identified and taken 
forward for further biochemical and functional characterisation (5). Primary Screen of Rho 
regulators was performed and visually analysed previously by Jenni Erasmus.   
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target. SiRNA transfections were performed in low calcium medium using RNAifect 
(Qiagen) transfection reagent, at a ratio of 1:3 oligo to transfection reagent according to 
manufacturers’ instructions. Cells were incubated at 37°C in 5% CO2 
2.13.3  Immunofluorescence staining 
for four hours then 
medium changed to fresh low calcium medium. Transfections were for 72 hours with no 
further changes of medium.   
Cells were fixed, permeabilised and stained as above, using HECD-1 anti-E-cadherin 
antibody, DAPI and Phalloidin. Reagents were added to the wells using a Well-Mate 
microplate dispenser (ThermoFisher) and removed by flicking. Cells were mounted by 
adding Mowiol to the wells.  
2.13.4  Image acquisition 
Primary RNAi screen images were acquired using a GE Healthcare InCell 3000 with the 
acquisition parameters in table 2.5 (collaboration with Simon Stockwell, Institute of Cancer 
Research, London, UK). Rho GEF validation screen images were acquired using a 
Cellomics Array Scan IV with the acquisition parameters in table 2.6 (collaboration with Dr. 
Mike Howell, Cancer Research UK, London).  
2.13.5 Visual and quantitative image analysis 
For the Primary RNAi screen, 8-bit TIFF files of the 3rd Z-slice were inserted into a 96-well 
stack using an RNAi analysis programme (developed in-house, Ann Wheeler and Chris 
Tomlinson, Imperial College London).  For the Rho GEF Validation RNAi screen one field 
of view was used in the 96-well stack. To quantitatively analyse the acquired images, a 
custom-designed automated image-analysis software was used using the workflow 
outlined in figure 2.2. Images were normalised to a set of positive controls (Scrambled 
oligonucleotides) and Mock-treated controls on a plate-by-plate basis (Fig. 2.6A). 
Thresholds were set for the controls then applied globally to all experimental images per 
96-well plate. Quality control analysis was also carried out visually for each well.  Failed 
acquisitions and wells less than 90% confluent were discarded. Normalised values were 
then used to calculate a Z-score for each experimental well using the equation in figure 
2.6B.  Primary screen candidate proteins were selected if average (mean or median) Z-
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scores were outside of the cut-of values set as one standard deviation of the controls. For 
the validation screen, hits were selected if two or more of the individual oligos against a 
target were outside the positive cut off or if two or more were outside the negative cut off. 
 
 
 
Acquisition parameter Value 
E-cadherin 647 nm 
F-Actin 488 nm 
DAPI 364 nm 
Infrared autofocus Offset -1μm 
Frames 4 per section 
Spacing 1 µm 
Exposure 1.7 ms 
Binning 1 
Flat field none 
Table 2.5.  Image acquisition parameters for the InCell 3000 microscope. 
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Acquisition parameter Value 
E-cadherin Cy5 filter 
F-Actin FITC filter 
DAPI UV filter 
Autofocus Green channel 
Frames 2  at same z-plane 
Table 2.6.  Image acquisition parameters for the Cellomics ArrayScan IV 
microscope. 
 
 
 
  
 
 
Figure 2.6 Calculations used for statistical analysis of screen data. A) Raw % Area values in 
each experimental well were normalised to the controls selected for each 96-well plate. This was 
achieved by dividing the % Area value for each well by the mean % Area value for the chosen 
controls to give χ
E
. The same calculation was made to each control well to determine the 
normalised control values to give χ
C
. B) The mean of the normalised controls (μχ
C
) and the 
standard deviation of the normalised control (σχ
C
 ) was then used to calculate the Z-score for each 
experimental well.  
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3 Role of EGFR and the GEFs DOCK180 and Trio 
in junction formation and maturation  
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3.1 Introduction 
3.1.1 Mechanism of cadherin-EGFR crosstalk during junction assembly 
Upon induction of cell-cell contacts, E-cadherin is known to co-operate with EGFR to 
induce Rac activation in a ligand-independent manner (Betson et al, 2002). However, the 
molecular mechanisms that bridge the gap between EGFR and Rac activation, in this 
context, remain completely unknown. It is likely that EGFR is phosphorylated upon E-
cadherin-mediated stimulation in a distinct manner to EGF-mediated EGFR activation 
(Humtsoe & Kramer, 2010; Morandell et al, 2008). The ligand-independent 
phosphorylation state of EGFR might provide insight into the signalling pathways that 
transduce cadherin-EGFR signalling to activate Rac. 
Rho GEF proteins are key mediators of Rac activation in response to external signalling 
(Rossman et al, 2005; Schmidt & Hall, 2002a). Sos1, Vav2 and Tiam1 have been 
implicated in EGF stimulated Rac activation (Itoh et al, 2008; Marcoux & Vuori, 2003; 
Pandey et al, 2000; Ray et al, 2007; Scita et al, 1999; Scita et al, 2000) but current 
findings show these proteins are either not recruited to E-cadherin or are not required for 
Rac activation upon initial cell-cell contact formation (J. Erasmus, unpublished; Kraemer et 
al, 2007). Therefore, it may be that a number of Rac GEFs, distinct from those in canonical 
EGFR signalling, are recruited and activated during de novo junction formation (Morandell 
et al, 2008; Zaidel-Bar et al, 2007).  
3.1.2 Rac activation by DOCK180 
Of the many Rac GEFs identified to date, few are known to regulate AJ formation 
(McCormack et al, 2013; Rossman et al, 2005). One candidate GEF of interest is 
DOCK180. DOCK180 is the proto-typical member of the DOCK family of GEFs, 
possessing two DOCK Homology Regions (DHR), for localisation and GEF activity (Fig. 
3.1A) (Brugnera et al, 2002; Cote & Vuori, 2002; Hasegawa et al, 1996). Originally, it was 
hypothesised that DOCK180 GEF activity required interaction with the scaffold protein 
ELMO1 as a bi-partite GEF complex (Brugnera et al, 2002; Gumienny et al, 2001; Lu et al, 
2004). However, conflicting studies reported that ELMO1 is dispensable for DOCK180-
mediated Rac activation (Cote & Vuori, 2002; Côté & Vuori, 2006; Kiyokawa et al, 1998). 
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Figure 3.1 Domain structures of DOCK180 and Trio Rho family GEF proteins. A) DOCK180 
has an N-terminal SH3 domain required for the interaction with ELMO proteins which modulate the 
GEF activity of DOCK180. It also consists of the two GEF functional domains DOCK Homology 
Region (DHR) 1, necessary for subcellular localisation, and the DHR2 domain required for Rac 
binding and nucleotide exchange. A C-terminal poly-proline motif binds other regulatory proteins 
such as the adaptor proteins NCK and CRKII. B) Trio is a large-multidomain protein consisting of a 
lipid-binding Sec14 domain and multiple protein-interacting Spectrin repeats.  Trio has two GEF 
domains consisting of the tandam DH-PH domains seen in Dbl GEF family members. The N-
terminal GEF domain (GEFD1) has specificity for RhoG and Rac activation whilst the C-terminal 
GEFD2 domain specifically activates RhoA. Trio also contains an SH3 domain, Ig domain and a C-
terminal Serine/Threonine (S/T) kinase domain. Numbering indicates amino acids in A and B. 
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More recently, evidence suggests that EMLO1-DOCK180 interaction is required for 
transducing Rac-activated signalling to drive cellular processes such as the phagocytosis 
of apoptotic cells and cell migration, but not for Rac activation per se (Grimsley et al, 2004; 
Komander et al, 2008; Patel et al, 2010). In-depth biochemical studies now show that 
DOCK180 is likely to exist in an autoinhibited conformation, whereby the SH3 domain 
interacts with the DHR2 domain (Lu et al, 2005). Additionally, DOCK180 is thought to be 
constitutively bound to ELMO in cells (Cote et al, 2005; Gumienny et al, 2001), and ELMO 
itself exists in an autoinhibited conformation in resting cells (Patel et al, 2010). The current 
hypothesis is that upon targeting to the appropriate cellular compartment (i.e. the plasma 
membrane) which may involve RhoG (deBakker et al, 2004; Katoh & Negishi, 2003), 
ELMO autoinhibition is relieved by an unknown mechanism which leads to further relief of 
DOCK180 inhibition (Patel et al, 2010). This results in spatially restricted Rac activation to 
a multimeric protein platform to guide appropriate signalling in response to Rac (Patel et 
al, 2010).  The mechanisms that allow relief of autoregulation remain to be elucidated. 
Nevertheless, DOCK180 is well known to regulate Rac activity to drive three conserved 
cellular developmental processes: engulfment of apoptotic cells and phagocytosis, cell 
migration and myoblast fusion in C.elegans, Drosophila and mammals (Cote & Vuori, 
2002; Cote & Vuori, 2007; Meller et al, 2005; Miyamoto & Yamauchi, 2010).  Several lines 
of evidence suggest DOCK180 may be able to govern Rac activity during cell-cell contact 
assembly. First, in Drosophila, DOCK180 governs actin organisation at the leading edge of 
the migrating epidermis during dorsal closure (Erickson et al, 1997), a process that 
requires highly coordinated regulation of cell-cell contacts (Muñoz-Soriano et al, 2012).  
Secondly, DOCK180 is required for myoblast fusion in mammals in vivo (Laurin et al, 
2008) and in Drosophila (Erickson et al, 1997; Nolan et al, 1998), where expansion of 
initial cell-cell contacts is defective (Nolan et al, 1998). Furthermore, evidence suggests it 
is plausible that DOCK180 could participate in EGFR signalling as DOCK180 mediates 
Rac activation downstream of another growth factor receptor, PDGR/VEGFR-family-1 
(PVR1), to drive border cell migration during Drosophila oogenesis (Duchek et al, 2001). 
This is a process also known to involve the Drosophila classical cadherin, DE-cadherin 
(Niewiadomska et al, 1999) and a parallel pathway involving EGFR (Duchek & Rørth, 
2001). In this specific context, DOCK180 has not been demonstrated to participate 
downstream of ligand stimulation of EGFR. However, circumstantial evidence suggests 
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there could be interplay between EGFR and DOCK180 in other contexts. For example, 
DOCK180 binds to the SH3-domain containing adaptor protein CRK (Hasegawa et al, 
1996) and forms a complex with the p130-Cas adaptor proteins to stimulate Rac activation 
(Cote & Vuori, 2007). Importantly, adaptor proteins such as CRK are known to be 
regulated by activated growth factor receptors (Feller et al, 1998), and could therefore 
provide a link between EGFR and DOCK180. Together, these previous studies provide a 
basis for the prediction that DOCK180 may mediate Rac activation downstream of the 
cadherin-EGFR complex as junctions assemble.  
To this end, preliminary studies in the lab show that upon DOCK180 depletion junction-
induced Rac activation is abolished (J. Erasmus, unpublished), a phenotype similar to that 
of EGFR inactivation or depletion (Betson et al, 2002) J. Erasmus, unpublished). 
Moreover, DOCK180 depletion leads to increased susceptibility of newly formed cell 
aggregates to mechanical dissociation, suggesting DOCK180 is required to stabilise 
nascent cell-cell contacts (J. Erasmus, unpublished). However, to date the relationship of 
EGFR and DOCK180 remains to be elucidated. 
3.1.3 Rho GTPase activation by Trio 
As E-cadherin ligation triggers multiple cellular processes to drive proper epithelial 
biogenesis, it is possible that multiple GEFs are required. It is not currently known how 
multiple GEFs define distinct cellular processes downstream of a common stimulus (i.e. 
cadherin homophilic binding) or at what level of the signalling hierarchy specificity is 
defined. Identifying the role that multiple Rho GEFs play in epithelial biogenesis and how 
they are regulated, will help to understand the molecular networks and crosstalk 
mechanisms which co-operate to build junctions. 
A second protein of interest to operate downstream of EGFR is the multi-domain protein 
Trio (Fig. 3.1B). Trio has a protein kinase domain and two GEF domains (Debant et al, 
1996). The separate GEF domains drive nucleotide exchange on RhoG/Rac and RhoA 
GTPases (Blangy et al, 2000; Debant et al, 1996). Each GEF domain is differentially 
regulated by its associated C-terminal PH domain, whereby PH1 promotes GEF activity of 
DH1, whilst PH2 is inhibitory to DH2 (Bellanger et al, 2003). Trio binds to the trans-
membrane tyrosine-phosphatase LAR (Leukocyte common Antigen-Related) (Debant et 
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al, 1996), a protein tyrosine phosphatase that can be modulated by EGFR signaling (Ruhe 
et al, 2006).  Furthermore Trio has also been shown to act both in conjunction with 
DOCK180 and in distinct pathways to regulate Rac activity in apoptotic cell engulfment in 
C. elegans (deBakker et al, 2004; Lundquist et al, 2001).  
Importantly, Trio has been shown to interact with an actin binding protein, TARA, to 
regulate the actin cytoskeleton (Seipel et al, 2001). In mature epithelial MDCK cells with 
stable contacts, Trio is inhibited by association with TARA (Seipel et al, 2001; Yano et al, 
2011). When TARA-mediated inhibition of Trio is lost, Rac activity increases, leading to a 
reduction in junctional E-cadherin. Intriguingly, in this study on mature cell-cell contacts, 
Trio activation appears to have a minimal effect on the actin cytoskeleton. Furthermore, 
Yano and colleges did not investigate the contribution of Trio to the assembly of cadherin-
based adhesions (Yano et al, 2011). Other studies however, have implicated Trio in 
regulation of cadherin-based signaling during morphogenesis and differentiation. Trio 
regulates both the protrusion of neural crest cells and the organisation of neuronal clusters 
in the hindbrain downstream of a type II classical cadherin, cadherin-11 (Backer et al, 
2007; Kashef et al, 2009). Further studies in mammals show that Trio mediates myoblast 
fusion downstream of M-cadherin (Bach et al, 2010; Charrasse et al, 2007).  These 
processes share features relevant to the early stages of junction assembly.  Taken 
together, these studies underscore the hypothesis that Trio may play a role in regulating 
assembly of E-cadherin based junctions.  
3.2 Hypothesis and aims 
To this end, I hypothesise that E-cadherin ligation induces a profile of EGFR tyrosine 
phosphorylation distinct from ligand-dependent stimulation.  I predict that DOCK180 
localises to cell-cell contacts and its localisation and/or activation is regulated by EGFR 
and that the GEF activity of Trio is important for regulating Rac activity during cell-cell 
contact formation.  
 
I aim to characterise the specific pattern of EGFR tyrosine phosphorylation upon junction 
initiation to gain insight into how distinct cell-cell adhesion-driven cellular processes are 
governed. I will also investigate whether DOCK180 and Trio are required for cell-cell 
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junction assembly and consider how they regulate Rho GTPase activity to drive junction 
maturation and stability. 
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3.3 Results 
3.3.1 Ligand-independent modulation of EGFR phosphorylation during junction 
assembly. 
Although ligand-independent activation of EGFR has been previously demonstrated 
(Betson et al, 2002; Pece & Gutkind, 2000; Shen & Kramer, 2004), the precise pattern of 
tyrosine phosphorylation stimulated by E-cadherin-mediated junction formation has not 
been established in normal cells. Here I compared ligand-independent calcium-induced, 
with EGF-stimulated ligand-dependent, phosphorylation at tyrosine residues 992, 1045, 
1068, 1086, 1143 and 1172 at 0, 5, 15 and 30 minutes stimulation (Fig. 3.2).  Attempts to 
probe for phospho-tyrosine 845 were unsuccessful. The two profiles of phoshorylation 
differed between the two stimuli (Fig. 3.2). Compared with total EGFR levels, EGF-
stimulated activation led to an increase in phosphorylation over time of most residues 
tested (apart from residue 1148), whereas calcium stimulation did not. Instead, following 
calcium treatment, levels of phospho-tyrosine residues 1045, 1068 and 1148  appeared 
reduced after 5 minutes and remained reduced over time, whereas 992, 1086 and 1172, 
although decreased at 5 minutes,  appeared to recover towards to basal levels (T=0 
minutes) by 30 minutes (Fig. 3.2).  This compared to ligand-stimulation which lead to 
increased phosphorylation levels without an initial decrease for most residues (Fig. 3.2).  
The data indicate that EGFR tyrosine phosphorylation is modulated by ligand-independent 
stimulation and that the profile of modulation differs from the canonical EGF-induced, 
ligand-dependent phosphorylation. 
3.3.2 EGFR is required for recruitment of F-actin to clustered E-cadherin 
Depletion of EGFR results in fragmentation of E-cadherin staining at junctions induced for 
30 minutes (J. Erasmus, unpublished). However, there is little information specifically 
linking modulation of EGFR activity by E-cadherin to the cellular processes driven by 
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Figure 3.2 Ligand-independent modulation of EGFR phosphorylation during junction 
assembly. Confluent monolayers of keratinocytes cultured in low calcium medium were induced to 
form junctions by the addition of 1.8mM CaCl2 for 5, 15 or 30 minutes. Control cells were 
maintained in low calcium medium (0 minutes). Alternatively, cells were treated with 10μM EGF to 
stimulate ligand-dependent EGFR phosphorylation. After hypotonic lysis, particulate fraction-
containing membranes were analysed by Western blot using specific antibodies against the EGFR 
phospho-tyrosine (pY EGFR) residues shown, or total EGFR. Representative blots from a calcium 
(N=3) and EGF stimulation experiment (N=2).  
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clustered E-cadherin complexes. One such process is the Rac-dependent recruitment of 
F-actin to sites of homophilic E-cadherin binding (Braga et al, 1997), as EGFR is required 
for Rac activation (Betson et al, 2002). I therefore hypothesise that EGFR is required for 
the recruitment of F-actin to clustered E-cadherin. To investigate this hypothesis, I treated 
cells with anti-E-cadherin coated beads (α-cad) and assessed the recruitment of F-actin to 
attached beads by fluorescence imaging. In control cells (treated with scrambled siRNA), 
F-actin was recruited to α-cad beads in the form of puncta seen at the plane of imaging 
within the bead area (Fig. 3.3A). Upon depletion of EGFR (Fig. 3.3B), the number of 
attached beads containing recruited F-actin was significantly decreased compared with 
controls (p=0.0216) (Fig. 3.3C). The data suggest that EGFR is required for recruitment of 
F-actin to clustered E-cadherin complexes, a phenotype similar to Rac1 inactivation 
(Braga et al, 1997; Lambert et al, 2002).  
3.3.3 DOCK180 is recruited to newly forming cell-cell contacts independently of 
EGFR 
Two lines of unpublished data (J. Erasmus, unpublished) suggest that DOCK180 may play 
a role downstream of E-cadherin adhesion in epithelial cells. First, DOCK180 depletion 
abolishes calcium-induced Rac activation after 5 minutes, a similar phenotype to depletion 
of EGFR. Second DOCK180 depletion does not prevent proper formation of cell-cell 
contacts, but reduces the stability of newly-formed cell aggregates. A prediction from these 
data is that DOCK180 is recruited to AJs during cell-cell contact formation and that its 
localisation may require EGFR signalling. To assess the localisation of DOCK180, I 
induced junctions for different time points and probed for endogenous E-cadherin and 
DOCK180 by immunofluorescence staining. In control cells (T=0 minutes), E-cadherin and 
DOCK180 were present at low levels in a diffuse pattern throughout the cytoplasm (Fig. 
3.4A total panels). E-cadherin was clearly recruited to newly-formed junctions with a 
three-fold increase from 5 minutes to 30 minutes (p=0.0018) (Fig. 3.4A E-cadherin 
junctional panel and Fig. 3.4B). A pool of DOCK180 localised to the junctional region, 
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Figure 3.3 EGFR is required for recruitment of F-actin to clustered E-cadherin. Confluent 
monolayers of keratinocytes cultured in low calcium medium were treated with control scrambled 
(Con, Scr) or EGFR siRNA oligos, then incubated for 15 minutes with polystyrene beads coated 
with anti-E-cadherin antibody (α-cad). Cells were fixed and stained for F-actin using fluorescently-
labelled Phalloidin. A) Micrographs showing recruitment of F-actin to beads after control or EGFR 
siRNA. Zooms show the presence of F-actin puncta as indicated by the arrows. B) Representative 
Western blot showing the efficiency of knockdown for the experiment shown in panel A. Blots were 
probed anti-EGFR or GAPDH antibody as a loading control. Molecular weight markers are shown 
on the right of the panels. C) Quantitative analysis of the percentage of beads scored as positive 
for F-actin recruitment. N=4. Graphs show mean and error bars are SEM. * = p<0.05 after 
Unpaired Student’s t-Test.  Scale bars = 10µm (A) and 10µm (zoom). 
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Figure 3.4 DOCK180 is recruited to newly forming cell-cell contacts. Monolayers of confluent 
keratinocytes were maintained in low calcium medium (time zero, controls) or induced to form 
junctions by the addition of 1.8mM CaCl2 for 5 or 30 minutes. Cells were fixed at the time indicated 
and stained for endogenous E-cadherin (Magenta) and DOCK180 (Green). A) Projected confocal 
Z-slices positive for E-cadherin and DOCK180 are shown for each time point (Total and Merge 
panels). E-cadherin images were segmented by intensity thresholding to define the junctional 
region, which was then used to identify DOCK180 localisation at cell-cell contacts  (Junctional 
panels; described in section 2.2.4, Fig. 2.1 and 2.2). Bottom panels show the line-scan profiles 
between two junctions as indicated by the dotted line on the merge images above.  Arrows indicate 
the direction of the line scan corresponding with left to right on the graphs below. B) Quantification 
of E-cadherin and DOCK180 levels at junctions at 5 and 30 minutes. The junctional area in pixels 
is given as a percentage of the total image area (% total area). Groups were analysed using 
Unpaired Student’s t-Test, *=p<0.05, **=p<0.01. N=3. Graphs show mean and error bars show 
SEM. Scale bar = 10μm. 
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which also increased over time by one-fold from 5 minutes to 30 minutes  (p=0.0162) (Fig. 
3.4A DOCK180 junction panel and Fig. 3.4B). The line scan intensity plot profiles showed 
peaks of E-cadherin signal corresponding to junctional regions, with associated peaks of 
DOCK180 signal in the peri-junctional and junctional regions (Fig. 3.4A bottom panel).  
Taken together, these results indicate that DOCK180 is present at cell-cell contacts from 
the very early stages of junction formation (5 minutes) and remains associated with 
junctions as they mature.  
To establish whether DOCK180 recruitment requires E-cadherin, I treated keratinocytes 
with α-cad beads and visualised endogenous DOCK180 by immunofluorescence. Control 
beads (coated with BSA) were not able to induce the redistribution of cytoplasmic 
DOCK180 to attached beads (Fig. 3.5A). In contrast, DOCK180 was localised to α-cad 
beads in a ring-like configuration (Fig. 3.5A). The number of α-cad attached beads positive 
for DOCK180 recruitment was significantly increased compared to control beads 
(p=0.0006) (Fig. 3.5B).  Interestingly, after EGFR depletion (Fig. 3.5C), DOCK180 was 
localised to α-cad beads to the same extent as in control-treated cells (Fig. 3.5D and 
3.5E). These data suggest that DOCK180 is specifically recruited to clustered E-cadherin 
complexes and this is independent of EGFR activity. Yet, it is possible that EGFR may 
regulate DOCK180 activation rather than re-localisation to junctions. 
3.3.4 DOCK180 is not required for F-actin recruitment to clustered E-cadherin 
It is known that both DOCK180 and EGFR activity are required for junction-induced Rac 
activation (Betson et al, 2002; J, Erasmus unpublished) and that Rac activation is 
important for F-actin recruitment to clustered cadherins (Braga et al, 1997). I hypothesise 
that DOCK180 siRNA treatment will result in a similar phenotype to EGFR depletion and 
reduce recruitment of F-actin to clustered cadherins.  After treatment with DOCK180 
siRNA (oligo#1 or oligo#4) (Fig. 3.6A), F-actin puncta were localised to α-cad beads to the 
same extent as in control-treated cells (Fig. 3.6B and 3.6C). This indicates that in-fact, 
DOCK180 is not required for the Rac-driven recruitment of F-actin to clustered cadherin 
complexes.
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Figure 3.5 DOCK180 is specifically recruited to clustered E-cadherin in an EGFR-
independent manner. Keratinocytes grown to confluence in low calcium medium were incubated 
for 15 minutes with anti-E-cadherin- (α-cad) or BSA-coated control polystyrene beads. Cells were 
fixed and stained for endogenous DOCK180. Arrows indicate enrichment of DOCK180 around the 
periphery of the attached bead. A) Brightfield images showing representative bead and 
corresponding epifluorescence image of DOCK180. B) Quantification of the percentage of 
attached beads with recruitment of DOCK180. C) Western blots showing efficiency of EGFR 
silencing for experiments shown in D-E. Membranes were probed for the proteins shown on the 
left; molecular weight markers are shown on the right (KDa). D) Epifluorescence images of cells 
treated with siRNA against EGFR or a scrambled control (Con). Zooms show area of attached 
bead outlined in the panel above.  E) Quantification of DOCK180-positive beads after EGFR or 
control (Con) siRNA. B and E are derived from A and D, N=3. Graphs show means and errors bars 
are SEM. *** =p<0.001 after Unpaired Student’s t-Test. Scale bars = 1µm (A and D zoom) and 
10µm (D). 
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Figure 3.6 DOCK180 is not required for F-actin recruitment to clustered E-cadherin.  After 
DOCK180 depletion (oligo#1 or #4) or control siRNA (Con), confluent monolayers of keratinocytes 
maintained in low calcium medium were incubated with anti-E-cadherin-coated (α-cad) polystyrene 
beads for 15 minutes. A) Representative Western blots of DOCK180 knockdown efficiency. 
GAPDH was used as loading control. B) Epifluorescence images of cells stained for F-actin using 
fluorescently-labelled Phalloidin. Zooms are shown of the area highlighted by the white boxes.  
Arrows indicate F-actin puncta. C) Quantification of the percentage of attached beads containing F-
actin recruitment. N=3. Graphs show means and error bars are SEM. Data not significant after 
One-Way ANOVA. Scale bars = 10µm and 1µm (Zoom). 
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In conclusion, these results show that DOCK180 localises to cadherin contacts in an 
EGFR-independent manner. Despite the requirement of DOCK180 for junction-induced 
Rac activation (J. Erasmus unpublished), DOCK180 does not drive the Rac-specific 
recruitment of F-actin to cadherin clusters. Further studies to assess the link between 
EGFR and the mechanisms of DOCK180 activation are ongoing. 
3.3.5 Trio GEF domains 1 and 2 may both be important for perturbation of 
junctional E-cadherin by exogenous Trio  
Recent studies showing a role for the multi-domain GEF Trio in cadherin based adhesion 
(Bach et al, 2010; Charrasse et al, 2007; Yano et al, 2011), promoted us to investigate the 
role of Trio in E-cadherin-driven epithelial biogenesis. To establish whether Trio is 
important for junction assembly, I tested whether increased Trio activity per se can perturb 
junction formation, and to what extent its ability to activate Rac and Rho are required.  I 
overexpressed full-length wild-type Trio (Trio-WT) or one of two constructs with mutations 
that render either GEF domain inactive: mutations Q1368A and L1376E in Rac GEF 
domain 1 GEFD1 (TrioG1QA/LE) or single mutation L2051E in RhoA GEF domain 2 (TrioG2LE; 
Fig. 3.7A).  Exogenous full-length Trio-WT inhibited the assembly of AJs compared with 
GFP -transfected control cells (Fig. 3.7B). However, upon overexpression of TrioG1QA/LE 
junctions were able to form as well as, if not better than, control cells (Fig. 3.7B). Similarly, 
cells expressing TrioG2LE
Quantification of E-cadherin levels at junctions (as a percentage of a transfected cell, % 
total cell) showed no significant changes between the means over all conditions. This was 
due to the poor reproducibility of the data over the three replicates. Experiments 1 and 2 
followed the same pattern as obtained by visual analysis: that Trio-WT expression reduced 
junctional E-cadherin, and that Trio
 assembled junctions to the same extent as control cells (Fig. 
3.7B). 
G1QA/LE and TrioG2LE did not (Fig. 3.7C). The visual and 
quantitative trends imply that Trio activity is detrimental for AJ formation and both GEF 
domains participate in this function. The greater inhibition of Trio-mediated E-cadherin 
disruption by GEFD1 inactivation compared to GEFD2 inactivation may indicate that a 
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Figure 3.7 Trio GEF domains 1 and 2 may both be important for perturbation of junctional E-
cadherin by exogenous Trio.  A) Schematic representation of Trio cDNA constructs used for 
overexpression analyses (Trio wild-type (Trio-WT), Trio GEFD1 dead (TrioG1QA/LE), Trio GEFD2 
dead (TrioG2LE). B-C) Confluent monolayers of keratinocytes cultured in the absence of cell-cell 
contacts were transfected with full-length GFP-tagged Trio cDNAs or with a pEGFP vector control 
(GFP vector). After 8 hours post-transfection, cells were induced to form contacts for 30 minutes, 
fixed and stained for E-cadherin. B) Epifluorescence images of GFP-expressing cells (left-hand 
panels and merge) and corresponding E-cadherin (middle panels and merge). Right-hand panels 
show merged images. Arrows indicate junctions with normal levels of E-cadherin. Arrowhead 
indicates a junction with reduced E-cadherin. C) Quantification of the area of junctional E-cadherin 
(Junc. E-cad) expressed as a percentage of the whole cell (% total cell, quantification described in 
section 2.2.4 and Fig. 2.3). Each value has been normalised to the mean of the control condition 
within a replicate.  Graph show replicate values from three independent experiments with mean. 
Scale bar = 10µm. 
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coordinated feedback mechanism could mediate interplay between Rac and RhoA activity.  
3.3.6 Trio depletion increases E-cadherin, but not F-actin, insolubility at cell-cell 
junctions 
The above results indicate a role of Trio over-activation in de-stabilizing E-cadherin at AJs. 
I hypothesise that, conversely, loss of Trio will decrease solubility of E-cadherin and as 
such, stabilise E-cadherin at junctions. To test this hypothesis, I depleted cells of Trio and 
after junction induction pre-extracted cells with Triton X-100 to enable evaluation of the 
detergent-insoluble fraction of proteins. Stable cadherins such as those interacting with the 
underlying cytoskeleton or membrane bound proteins are more resistant to detergent-
extraction and are found in an insoluble pool (Marrs et al, 1993; McNeill et al, 1993; Shore 
& Nelson, 1991) and both soluble and insoluble E-cadherin reside at cell-cell contacts 
(Braga et al, 1995). Upon Trio depletion (Fig. 3.8A), E-cadherin and F-actin localised to 
junctional regions with the same morphology as in control-treated cells (Fig. 3.8B), with F-
actin arranged properly into thin bundles in the peri-junctional region (Fig. 3.8B). Trio 
depletion significantly increased the levels of insoluble E-cadherin at junctions (E-cad, 
p=0.0119), but did not significantly alter the levels of insoluble F-actin at junctions (Jun-A) 
or in the cytoplasm (Cyt-A) (Fig. 3.8C-E). Taken together, these results show that 
depletion of Trio leads to an increase in E-cadherin incorporation into and stability of 
newly-forming contacts without a concurrent increase in F-actin insolubility.  
3.3.7 Trio may be dispensable for F-actin recruitment to clustered E-cadherin 
It could be that E-cadherin and F-actin stabilisation may be regulated by different aspects 
of Rac signalling. I hypothesise that Trio might not be required for Rac-driven F-actin 
recruitment to beads, as a decrease in Jun-A was not observed previously in the absence 
of Trio.  In cells efficiently depleted of Trio (Fig. 3.9A) or in control-treated cells, F-actin 
was recruited in clusters of puncta to a proportion of attached beads (Fig. 3.9B and C; 
41.69% and 50.19% respectively). However, this difference was not statistically significant 
(p=0.189). This indicates that the Rac activity by endogenous Trio may be dispensable for 
recruitment of F-actin to clustered cadherin complexes. The implication is that either an 
alternative Rac-dependent or a RhoA-driven mechanism could be at play 
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Figure 3.8 Trio depletion increases E-cadherin insolubility at cell-cell junctions 
independently of F-actin solubility. Cultures of confluent keratinocytes maintained in low calcium 
conditions were treated with siRNA against Trio (Trio#4) or a control scrambled (Con) for 48 hours. 
Cells were induced to form junctions for 30 minutes. Cells were pre-treated with 0.5% Triton-X 100 
to extract soluble proteins, fixed and stained for E-cadherin (Top panels and merge) and F-actin 
(Middle panels merge). A) Efficiency of Trio knockdown relative to control-treated cells. Beta-
catenin was used as loading control. B) Projected confocal Z-slices positive for E-cadherin and 
corresponding F-actin are shown for each time-point. Arrows indicate junctional staining. 
Arrowheads indicate cytoplasmic localisation. C-E) Quantification of protein measured as a 
percentage of the whole image (Area (% total)) after intensity thresholding (see section 2.2.4, Fig. 
2.1 and 2.2 for image quantification).  Values are normalised to the mean of the control within a 
replicate.  All data points for each replicate from three independent experiments are shown. C) 
Junctional E-cadherin (E-cad). D) Junctional F-actin (Jun-A). E) Cytoplasmic F-actin (Cyt-A). 
Graphs show means.  * = p<0.05 after Unpaired Student’s t-Test.  Scale bar= 10µm. 
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Figure 3.9 Trio may be dispensable for F-actin recruitment to clustered E-cadherin. Bead 
assays using anti-E-cadherin-coated (α-cad) beads were performed for 30 minutes on cells 
depleted of Trio. A) Western blots showing efficiency of Trio depletion for images shown in B. 
Beta-catenin is shown as a loading control. B) Micrographs of F-actin recruitment to beads after 
control (Con) or Trio siRNA (Trio) treatment. Arrows show F-actin-positive beads whilst 
arrowheads indicate F-actin-negative beads. Zooms depict areas outlined above with arrows 
indicating F-actin puncta. C) Quantification of the percentage of F-actin-positive beads per 
condition. N=3. Values shown represent mean with SEM error bars. P-values are derived from 
Unpaired Student’s t-Test. Scale bars = 10µm and 1µm (zoom). 
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downstream of Trio.  
3.3.8 RhoA is activated by calcium-induced cell-cell contact formation 
Before investigating the potential role of endogenous Trio on RhoA at AJs, it was 
necessary to determine the activation state of RhoA as junctions assemble. Previous 
investigations into cadherin-induced RhoA activation have yielded inconsistent results. 
This is in-part due to differences in time-points measured, and in-part due to the 
methodologies used. When junctions are reconstituted in MDCK cell by calcium add-back, 
following initial calcium chelation in cells with pre-formed junctions, RhoA is not activated 
by 30 minutes (Nakagawa et al, 2001). Similarly, ligation of CHO cells exogenously 
expressing C-cadherin to immobilised C-cadherin ectodomains results in inactivation of 
RhoA activity at 30 minutes (Noren et al, 2001). However, in mouse keratinocytes RhoA is 
activated by 60 minutes following calcium-induction of confluent cells grown in the 
absence of cell-cell contacts (Calautti et al, 2002; Nakagawa et al, 2001). Importantly, the 
level of RhoA activity during the initial stages of cell-cell contact assembly (before 10 
minutes) has not been assessed in cells expressing endogenous E-cadherin.  
Here I investigated the activation profile of RhoA, in cells cultured to confluence without 
cell-cell adhesions, in the absence of serum-stimulation. I also assessed the contribution 
of cadherin signalling to calcium-induced RhoA activation. Using GST-Rhotekin-Rho 
Binding Domain (GST-RTK), I found that RhoA•GTP was rapidly increased following cell-
cell contact formation for 5 minutes (Fig. 3.10A). When expressed as fold-change from 
basal levels without cell-cell contacts (time zero), the peak of RhoA activation at 5 minutes 
(10 fold  increase) sharply decreased by 15 minutes (2.74 fold increase) (Fig. 3.10B). 
These data show that calcium-induced junction formation rapidly and robustly induces the 
activation of RhoA, but as junctions continue to form, RhoA activity is reduced to levels just 
above those in unstimulated cells. 
To investigate whether RhoA activation occurs in a cadherin-dependent mechanism, I pre-
treated cells on ice with anti- E- and P-cadherin antibodies to block homophilic binding, 
before inducing contacts with calcium at 37°C. Preliminary data suggested that in the 
absence of anti-cadherin antibodies, a reduction in temperature alone had a great effect 
on inducing RhoA activation and addition of calcium was able to attenuate this response 
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Figure 3.10 RhoA is activated by calcium-induced cell-cell contact formation. Keratinocytes 
cultured to confluence without cell-cell contacts (time zero, controls), were stimulated to form 
junctions for 5, 15, 30 or 60 minutes. Effector pull-down assays using GST-Rhotekin-Rho binding 
domain-recombinant protein (GST-RTK) were performed to assess the fraction of GTP-bound 
RhoA in each sample. A) Western blots showing levels of GTP-bound RhoA. RhoA from lysates 
(total) and amido black membrane stain of RTK protein are also shown. B) Densitometric 
quantification of RhoA•GTP/Total RhoA ratio, expressed as fold-change from levels at time zero. 
Mean values of three independent experiments with SEM error bars are shown. One sample t-
Tests performed on 5 and 30 minutes, α = 0.025, *=p<0.025. C, D) Cells were maintained at 4°C 
for 10 minutes in the presence or absence of anti-E- and anti-P-cadherin antibodies (+ or - α-cad). 
Cells were moved to 37°C and incubated for 5 minutes in the presence or absence of calcium (+ or 
- Ca2+) before lysis. Lysates were then subjected to GST-RTK effector pull-down. C) Control 
experiment representing the effect of calcium addition on cells previously maintained at 4°C in the 
absence of α-cad antibodies (N=1). D) Representative blots showing the effect of pre-treatment 
with α-cad antibodies on RhoA•GTP levels after 5 minutes calcium addition (N=3). 
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(Fig. 3.10C). However, pre-incubation with anti-cadherin antibodies blocked calcium-
mediated attenuation of temperature-induced RhoA activation (Fig. 3.10D). This suggests 
that, under these experimental conditions, the mechanism of RhoA inactivation may be 
partially dependent on cadherins. More experiments are required to ascertain the precise 
contribution of a cadherin-mediated mechanism to calcium-induced RhoA activation. 
3.3.9 Trio depletion attenuates junction-induced stimulation of RhoA activity 
One important question is whether RhoA activation at 5 minutes can be mediated by Trio. 
(Fig. 3.11A). In Trio-depleted cells, the levels of RhoA•GTP in unstimulated cells were 
increased two-fold compared with controls. However, this increase was not statistically 
significant (Fig. 3.11B and C). Upon induction of cell-cell contacts by addition of calcium, 
control cells were able to activate RhoA, though this change was not statistically significant 
from 0 minutes. This apparent activation was lost in Trio-depleted cells (Fig. 3.11B and 
D).  Taken together these data speculatively indicate that Trio may help maintain low 
levels of RhoA•GTP in cells without junctions, and be required for rapid RhoA activation 
upon cell-cell contact induction. However, firm conclusions from this data should be 
reserved until further experiments are performed to strengthen the statistical significance 
and confirm the phenotype of Trio depletion.  
In conclusion, I have shown that Trio activation is detrimental to the ability of cell-cell 
adhesions to assemble, whereas inactivation of Trio GEF activity may promote E-cadherin 
incorporation into junctions.  It is not yet clear whether upregulation of the insolubility of E- 
cadherin upon loss of Trio function is due to loss of Rac GEF or RhoA GEF activity.   
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Figure 3.11 Trio depletion attenuates junction-induced stimulation of RhoA activity. 
Keratinocytes grown in the absence of cell-cell adhesion were treated with Trio (Trio) or control-
scrambled (Con) siRNA for 48 hours. Cells were induced to form junctions for 5 minutes then 
lysates were subjected to effector pull-down assays using GST-RTK. Samples were assayed for 
GTP-bound RhoA and compared to RhoA levels in the total lysate. A) Western blots showing 
efficiency of Trio depletion. Beta-catenin was used as a loading control. B) Levels of RhoA•GTP 
after pull-down assay.  Lysates were probed for total RhoA and GAPDH as loading control. Amido 
black staining of membranes for GST-RTK are also shown. C,D) Quantification of active RhoA 
levels.  Values obtained for the RhoA•GTP were corrected for the total levels of RhoA in each 
samples.  C) Basal levels of active RhoA were obtained by expressing results relative to time zero 
of cells treated with control oligos.  D) Junction-dependent activation of RhoA was obtained by 
expressing values relative to time zero in each siRNA condition. Graphs show means of three 
independent experiments with SEM error bars. One sample t-Tests between Con and Trio (C) and 
0 and 5 minutes (Con and Trio, (D)) were not significant. 
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3.4 Conclusions  
These studies into the upstream regulation of Rho GTPases reveal novel information 
about how RhoA and Rac activities are regulated by different GEFs during epithelial 
biogenesis.  I show that RhoA is transiently activated by calcium-induced contact 
assembly. This may in-part require the GEF Trio as loss of Trio tends to inhibit junction-
induced RhoA activation. Moreover, inhibition of Trio function as a RhoA GEF, by mutation 
of each GEF domain, potentially rescues the reduction in junctional cadherin induced by 
wild type Trio.   
I also gain new insight into the mechanisms required for Rac-mediated signalling as 
junctions form.  Firstly, the profile of EGFR phosphorylation upon junction induction differs 
from that of ligand stimulation, suggesting that E-cadherin can modulate EGFR 
autophosphorylation state in a contact-dependent manner. Secondly, I show that 
DOCK180 localises to newly forming AJs and specifically to clustered cadherins.  
However, the localisation of DOCK180 is independent of EGFR. 
Finally, I find that EGFR functionally couples cadherin-ligation to Rac-mediated cellular 
signalling as loss of EGFR partially blocks F-actin accumulation at sites of cadherin-
clustering.   DOCK180 and Trio are dispensable for this particular process but are required 
for stabilisation of E-cadherin (J. Erasmus, unpublished) and regulation of E-cadherin 
insolubility, respectively.  Therefore, we have shown that multiple Rho GEFs participate in 
distinct processes to drive proper epithelial biogenesis.  
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3.5 Discussion 
3.5.1 Cell-cell contact formation triggers an early wave of RhoA activation 
Initial cell-cell contact formation can transiently stimulate RhoA activation. It suggests that 
early contact formation drives an initial wave of RhoA activation that is resolved as junction 
formation proceeds.  In mouse keratinocytes, Calautti and colleagues observed RhoA 
activation levels were not elevated above basal levels after 10 and 30 minutes stimulation 
(Calautti et al, 2002). However, extremely early time points such as 5 minutes were not 
measured and therefore likely missed the early transient peak of RhoA activity (Calautti et 
al, 2002). Together our findings indicate a very early initial wave of RhoA activation which 
occurs in the first 10 minutes following contact initiation.  
This is the first time that initiation of cell-cell contact assembly by calcium-addition alone 
has been shown to robustly stimulate early RhoA activation.  Weak activation of RhoA was 
observed in cells requiring disassembly of pre-formed junctions with EGTA-treatment prior 
to addition of calcium ions (Noren et al, 2001). Under such conditions, disassembly of 
junctions can also activate RhoA (Samarin et al, 2007). Furthermore, EGTA-treated 
rounded cells first undergo cell spreading in order to initiate cell-cell contacts: a process 
known to inactivate RhoA (Jackson et al, 2011). Together these processes, independently 
of the cell-cell adhesion process, may contribute to changes in GTP-bound RhoA (Noren 
et al, 2001).   
How calcium addition triggers RhoA activation is still unknown. Cadherin ligation could 
modulate Rho GEF activity such as in the case of Tiam1 regulation during TJ assembly in 
MDCK cells (Guillemot et al, 2008). A transient peak of Rac activity is controlled by 
upregulation of Tiam1 followed by its inactivation (Guillemot et al, 2008). Alternatively, 
modulation of Rho GAP activity could regulate the activation state of RhoA. Although 
several Rho GAPs are implicated in epithelial junction maintenance (McCormack et al, 
2013), as yet, none have described roles in AJ formation.  Having established the RhoA 
activation profile in our model of calcium-induced cadherin-mediated junction formation, 
we are now able to look specifically at the signalling mechanisms that regulate this 
process.  
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Whether calcium-induced contact formation is cadherin-dependent remains unresolved. 
My assessments were hampered by the finding that pre-incubating cells on ice before 
inducing junctions invokes a large activation of RhoA. This could be a stress-response, as 
Rho/ROCK signalling can be induced even by cooling to 28°C in HEK293 and vascular 
smooth muscle cells (Bailey et al, 2004). It is not clear why calcium addition attenuates 
RhoA activation. However, the addition of anti-cadherin anti-bodies blocked the effect of 
calcium indicating that calcium signals via cadherins to counter/inhibit the stress-induced 
increase in active RhoA. Further experiments are required to confirm the dependency of 
cadherins in junction induced RhoA activation. 
3.5.2 Integration of RhoA and Rac activation could be mediated by Trio 
Here, I have uncovered a novel role for Trio in junction formation in normal human 
keratinocytes. My data suggest that Trio may be necessary for the transient junction-
induced RhoA activation.  Regarding Rac signalling, due to time constraints I have not 
demonstrated that, in keratinocytes, Trio activates Rac1 during junction assembly.  This 
will be important to ascertain in the future. These results are interesting in the context of 
previous reported functions of Trio in epithelial biogenesis and epithelial-derived cancers, 
where aberrant activation of Trio leads to disruption of intercellular contacts. Trio mediates 
apical constriction via RhoA/ROCKI during Xenupus gastrulation (Plageman et al, 2011) 
and when over expressed causes a rough-eye phenotype in Drosophila via Rac activation 
(Lee & Thomas, 2011). High expression levels of Trio have been found in breast tumours 
(Lane et al, 2008) and amplification of Trio is associated with an invasive phenotype in 
bladder tumours (Zheng et al, 2004). Currently, little is known about the role of Trio in 
normal mammalian epithelial tissue. Upregulation of Rac-mediated Trio signalling in 
MDCK cells with mature AJs causes repression of E-cadherin transcription (Yano et al, 
2011). 
As both Trio GEF domains appear to contribute to AJ assembly, it suggests interplay 
between Trio-mediated Rac and RhoA activation (Bellanger et al, 1998). Intramolecular 
regulation of the two GEF domains of Trio may be a mechanism for integrating such Rho 
GTPase signalling at junctions.  GEFD1 inhibition tends to block the ability of Trio to 
disrupt junctions to a greater extent than GEFD2 inhibition. Moreover, in some cases, 
GEFD1 appears to increase E-cadherin levels. These observations imply that Trio-driven 
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RhoA exchange activity by GEFD2 may be inhibited when Trio GEFD1 activity is 
inactivated, consistent with the effect of depletion of Trio when both GEF domains are 
absent. As the PH domain of Trio GEFD2 is autoinhibitory for GEFD2 exchange activity 
(Bellanger et al, 2003), it is plausible that activation of GEFD1 is required for GEFD2 relief 
of autoinhibition (Fig. 3.12).  
The ability of Trio to integrate multiple signalling pathways has been demonstrated 
previously. Trio can operate in parallel pathways such as in C. elegans where two distinct 
Trio isoforms utilise the RhoA- and Rac-GEF domains to drive cell guidance pathways 
necessary for excretory canal outgrowth (Marcus-Gueret et al, 2012). Trio can also add 
complexity to a single signal transduction pathway in order to co-ordinate downstream 
responses. For example, in Drosophila and human HeLa cells both Trio-GEF domains are 
required for transduction of mitogenic signals downstream of Gαq activation (Vaqué et al, 
2013). These studies support the prediction that the role of Trio in cell-cell contact 
assembly may be to co-ordinate Rac and RhoA signalling outcomes.   
Although Trio Rac-GEF activity is required for junction disruption, interestingly, Trio 
depletion does not appear to interfere with the classical Rac1 cellular process on junctions: 
recruitment of F-actin to clustered cadherin complexes (Braga et al, 1997; Lambert et al, 
2002). Additionally, my findings suggest that Trio might regulate E-cadherin solubility 
without affecting the underlying cytoskeleton. Both GEF domains in Trio are required to 
perturb cell-cell contacts.  What mechanism Trio regulates or whether this is Rho GTPase-
dependent is not clear.  
Three possibilities could explain the increased insolubility of E-cadherin in the absence of 
Trio.  The first is that Trio regulates the localisation of E-cadherin into detergent-resistant 
lipid raft domains via Rac or RhoA signalling. In MDCK with mature junctions, activated 
Rac and RhoA are able to decrease solubility of other junction-associated proteins such as 
Claudin-1 and 2 at TJs (Bruewer et al, 2004). Although in these cells dominant negative 
Rac decreased E-cadherin solubility (Bruewer et al, 2004), it could be that during contact 
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Figure 3.12 Proposed mechanism of Trio autoregulation following E-cadherin ligation. Trio 
GEFD2 is composed of the tandem DH2-PH2 motif. PH2 is known to autoinhibit the nucleotide 
exchange activity of DH2 (Bellanger et al. 2003). When GEFD1 dead Trio is overexpressed levels 
of E-cadherin at cell-cell adhesions increase, consistent with the increased stability of E-cadherin 
seen when Trio is depleted, suggesting GEFD2 is also inhibited when GEFD1 is inactive.  The 
model proposes a feed-forward mechanism to relieve autoinhibition of GEFD2 to fully activate Trio. 
This may be induced by the binding of active Rac to the DH1 of GEFD1. When GEFD2 is 
inactivated this would have no effect on GEFD1 activation and thus GEFD1 exchange activity can 
still persist. Therefore, temporal regulation of Trio GEF activity may be a mechanism to 
appropriately co-ordinate multiple Rho GTPase signalling pathways in time and space. Dotted lines 
represent proposed mechanisms. Blue double-headed arrow represents stabilisation of E-
cadherin. 
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assembly, differential requirements for RhoA and Rac activation can modulate E-cadherin 
solubility in a Trio-driven manner.  
Alternatively, Trio could regulate the cholesterol or protein composition of lipid rafts. E-
cadherin association with detergent-resistant lipid rafts is necessary for clustering during 
internalisation of Listeria monocytogenes (Seveau et al, 2004).  This clustering process is 
proposed to be analogous to clustering in cis during AJ formation (Seveau et al, 2004). 
Therefore, it is feasible that Trio functions to regulate lipid composition to maintain 
cadherin dynamics.  Furthermore, Trio could modulate lipid raft proteins such as the 
Reggie/Flotillin proteins that have been implicated in E-cadherin macropinocytosis (Solis et 
al, 2012).  
Finally, another factor affecting E-cadherin solubility is its interaction with the catenins 
(Delva & Kowalczyk, 2009), which can enrich the insoluble pool of E-cadherin. Binding of 
p120ctn stabilises E-cadherin by blocking E-cadherin internalisation (Ireton et al, 2002; 
Miyashita & Ozawa, 2007; Xiao et al, 2005). Recent studies indicate that, in addition to the 
ability of p120ctn to modulate RhoA activity, RhoA activation downregulates p120ctn-M-
cadherin association and M-cadherin degradation (Charrasse et al, 2006).  It is therefore 
plausible that Trio could mediate Rho-dependent disassociation of p120ctn
3.5.3 Junction induction modulates EGFR tyrosine phosphorylation status in a 
manner distinct to ligand-dependent EGFR phosphorylation 
 leading to 
modulation of E-cadherin solubility, thus providing a mechanism to maintain lateral mobility 
during junction assembly.   
Our data suggests that EGFR regulation by E-cadherin is achieved by differential 
modulation of EGFR tyrosine phosphorylation distinct to that invoked by EGF stimulation.  
Whereas EGF treatment robustly activates several tyrosine residues, calcium stimulation 
appears to invoke initial dephosphorylation with increases in phosphorylation on some 
residues as junction-formation progresses. Activation levels of specific EGFR tyrosine 
residues can range from 2.5-40% depending on the cellular context (Jones et al, 2006; Wu 
et al, 2006), suggesting that levels of activation as well as distinct profiles of tyrosine 
residues facilitate signalling variation. The distinct modulation of EGFR upon cadherin 
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ligation suggests that regulation of EGFR-mediated signalling (directly or indirectly) is 
important for junction assembly-driven signal transduction. This could be achieved via a 
reduction in available binding sites for the interacting proteins as a result of lower levels of 
activation. As a consequence, an inherent preference for only high affinity interactions 
would follow, thus refining the repertoire of signalling molecules in a contact-dependent 
manner (Morandell et al, 2008).  
Our work is supported by studies showing that EGFR is differentially phosphorylated at 
several tyrosine residues upon junction-induction in human head and neck squamous cell 
carcinoma (HNSCC) -derived cells (HSC3) (Humtsoe & Kramer, 2010).  Clear distinctions 
from ligand-dependent activation account for cell-cell adhesion-specific signal transduction 
(Humtsoe & Kramer, 2010). However, the specific pattern of phosphorylated residues 
differs from our findings, most likely due to the differences in molecular make-up of normal 
and tumour-derived cells. It is well documented that phosphorylation of EGFR differs 
considerably between cell types (Morandell et al, 2008). Some primary cancer cells and 
tumour-derived cell lines expressing extremely high levels of EGFR exhibit overactivation 
of many signal transduction molecules (Blagoev et al, 2003). By using normal primary 
human keratinocytes, I have gained insight into the cell-cell contact assembly-mediated 
regulation of EGFR in a physiological context.  
On the other hand, other studies found EGFR global phosphorylation levels increase  upon 
junction assembly (Fedor-Chaiken et al, 2003; Pece & Gutkind, 2000). In these studies 
junctions were induced with addition of calcium-containing fresh medium after EGTA-
mediated contact-disassembly. By adding calcium ions only to confluent cells grown 
without cell-cell adhesions, I prevent the effect serum stimulation might have on EGFR 
activation (Humtsoe & Kramer, 2010).  
Additionally, whole cell lysates were used to investigate EGFR phosphorylation in earlier 
studies (Fedor-Chaiken et al, 2003; Humtsoe & Kramer, 2010; Pece & Gutkind, 2000; 
Shen & Kramer, 2004).  In this case, there is no distinction from surface-bound and 
intracellular EGFR. EGFR signalling can occur from intracellular vesicles (Baass et al, 
1995; Burke et al, 2001), which could mask the specific profile of surface-bound EGFR 
phosphorylation.  Although co-immunoprecipitation of activated EGFR with E-cadherin 
(Fedor-Chaiken et al, 2003) and co-segregation of active EGFR  with cell lysate fractions 
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containing cadherins (Shen & Kramer, 2004) have been demonstrated, this does not rule 
out detection of cadherin-EGFR complex in the endocytic compartment. Whether E-
cadherin modulates surface-bound or internalised EGFR signalling to mediate junction 
assembly remains unresolved.  
3.5.4 Implication of cadherin-mediated EGFR signalling during early junction 
formation 
The differential phosphorylation patterns of EGFR seen under ligand-dependent and 
ligand-independent conditions (Humtsoe & Kramer, 2010) may be modulated by activation 
of protein tyrosine phosphatases triggered by junction assembly. Indeed, several tyrosine 
phosphatases are found at AJs (Bertocchi et al, 2012), with PTP1B binding to the 
cadherin-catenin complex (Sheth et al, 2007). Recent computational models suggest that 
rapid dephosphorylation of EGFR at the plasma membrane may prevent its endocytosis 
(Monast et al, 2012), as is the case of DEP-1 tyrosine-phosphatase-mediated 
dephosphorylation of EGFR in HeLa cells (Tarcic et al, 2009). Downregulation of phospho-
Y1045, a residue important for recruitment of the ubiquitin ligase Cbl to EGFR 
(Swaminathan & Tsygankov, 2006), might provide a mechanism to block EGFR 
internalisation upon junction assembly.  Importantly, cadherins can inhibit growth 
promoting GFR signalling by blocking GFR internalisation. VE-cadherin triggers 
dephosphorylation of VEGFR (Lampugnani et al, 2006), whereas E-cadherin-ligation 
triggers Merlin recruitment to prevent EGFR internalisation (Curto et al, 2007). It is therefore 
plausible that E-cadherin could prevent internalisation of EGFR by modulating EGFR 
phosphorylation to attenuate EGFR signalling responses.  
On the other hand, the tyrosine phosphatase SHP2 promotes EGFR driven Ras signalling 
via dephosphorylation of EGFR tyrosine residues necessary for the recruitment of the Ras 
inhibitor RasGAP (Agazie & Hayman, 2003). Upon dephosphorylation, RasGAP is no 
longer in the vicinity of Ras GTPase and therefore the latter can be activated by GEF 
proteins. This provides evidence that dephosphorylation of EGFR can promote positive 
downstream signalling, suggesting a mechanism for fine-tuning and coordinating specific 
signalling pathways required for junction assembly. 
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Consistent with this idea, although phosphorylation of Y1045, Y1068 and Y1148 appear 
downregulated, Y992, Y1086 and Y1173 seem to recover activation as junction-formation 
progresses. The phosphorylation of these specific tyrosine residues might contribute to 
junction-induced signal transduction. The adaptor protein Growth factor receptor-bound 
protein 2 (Grb2) can interact with several of the residues tested (Y1068, Y1086, Y1148 
and Y1172) (Batzer et al, 1994; Okutani et al, 1994; Schulze et al, 2005; Ward et al, 1996), 
as can the Rho GEF Vav2 (Y992 and Y1148) (Tamás et al, 2003). Thus, a possible 
mechanism emerges downstream of junctions in the temporal regulation of signalling 
component recruitment to EGFR. Grb2 is able to interact with the Ras and Rac GEF Sos1 
to mediate EGFR-stimulated signalling (Nimnual & Bar-Sagi, 2002; Pessin & Okada, 1999) 
and has been shown to bind to DOCK180 (Matsuda et al, 1996).  Temporally controlled 
recruitment of Rac GEFs either directly (Vav2) or indirectly via adaptor proteins such as 
Grb2 could perhaps define the spatio-temporal activation of Rac in this context.  
The functional consequences of adhesion-dependent EGFR activity modulation at nascent 
cell-cell adhesions have not been previously well explored. I have found that EGFR is 
important for the regulation of F-actin recruitment to clustered cadherins. This novel finding 
suggests that EGFR acts to functionally couple cadherin signalling to a junction-specific, 
Rac-mediated cellular outcome, consistent with the requirement for EGFR activity in 
adhesion-induced Rac activation (Betson et al, 2002; Goodwin et al, 2003). The level of 
attenuation in F-actin recruitment achieved by EGFR depletion was consistent with 
attenuation of Rac signalling (Braga et al, 1997) or loss of the scaffold protein Ajuba, which 
reduce levels of F-actin recruitment by around fifty percent (Braga et al, 1999; Nola et al, 
2011).  
3.5.5 DOCK180 is localised at nascent cell-cell adhesions in an EGFR-independent 
manner 
I have shown that DOCK180 localises to newly forming cell-cell contacts. This localisation 
is specific to clustered E-cadherin and independent of intracellular calcium signalling.  This 
supports the hypothesis that DOCK180 is in the vicinity of AJs in order to regulate junction-
induced Rac activation. EGFR is also not required for the distribution of DOCK180 to 
clustered E-cadherin. That EGFR is not required raises the possibility that, if EGFR and 
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DOCK180 are part of the same signalling cascade, EGFR might regulate DOCK180 
activation state rather than subcellular localisation.  
The localisation of DOCK180 at forming junctions is in line with recent work which shows 
that DOCK180 localises to focal adhesion upon stimulation (Kiyokawa & Matsuda, 2009; 
Pratt et al, 2005; Siu et al, 2011; Tachibana et al, 2009).  Localisation of DOCK180 to 
lamellipodia is reduced in MEFs deficient in the scaffold protein Ajuba (Pratt et al, 2005), 
whereas the adaptor ANKDR28 recruits DOCK180 to focal adhesions in migrating HeLa 
cells (Tachibana et al, 2009).  Other studies have shown that binding of DOCK180 DHR1 
domain to PtdIns(3,4,5)P3-rich regions targets DOCK180 to the plasma membrane (Cote 
et al, 2005; Kobayashi et al, 2001; Premkumar et al, 2010). Whether this is the case in 
cell-cell adhesion in keratinocytes is unclear. PtdIns(3,4,5)P3
It could be that cadherin ligation independently stimulates both PI3K activity to generate 
PIP3 and recruit DOCK180, and modulate EGFR activity required for DOCK180 activation 
once it is at the plasma membrane.  Although PI3K targets DOCK to membranes, it was 
shown to be dispensable for DOCK180-mediated Rac activation (Kobayashi et al, 2001). 
This dual approach could account for the fact that PI3K is not necessary for Rac activation 
during junction assembly: if PI3K inhibition perturbs DOCK180 localisation, but EGFR is 
still be able to promote Rac activation via DOCK180 at a different sub-cellular localisation, 
this could explain the observation of no loss of total Rac activity in biochemical assays 
upon PI3K inhibition (Betson et al, 2002).  Conversely, if EGFR is lost then irrespective of 
DOCK180 localisation, it cannot be activated by EGFR and therefore cannot mediate 
exchange on Rac, leading to the inhibition of Rac activation seen upon blockade of EGFR 
activity (Betson et al, 2002).  
 (PIP3) is generated by PI3K 
activity, but PI3K is dispensable for junction-induced Rac activation (Betson et al, 2002; 
Goodwin et al, 2003). 
3.5.6 Temporal activation of DOCK180 by EGFR 
A potential mechanism of DOCK180 activation at cell-cell contacts could be 
phosphorylation triggered by EGFR signalling. Recent studies have elucidated a regulatory 
tyrosine residue amenable to phosphorylation by the constitutively activated EGFRvIII 
mutant expressed in glioblastoma. EGFRvIII phosphorylates DOCK180 on tyrosine 722 via 
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the Src family of protein tyrosine kinases. This activation pathway leads to Rac signalling, 
cell survival and migration (Feng et al, 2012). Additionally, another EGFR (ErbB) family 
member Her-2 (ErbB2) phosphorylates DOCK180 on tyrosine 1181 in the DHR2 region, to 
activate Rac GEF activity, downstream of Heregulin binding (Laurin et al, 2013).  
Alternatively, EGFR might regulate the activity or localisation of the most well studied 
regulator of DOCK180-mediated Rac signalling: its binding partner ELMO (Komander et al, 
2008). It is thought that ELMO is required not for DOCK180-dependent Rac activation per 
se, but for facilitating downstream Rac signalling from the ELMO/DOCK180 complex 
(Komander et al, 2008). Evidence suggests that ELMO contains an autoinhibitory N-
terminal domain and an autoregulatory C-terminal domain (Patel et al, 2010). Under basal 
conditions ELMO is thought to be in an inhibitory closed conformation (Patel et al, 2010).  
It is not clear what signals activate ELMO, but RhoG is able to bind to ELMO and partially 
relieve autoinhibition (Katoh & Negishi, 2003; Patel et al, 2010). Further studies will 
characterise the phosphorylation state of DOCK180, its interaction with ELMO during 
junction induction, and if and how ELMO is activated at junctions. Whether these events 
are dependent on EGFR would help to clarify if DOCK180 is indeed downstream of the 
cadherin-EGFR signalling node as junctions assemble. 
3.5.7 Integration of EGFR, DOCK and Trio in Rac activation during epithelial 
biogenesis 
Although both DOCK180 and EGFR are required for Rac activation following calcium 
induction for 5 minutes (J. Erasmus, unpublished), depletion of each protein gives a 
distinct phenotype. EGFR depletion leads to disruption in cadherin staining at junctions 
formed for 30 minutes, while DOCK180 depletion has no effect (J. Erasmus, unpublished). 
Furthermore, EGFR depletion, but not DOCK180, perturbs recruitment of F-actin to 
cadherin complexes. These distinct phenotypes may suggest that (i) DOCK180 and EGFR 
are activated independently upon cadherin clustering or (ii) DOCK180 participates 
downstream of EGFR to regulate alternative Rac functions other than F-actin recruitment. 
It is known that small, spatially and temporally restricted pools of active GTPase are 
sufficient to facilitate multiple downstream signalling events (Pertz, 2010). Thus, regulation 
of Rac in time and space may account for these differences between EGFR and 
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DOCK180 on F-actin remodelling. As Rac activity is sustained as contacts mature (Betson 
et al, 2002; Nakagawa et al, 2001), it could be that DOCK180 is required for Rac mediated 
events that occur later and promote junction stabilisation. Indeed, although depletion of 
DOCK180 does not disturb assembly of cell-cell contacts, junctions are not as stable in 
dissociation assays (J. Erasmus, unpublished). 
On the other hand, the fact that DOCK180 and Trio are both dispensable for F-actin 
recruitment to clustered E-cadherin suggests that (i) neither Trio or DOCK180 are required 
for F-actin recruitment and function in alternative cellular processes or (ii) that the two 
GEFs could compensate for each other in a redundant manner.   It is not straight forward 
to reconcile the latter prediction. However, I propose a mechanism relying on both the 
spatial and temporal activation of Rac (Fig. 3.13).  DOCK180 depletion leads to reduced 
global levels of Rac activity upon junction induction (J. Erasmus, unpublished) but if Trio 
localises to junctions it could compensate for activation of the small pool of junctional-Rac 
permissive to F-actin recruitment (Fig. 3.13B). The inverse situation is possible, although I 
have not demonstrated a role of Trio in contact-induced Rac activity (Fig. 3.13B). To 
explain the role of EGFR in this model, I predict that EGFR is also important for localizing 
Rac to junctions in order to be activated. This reconciles the fact that although basal levels 
of GTP-bound Rac are increased when EGFR is blocked (Betson et al, 2002; J. Erasmus, 
unpublished), this is not further promoted upon cell-cell adhesion. This suggests that the 
partial phenotype given by EGFR may be due to inefficient localisation of Rac to the 
vicinity of the correct cellular machinery to drive F-actin recruitment when junctions are 
induced.  Although I have not formally identified specific cellular functions for Trio and 
DOCK180, it is clear that both GEFs are implicated in junction assembly and thus supports 
the hypothesis that multiple Rho GEFs are required to integrate signal transduction events 
downstream of a single stimulus during epithelial biogenesis.   
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Figure 3.13 Model of Rac-activation upon cell-cell contact formation. A) In cells with normal 
levels of EGFR, Rac is maintained in a GDP-bound state in low calcium conditions, EGFR has a 
basal level of phosphorylation (pink stars) and DOCK180 and Trio are inactive. B) Upon calcium 
binding, E-cadherin modulates EGFR phosphorylation, Rac is recruited to cell-cell adhesions, and 
DOCK180 and Trio are thought to be activated. EGFR drives F-actin accumulation to junctions, 
which may or may not be achieved by activation of DOCK180 and Trio. If DOCK180 and Trio do  
affect actin recruitment but are redundant, then depletion of either DOCK180 or Rac activation by 
the remaining GEF is sufficient to allow F-actin recruitment. Trio can also affect stabilisation of E-
cadherin, potentially via modulating RhoA activity.  
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3.6 Future work 
3.6.1 Cadherin-dependent activation of RhoA 
Previous attempts to address whether cadherin-clustering is sufficient to activate RhoA 
analysed spreading of CHO cells overexpressing C-cadherin on an immobilised cadherin-
substratum (Noren et al, 2001). The findings show that cadherin ligation alone was not 
able to activate RhoA. However, the interpretation of these results is complicated by the 
spreading of the cells, which is known to inactivate RhoA (Jackson 2011). Instead, an 
improved method to assess cadherin contribution to RhoA activation is to cluster cadherins 
with beads in cells expressing endogenous cadherins. This way one can interpret the 
results in the context of the endogenous cadherin signalling machinery without 
interference of cell spreading. 
Our previous experiments determined RhoA activation on a global scale, however, as with 
Rac activation, Rho GTPase activity can be highly spatially restricted (Nola et al, 2011; 
Pertz, 2010; Terry et al, 2011; Yamada & Nelson, 2007). To analyse spatial activation of 
RhoA, fluorescence lifetime imaging (FLIM) can be used. Specifically, a unimolecular 
FRET probe containing both RhoA as a donor and an effector as the acceptor (Heasman 
et al, 2010) undergoes FRET when RhoA is GTP bound and able to bind to effector, thus 
reducing the fluorescence lifetime of the RhoA donor. The probe could be used to localise 
RhoA activity during junction assembly and identify if active RhoA is at junctions at 5 
minutes. Depletion and overexpression of GEF proteins and their GEF-activity inactive 
mutants, in this assay, will assess the role of GEF proteins in spatial activation of RhoA. 
3.6.2 Confirmation of Trio GTPase specificity and role in junction assembly 
As Trio is able to regulate the activation states of Rac, RhoA and RhoG (Blangy et al, 
2000; Debant et al, 1996), it is not clear from my data how Trio controls the activation 
states of these proteins as cell-cell contacts form.  To identify whether Trio mediates RhoG 
and/or Rac activation, effector pull-down assays should be performed in Trio-depleted 
cells. Moreover, as the Rac domain is also able to induce RhoG activation this should not 
be overlooked when interpreting the role of Trio GEFD1 in junction formation.  The next 
step would be to investigate whether Trio activates Rac via RhoG activation or by an 
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independent pathway. Experiments could be performed to rescue depletion phenotypes 
with GEF specific domains or with GEF specific inhibitors (Blangy et al, 2006; Schmidt et 
al, 2002) to assess which domains are required for what process. For example, if siRNA-
depletion of RhoG is able to rescue the phenotype given by overexpression of Trio-WT, 
this would indicate that RhoG activation is required for Trio-mediated loss of E-cadherin.  
3.6.3 Establish if EGFR and DOCK180 are part of the same signalling pathway 
 
A number of key questions remain to be addressed. First, does DOCK180 translocate from 
a non-junctional localisation to junctions as they form and how is it targeted to the plasma 
membrane?  Visually, DOCK180 appears diffuse throughout cells devoid of junctions, but 
the extent to which DOCK180 and E-cadherin co-localise in these unstimulated cells was 
not assessed.  To evaluate if and how an interaction of DOCK180 and E-cadherin might 
be modulated as junction formation proceeds, pull-down assays using recombinant 
truncated E-cadherin cytoplasmic domain can be used.  Additional experiments should 
address whether the DHR-1 domain is necessary for cell-cell contact localisation, or 
whether interaction with other scaffold proteins such as Ajuba are required. 
 
Secondly, is DOCK180 part of a cadherin-EGFR signalling pathway?  To address whether 
EGFR is necessary for any E-cadherin-DOCK180 interaction, pull-down assays to detect 
interaction of DOCK180 with E-cadherin can be performed in the absence of EGFR.  If 
EGFR is required for E-cadherin-DOCK180 interaction, this would be abolished in the 
absence of EGFR. 
 
Third, how is DOCK180 activated and is this dependent on EGFR? Experiments to test the 
phosphorylation state of DOCK180 at positions Y722 and Y1181 and if this depends on 
EGFR can be performed in the presence and absence of EGFR during junction formation. 
If EGFR is required for DOCK180 activation the levels of phosphorylation of DOCK180 
may be reduced in the absence of EGFR during cell-cell contact formation.  
 
Finally, the role of ELMO at cell-cell contacts can also be addressed. Analysis of ELMO 
localisation and its depletion phenotype can be made. If ELMO dictates localisation of 
DOCK180, the prediction is disruption of DOCK180 distribution upon ELMO knockdown. 
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Further, if ELMO is required for DOCK180-mediated stabilisation of junctions one would 
predict that junctions are destabilised in the absence of ELMO.  Integration of the data 
gained from these multiple analyses can help to clarify the role of EGFR and DOCK180 in 
mediating cadherin-driven Rac activation.  
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4 Identification of Rho GEFs in AJ formation by 
medium-throughput RNAi screening 
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4.1 Introduction 
In the previous chapter, I found that the different Rho GEFs DOCK180 and Trio have 
different functions during epithelial biogenesis. Moreover, neither GEF was solely 
responsible for the Rac-mediated process of F-actin recruitment (Fig. 3.6 and 3.9), which 
suggests alternative Rac GEFs might be involved. Furthermore, there are many other 
molecular and cellular processes that are coordinated by a small number of Rho GTPases 
to form junctions, all of which are initiated by the common upstream signal of cadherin 
ligation (Braga & Yap, 2005; Watanabe et al, 2009). I hypothesise that other Rho GEFs 
play key roles in defining and integrating this network of signalling pathways that culminate 
in the generation of the epithelial phenotype.  
It is not, however, solely Rho GEF proteins that regulate the spatial and dynamic activation 
of Rho GTPases. This can also be achieved by Rho GAP proteins (Bernards & Settleman, 
2004). Very little is known about the Rho GAPs involved in cell-cell contact formation, or 
how they coordinate with Rho GEF proteins to drive this biological process (McCormack et 
al, 2013).  Additionally, despite the fact that there are 20 members of the Rho family of 
GTPases very few have been implicated in cell-cell adhesion assembly (Baum & 
Georgiou, 2011; Braga & Yap, 2005; Citi et al, 2011; Green et al, 2010; Watanabe et al, 
2009).  This is because focus has been on the well-studied Rho family members RhoA, 
Rac and Cdc42. Research into the remaining Rho family members might reveal that more 
of these proteins are involved in junction assembly. Finally, there is a plethora of Rho 
interacting proteins that each have abilities to drive distinct molecular processes 
downstream of Rho binding (Bishop & Hall, 2002; Kaibuchi et al, 1999), yet their roles in 
cell-cell adhesion remain poorly studied.   
One way to get an overview of whether any of these aforementioned proteins (numbering 
over 150 collectively), have important roles in epithelial biogenesis is to perform a loss-of-
function screen and analyse their effects on well-established markers of cell-cell adhesion 
(Boutros & Ahringer, 2008). Medium-throughput morphological screens are becoming a 
popular technique for rapid identification of networks of proteins that are mediators of 
particular biological processes (Chia et al, 2012; Winograd-Katz et al, 2009).  Visually 
analysed screens are a good way to assess the function of a large number of protein-
coding genes under well controlled experimental conditions; such has been the case for 
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RNAi screening in C. elegans to assign functions to genes in the C. elegans genome 
(Fraser et al, 2000; Kamath et al, 2003).  
Further to this, quantitative image analysis has become a valued tool to help analyse 
genotype-phenotype relationships in mammalian cell culture (Echeverri & Perrimon, 2006). 
Thorough optimisations of cell-based assays and good RNAi screen design are crucial for 
the generation of robust experimental data and meaningful subsequent interpretation of 
phenotypes. Furthermore, data mining is a very valuable step of the screening process 
and has been used successfully to define network associations for several biological 
processes such as Golgi regulation, focal adhesion mechanics and regulation of cell 
morphologies (Chia et al, 2012; Kiger et al, 2003; Winograd-Katz et al, 2009). This shows 
that overall, quantitative screening is a powerful tool for researchers wishing to approach 
their biological question from a top-down perspective (Bakal et al, 2007; Liu et al, 2009). 
Perturbations in the regulation of epithelial biogenesis can be detected as disruption of 
continuous cadherin labelling at the cell-cell boundaries and mis-localisation of F-actin 
structures within the cell. Quantitative image analysis has recently been used in our 
laboratory to identify actin-binding and -regulatory proteins that might be key players in 
epithelial biogenesis (V. Braga, unpublished).  In this screen, three well established 
morphological markers were used as output parameters: E-cadherin localisation to 
junctions, F-actin localisation to junctions and F-actin accumulation in peri-junctional 
regions (Watt et al, 1993; Zhang et al, 2005). After junction induction for 30 minutes by 
addition of calcium, in keratinocytes, the two populations of F-actin (junctional and thin 
bundles) can be easily distinguished by fluorescence microscopy (Fig. 1.5). In addition, E-
cadherin is by this time recruited to the nascent AJs and forms a distinct staining pattern at 
cell-cell contacts (Fig. 1.5). In the Braga study, controls were performed to assess the 
dynamic detection range of the quantitative method, which showed statistical differences in 
cells with varying degrees of cadherin and F-actin levels in the image. Here, my 
colleagues and I implement the cell-based RNAi screen assay developed by Braga et al. 
to identify Rho proteins and their regulators and interactors that might be involved in 
epithelial junction assembly. 
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4.2 Hypothesis and aims 
I hypothesise that a number of different Rho signalling pathway proteins are able to 
perturb junction formation, when depleted.   
 
I aim to quantitatively analyse image data collected from a primary RNAi screen of human 
Rho proteins, their regulators and interactors (performed by J. Erasmus), to identify a 
number of candidate proteins to take forward to a secondary validation screen. This 
quantitative analysis is undertaken in collaboration with J. McCormack, a PhD student 
whose interests lie in GAP proteins in junction formation. Here I aim to validate a subset of 
GEF Hits to i) identify which Rho GEFs are important for junction formation and ii) 
establish whether multiple Rho GEFs drive distinct cellular processes.  
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4.3 Results 
4.3.1 Measures of confluence in monolayers of keratinocytes 
For the primary screen, the library siRNA pools were organised across four 96-well plates 
termed Plate-A, Plate-B, Plate-C and Plate-D. Three replicate experiments were run in 
total, resulting in data from twelve individual 96-well plates. After visual analysis to check 
the acquisition quality of each plate, it was deemed necessary to discard Plate-C from 
replicate two completely.  The subsequent analysis was then performed using data from 
the remaining eleven plates.  
For the purposes of studying junction formation, it is necessary for cells to be grown to a 
confluent monolayer to avoid contribution of cell migration upon junction induction.  
Instances were found where wells were substantially under-confluent, most likely due to 
manual error during tissue culture, to cytotoxic effects of particular siRNA pools or effects 
on cell proliferation and adhesion. It was therefore necessary to visually score all wells for 
levels of confluence, which is suitable albeit time-intensive. Therefore, we investigated a 
way to automate confluence scoring to address whether the number of cells in an image or 
the Total F-actin Area for each well could be used as a proxy for the qualitative visual 
analysis (performed previously by J. Erasmus and V. Braga). 
Wells fully confluent were scored 0 (thereafter named as CF-0); wells with small gaps 
amounting to no more than approximately 10% of the image were scored 1 (CF-1); wells 
with large gaps were scored 2 (CF-2) and discarded from analysis (Fig. 4.1A). Box plots of 
the visual scores for confluence against the number of cells (automated nuclei count) 
showed that decreasing number of cells correlated with reduced median values of 
confluence scores for each class (Fig. 4.1B). The 25th percentile of CF-0 and the 75th 
percentile of CF-1 overlap (Fig. 4.1B), indicating that the difference between fully confluent 
and 90% confluent wells is small. However, the data for CF-1 and CF-2 are similar overall, 
suggesting that variations in the size of cells, rather than cell number could account for the 
considerable overlap of values.  Due to the risk of falsely categorising 90% confluent and 
non-confluent wells, cell number was not deemed sufficient as a measure of confluence. 
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Figure 4.1 Measures of confluence in monolayers of keratinocytes. A) Images of each well 
from all screen plates were scored visually for the level of confluence. Representative unprocessed 
E-cadherin images classified as confluent (CF-0), mostly confluent with gaps amounting to less 
than 10% (CF-1), and wells that were sub-confluent (CF-2). Wells scored as 2 were excluded from 
the analysis. B and C) Correlation of cell number (B) or thresholded Total F-actin Area as a 
percentage of the total image (% total) (C) with confluence scores to assess suitability of each 
parameter as a measure of confluence. B) Data is pooled from all wells from all plates. Box plots 
show median and interquartile range. Whiskers are the minimum and maximum values observed. 
C) Total F-actin Area (% total) with confluence score. Representative box plots of screen Plate-D 
three experimental replicates.   
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An alternative measure of confluence may be the value for F-actin in an image after 
background removal, but before processing (Total F-actin Area, as a percentage of the 
whole image). All plates were analysed separately and raw Total F-actin Area values were 
used. Figure 4.1C shows representative box plots for the three experimental repeats of 
Plate-D to give an idea of the reproducibility of replicate experiments (Fig. 4.1C).  In all 
three experiments, wells scored as CF-0 or CF-1 had very small interquartile ranges, with 
many values close to 100% (Fig. 4.1C). For sub-confluent wells with visual score CF-2, 
the median values were decreased compared with the other groups and showed a larger 
range of values (Fig. 4.1C). This implies that some of the maximum values obtained for 
sub-confluent wells are inside the interquartile range of wells classified as 90% confluent. I 
concluded that Total F-actin Area would not be a very reliable way to automatically score 
the confluence of individual wells. Yet, the use of Total F-actin values is a better strategy 
to evaluate confluence than cell number, and might be considered for larger screens, 
when visual scoring is not feasible. 
4.3.2 Distribution of Area measurements for the processed parameters  
For further statistical analysis, it is important to determine if the data is normally 
distributed. Since the screen is a targeted library against genes for proteins with similar 
functional properties we hypothesised that phenotypes might not be normally distributed. 
Once sub-confluent wells (CF-2) had been removed, we investigated the distributions of 
the raw Area values for the parameters E-cadherin (E-cad), Total F-actin, junctional actin 
(Jun-A) and cytoplasmic actin (Cyt-A). Individual plates were analysed as cross-plate 
comparisons may mask trends in distribution. Representative histograms of three Plate-D 
replicates are shown for each parameter (Fig. 4.2A-D right panels).  The distribution of E-
cad Area values were widely spread (Fig. 4.2A), whilst the Total F-actin Area showed a 
highly skewed distribution towards 100% (Fig. 4.2B), reflecting the fact that only wells of 
>90% confluence were measured. Jun-A Area showed a spread similar to E-cad Area but 
not to Total F-actin Area (Fig. 4.2C), whereas Cyt-A Area values had a narrower range 
than E-cad Area and Jun-A Area (Fig. 4.2D). Replicate three showed a slightly different 
profile for all parameters which could indicate the effectiveness of RNAi was altered in this 
experiment. Alternatively, if wells containing different siRNAs were discarded in each 
replicate then the remaining set of siRNAs on each replicate plate will differ.  These data 
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Figure 4.2 Distribution of Area (% total) measurements for the processed parameters. For 
each plate all Area (% total) values calculated for each well were plotted as histograms to show 
distribution of measurements. A-D) Left-hand panels show representative histograms of three 
experimental replicates (black, green or grey bars) of Plate-D. Dotted lines show predicted 
Gaussian distribution. Right-hand panels plot p-values after Shapiro-Wilks test for normality for 
each experimental repeat of the Plates-A to D. The red line indicates p=0.05. A) E-cadherin Area; 
5 unit bin widths. B) Total F-actin Area; 1 unit bin width. C) Junctional actin Area; 5 unit bin width. 
D) Cytoplasmic actin; bin widths of 5 units. P-values indicate the level of certainty that the null 
hypothesis can be rejected. Red lines represent p=0.05. 
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suggest that different siRNA treatments can produce a broad range of effects on E-cad 
and Jun-A, but cause a more restricted phenotype range on Cyt-A. 
Distributions were statistically analysed with the Shapiro-Wilks test, where the null 
hypothesis is that distributions are normal.  In general p-values for E-cad, Jun-A and Cyt-A 
Areas (Fig. 4.2A, C and D) reflected normal distributions, but some individual plates 
showed non-normal profiles. In contrast, all Total F-actin distributions rejected the null 
hypothesis (Fig. 4.2B). Differences between replicates of the same plate were also 
observed (Fig. 4.2A-D right-hand panels), likely because of the same reasons as stated 
above. Overall, normality testing showed that distributions were largely normal indicating 
that the library of targeted siRNAs is able to invoke a range of phenotypes. However, as 
some plates had non-normal profiles, non-parametric tests are to be used for further 
correlation analysis of the raw Area values.  
4.3.3 Correlation of cell number with Area for E-cad, Jun-A and Cyt-A 
I observed earlier (Fig. 4.1B) that a confluent well can display variability in the number of 
cells it contains.  This poses the question of whether cell number could influence the 
quantification of the parameters E-cad and Jun-A, which assess levels of staining at 
junctions. Raw data was used for this analysis, therefore plates were tested individually. 
Plate-D replicates shown as representative correlations showed that neither E-cad, Jun-A 
or Cyt-A appeared correlated with cell number as similar cell numbers were given across 
the range of Area measurements (Fig. 4.3A, C and E).  
Correlations were analysed with the non-parametric Spearman Rank test. Here, 
monotonic, rather than linear, relationships are measured. The null hypothesis for 
Spearman Rank is that there is no association between the two variables. R values that 
tend towards ±1 indicate a strong relationship between the two variables and associated p-
values indicate the confidence level for the observed interaction. E-cad and Jun-A Areas 
did not have a strong correlation with cell number (Fig. 4.3B and D).  This is reflected in 
that most individual plates had both small R values (inferring weak correlation), and 
associated p-values > 0.05. In these cases, the null hypothesis cannot be rejected. In 
contrast, Cyt-A Area weakly negatively correlated with cell number in some plates (Fig, 
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Figure 4.3 Correlation of cell number with Area (% total) measurements for E-cad, Jun-A 
and Cyt-A. Cell numbers for each individual plate were plotted against Area (% total) values for E-
cad (A), Jun-A (C) and Cyt-A (E). The strength of association was then measured using Spearman 
Rank analysis for E-cad (B), Jun-A (D) and Cyt-A (F). Replicate experiments are represented as 
coloured dots for Plate-D (A,C,E) or bars (B,D,F) in black (exp. 1), green (exp.2) or grey colour 
(exp.3) for all experimental repeats of Plates-A to D. * = p<0.05, **=p<0.005 *** = p<0.001.  
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4.3F). This could be due to an inverse relationship between cell size and amount of 
cytoplasm in confluent monolayers and is not wholly unexpected. Taken together these 
data show that in general, cell number did not influence the E-cad or Jun-A Area 
measurements in a well. This implies that any change in the level of E-cadherin and F-
actin at junctions, as a result of siRNA treatment, is independent of the number of cells.  
4.3.4 Z-score analysis and selection of candidate proteins  
To allow for inter-plate comparisons the data was normalised using a modified Z-score 
calculation (See material and methods section 2.4.5, figure 2.6).  As the raw data for some 
individual plates was not normally distributed, it was necessary to normalise raw scores to 
a set of siRNA control wells within each plate.  Once Z-scores were calculated for each 
well, the median Z-score values (if n=3) or mean Z-score values (if n=2) for each siRNA 
condition were calculated. We then assessed whether perturbations in the levels of E-
cadherin by a particular siRNA treatment (E-cad) correlated with the disruption of F-actin 
at junctions (Jun-A) or in the cytoplasm (Cyt-A). We used median or mean (herewith 
referred to as average, unless specifically indicated otherwise) Z-scores and made 
pairwise correlations between the processed parameters (Fig. 4.4A, B and C). Strength of 
correlation was assessed using Pearson’s correlation.  E-cad and Jun-A Z-scores had a 
strong positive correlation with R2 = 0.98 (Fig. 4.4A), whilst Cyt-A strongly negatively 
correlated with both E-cad and Jun-A (R2 
To select a subset of candidate proteins for further validation, all average Z-scores for E-
cad, Jun-A and Cyt-A were separately ranked from negative to positive and one standard 
deviation of the control Z-scores were used as cut-offs (Fig. 4.4D, E and F).  For E-cad 
and Jun-A the majority of Z-scores were negative, indicating that most siRNA treatments 
reduced the amount of E-cadherin or F-actin at junctions compared with controls. In 
contrast Cyt-A Z-scores were mostly positive, meaning that siRNA treatment increased the 
amount of F-actin in the cytoplasm compared with controls. These skewed siRNA profiles 
indicate that the proteins tested are important for the recruitment and/or stabilisation of E-
= 0.80 and 0.82, respectively) (Fig. 4.4B and C). 
These results suggest a functional link between the pathways that perturb E-cadherin and 
F-actin re-distribution upon junction formation. This implies that processes which affect the 
assembly of F-actin at the junctional complex are directly coupled to or indirectly co-
operate with those processes that regulate junctional E-cadherin localisation.    
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Figure 4.4 Z-score analysis and selection of candidate proteins. All raw Area (% total) values 
were normalised to within-plate controls to calculate Z-scores. Median or mean (average) values 
were calculated for each siRNA condition of the proteins tested. A-C) Correlations of average Z-
scores for E-cad, Jun-A and Cyt-A. Strength of association was measured by Pearson’s 
correlation. R2 values are shown in red. A) E-cad and Jun-A Z-scores. B) E-cad and Cyt-A Z-
scores. C) Jun-A and Cyt-A Z-scores). D-F) Average Z-scores ranked from negative to positive 
values for processed parameters E-cad (D), Jun-A (E), and Cyt-A (F). Dotted red lines indicate 
cut-offs at ±0.9. Proteins, that after depletion, had average Z-scores >0.9 or <-0.9 were selected 
as positive and negative candidate proteins respectively. G-I) Box plots showing distribution of Z-
scores for all control samples (Con), all proteins tested in the screen (All), and positive (+ve) and 
negative (-ve) candidate proteins. Boxes are median and interquartile range.  Whiskers are the 
minimum and maximum observed values. G) E-cad, H) Jun-A, I) Cyt-A.  
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cadherin and F-actin at junctions and to bundle the underlying cortical F-actin structures to 
strengthen junctions as they form.  
In total, 101 candidate proteins were selected and their Z-scores compared with all control 
Z-scores (Con) and Z-scores for all siRNAs tested in the screen (All) (Fig. 4.4G, H and I). 
This analysis showed that the interquartile range of values for E-cad, Jun-A or Cyt-A 
parameters did not overlap with that of the corresponding controls. By defining candidate 
proteins in this way, we have selected a number of proteins that have varying degrees of 
phenotype strength so we can investigate subtle and large perturbations in E-cadherin and 
F-actin distribution during cell-cell contact assembly.   
4.3.5 Analysis of candidate protein phenotypes 
We next asked whether the relationships between Z-scores for the processed parameters 
are still strong in the candidate protein data set. Pairwise correlations of Z-scores of E-cad 
and Jun-A were strongly positively correlated (Pearson’s correlation R2 = 0.98) (Fig. 4.5A, 
B and C), but there were slightly weaker correlations of Cyt-A with E-cad or Jun-A (R2 = 
0.74 and 0.77, respectively). This reflects the correlations seen when all the primary 
screen proteins were compared (Fig. 4.4). With respect to the subset of GEF candidates 
(35 proteins selected, Fig. 4.5D, E and F), E-cad and Jun-A also had a strong positive 
correlation (R2 = 0.97), but the correlations of Cyt-A with other parameters (R2
The strong correlations shown for the experimental parameters in all data sets analysed 
indicate a high likelihood that depletion of a protein would affect more than one parameter.  
To evaluate the extent that this occurs, the number of parameters affected by each 
depletion was scored.  Figure 4.6 shows images of a representative control well and a 
candidate protein that when depleted affected all three parameters. The processed images 
show how the E-cad, Jun-A and Cyt-A measurements reflect the perturbation to E-
cadherin and F-actin distribution at the junction and F-actin in the cytoplasm (Fig. 4.6A 
 = 0.58 to 
0.65) were weaker than that of All candidates. The difference in Cyt-A correlations 
suggests that the depletion of GEF proteins may have a distinct effect on junctions than 
Rho GAPs, effectors and small GTPases. Nevertheless, the overall profiles are very 
similar and indicate that the subset of GEF proteins selected is a bona fide subset of the 
candidate proteins.  
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Figure 4.5 Z-score correlations of candidate proteins. A-C) Z-scores were correlated for All 
the candidate proteins identified (All candidates) for E-cad and Jun-A (A) or Cyt-A (B) or Jun-A 
and Cyt-A (C). Pearson’s correlation R2 values are shown in red. D-F) The same analysis shown 
in A-C was performed for the subset of GEF candidates E-cad and Jun-A (D) or Cyt-A (E) or Jun-
A and Cyt-A (F). 
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Figure 4.6 Representative images of a candidate protein. Keratinocytes grown to confluence 
were induced to form contacts for 30 minutes after treatment with pools of four oligonucleotides 
for Scramble (Control) or target protein (Candidate). A) Cells fixed and stained for E-cadherin, F-
actin using Phalloidin and nuclei using DAPI.  Images shown are representative of wells treated 
with siRNA oligos controls (top row) and against a target protein selected as candidate (bottom 
row). Merge images are shown on the right. Arrows and arrowheads indicate junctional 
localisation of E-cadherin and F-actin, respectively. B) Raw images in A, were processed by 
intensity thresholding (see materials and methods 2.4.6, figures 2.1 and 2.2) to obtain E-cad, 
Jun-A and Cyt-A processed images. Block arrows and arrowheads indicate junctional E-cad and 
F-actin respectively. Line arrows show thin bundles represented as Cyt-A after processing.  
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and B). The proportion of proteins showing the distinct perturbations in each dataset was 
then plotted (Fig. 4.7A left panel). Out of all candidate proteins selected, 23% perturbed 
only a single parameter (4% E-cad, 15% Jun-A and 4% Cyt-A), only 8% perturbed two 
parameters (6% E-cad/Jun-A, 1% E-cad/Cyt-A, 1% Jun-A/Cyt-A) and the majority (69%) 
perturbed all three parameters. The overall profile of phenotypes observed in the GEF 
proteins was very similar to the candidate proteins: around a quarter perturbed a single 
parameter and the vast majority interfered with E-cad, Jun-A and Cyt-A together (Fig. 4.7A 
right panel).The main difference was seen among the pool of proteins affecting a single 
parameter. There was a large increase in the proportion of GEF proteins perturbing F-actin 
in the cytoplasm (6% E-cad, 3% Jun-A and 18% Cyt-A). This suggests that the candidate 
proteins in general govern cellular processes that regulate the cytoskeleton and 
consequently perturb E-cadherin regulation. Whether these proteins all regulate a small 
number of cellular functions or if each has its own specific function requires further 
investigation.   
Next we assessed whether there was enrichment of a particular functional class of 
proteins in the candidate dataset when compared with the proportions of all the proteins 
tested (Fig. 4.7B). Among the candidate proteins, the proportion of GAP proteins, small 
GTPases and their interacting proteins increased by 4-6%. Interestingly, the proportion of 
GEF proteins remained the same. These changes in proportions may suggest that a 
smaller repertoire of GEF proteins is required to regulate the distinct processes involved in 
cell-cell adhesion.  
4.3.6 Z-score correlations of GEF validation screen  
To confirm the phenotypes observed in the primary screen, I independently performed a 
secondary validation screen on 33 GEF candidate proteins using four individual oligos per 
target, randomly distributed across three 96-well Plates. The data collection, quality control 
and Z-score calculations were done as previously described. To evaluate the relationship 
between parameters, I performed pairwise correlations and used Pearson’s correlation to 
assess the strength of the associations (Fig. 4.8A, B and C). E-cad and Jun-A correlated 
positively (R2=0.69) (Fig. 4.8A) whilst Cyt-A only weakly correlated negatively with E-cad 
and Jun-A (R2=0.48 for both pairings) (Fig. 4.8B and C). The reduced correlation of Cyt-A 
with the other parameters reflects a decrease in the number of siRNAs that perturb all 
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Figure 4.7 Analysis of candidate protein phenotypes. Analysis of the various phenotypes 
given by All candidates and the subset of GEF candidates.  A) Distribution of the phenotypes 
shown by All candidate proteins (Left graph) and GEF Candidates (Right graph). SiRNA can 
perturb one (1), two (2) or three (3) of the processed parameters E-cad, Jun-A and Cyt-A. 
Phenotype combinations are colour-coded as shown in the key (diagram below). B) Proportion of 
different protein classes tested in the primary screen and for those that were selected in All 
candidates. Protein classes are indicated in the Key (left diagram). 
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Figure 4.8 Z-score correlations of GEF validation screen. A-C) Average Z-scores for all 
individual siRNA oligos tested in the GEF validation screen for E-cad and Jun-A (A) or Cyt-A (B) 
or Jun-A and Cyt-A (C). Correlation strengths were evaluated using Pearson’s correlation. R2 
values shown in red. 
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three parameters. This could result from a reduction in false positive results due to 
elimination of off-target effects of pooled siRNAs in the primary screen, or an increase in 
siRNAs that did not have an effect in the validation screen when tested individually.  
4.3.7 GEF Hit phenotype profile and Rho GTPase substrate specificity 
I next classed a GEF as a Hit if two or more of the four individual oligos for a GEF were 
outside the same cut-off (Z-score +/- 0.8) (Fig. 4.9A, B and C). If for a given GEF, two 
oligos were greater than +0.8 but two oligos were more negative than -0.8, this GEF would 
not be classed as a Hit as the ambiguous result required more testing. Using this criterion I 
selected 20 GEF Hits from the 33 tested. Of all the GEF Hits, 40% perturbed only one 
parameter (Fig. 4.10A). Of these, E-cad alone was mostly affected (20%), and a large 
proportion of GEF Hits affected Cyt-A alone (15%). Two parameters were affected by 35% 
of GEFs and most of these were E-cad and Jun-A together. Finally only 25% of GEF Hits 
were able to perturb all three parameters simultaneously. Overall these data indicate that 
GEF proteins might be responsible for directing a number of specific cellular programs that 
act on E-cadherin or F-actin separately to culminate in proper junction formation. 
I next addressed whether there was enrichment of a particular Rho substrate among the 
GEF Hit dataset. I used the information from the literature to show the in vivo specificity of 
a GEF for the three well-studied GTPases RhoA, Rac and Cdc42 (Fig. 4.10B). I found that 
out of the 20 GEF Hits 19 have in vivo GEF activity. Nine have been shown to regulate 
Rac activation either specifically, or as well as RhoA and Cdc42. Six GEF Hits are RhoA 
regulators and interestingly nine are Cdc42 regulators. This is an unexpected finding as, in 
keratinocytes, Cdc42 activation was found to be dispensable for AJ formation (Erasmus et 
al, 2010) and could indicate that these GEF Hits mediate their effects in cell-cell adhesion 
via an unidentified Rho GTPase. Overall there was no enrichment for a particular Rho 
substrate for the GEF Hits implying that the GEFs regulate a variety of Rho GTPase in 
junction assembly. 
At this stage, it is important to obtain specific information about the relationships between 
the types of GEFs responsible for different phenotypes and how their known molecular 
and cellular functions are integrated in AJ formation. To get an initial 
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Figure 4.9 Alignment of Z-scores by protein to determine GEF Hits. A-C) All average Z-
scores for each of the four individual siRNAs for a protein (represented by bars and coloured as 
shown in the key) were grouped together and plotted for E-cad (A), Jun-A (B) and Cyt-A (C). 
Dotted red lines show cut-offs at ±0.8 used to define a hit oligo. Proteins are classified as GEF 
Hits if two or more oligos were hits selected by the same cut-off. X-axis shows GEF proteins 
organised in alphabetical order from left to right. 
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Figure 4.10 GEF Hit phenotype profile and Rho GTPase substrate specificity.  A) Phenotype 
profile of selected GEF Hits. SiRNA can perturb one (1), two (2) or three (3) of the processed 
parameters E-cad, Jun-A and Cyt-A. Phenotype combinations are colour-coded in the Key. 
Values are given in percentages. B) GEF Hit Rho GTPase substrate specificities given as in vivo 
activity. Values are the number of GEFs with specificity for the category indicated. Rac, RhoA 
and Cdc42 only are shown.  Some GEF Hits can activate other Rho GTPases. This information is 
given in table 4.1.  
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overview, I clustered the GEF Hits into nine distinct groups according to their screen 
phenotype. I then collated, from the literature, information about the Rho GTPase 
specificity in vitro and in vivo, known cellular and molecular mechanisms and clinical 
disease associations (Table 4.1). A number of interesting observations can be made. For 
most particular phenotype groups, no enrichment of specific Rho substrate was observed 
as Rho, Rac and Cdc42 activators were found in most categories. However, the two GEFs 
(DOCK8 and FGD4) giving the phenotype of E-cad and Jun-A upregulation coupled with 
downregulation of Cyt-A, are both Cdc42 GEFs, whereas the inverse phenotype is given 
by two RhoA GEFs Net1 and ARHGEF2 (GEF-H1), indicating a putative link between 
these GTPases and phenotype. There were however, no clear patterns of associations of 
diseases or similar molecular and cellular processes with a particular screen phenotype. 
Interestingly, there was a strong global association of the GEF Hits with just two broad 
clinical diseases pathologies: neurological disorders and tumourigenesis (Table 4.1). I 
investigated this finding further using Gene Ontology annotations (www.goterms.org) to 
study the global distribution of molecular and cellular properties of the GEF Hits.  I found 
that, in support of the literature findings, many GEF Hits have roles in regulating the 
central and peripheral nervous system and cell survival (Figure 4.11). Processes such as 
neuronal development strongly rely on cell-cell communication and networking, thus these 
findings indicate that the molecular processes required for such interactions could, in 
addition to other cellular processes, play a role in AJ assembly.   
Finally, I chose a number of GEF Hits to take forward for in-depth biochemical and 
functional characterisation to identify their roles in AJ formation. Targets were selected if (i) 
no previous role at AJs had been shown, (ii) the GEF was not previously well 
characterised, (iii) some genetic and molecular information was available, (iv) expression 
in keratinocytes was implied from the literature and, (v)  there were readily available 
molecular and biochemical tools. To this end, I selected P-Rex2 (phosphatidylinositol-
3,4,5-trisphosphate-dependent Rac exchange factor 2, also known as DEPDC2 (DEP 
domain containing protein 2)) and ARHGEF10 as my targets (table 4.1). Due to technical 
difficulties with depletion of P-Rex2 I focussed entirely on ARHGEF10. The validated 
screen phenotype of ARHGEF10 depletion gave increased levels of junctional E-cad 
independently of changes to F-actin distribution (Fig. 4.12), suggesting ARHGEF10 is a 
negative regulator of AJ formation. This makes ARHGEF10 an interesting target for further 
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studies. The biochemical and functional characterisation of ARHGEF10 is the focus of 
chapter 5.  
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ARHGEF10        [
3  H] GDP release   RhoB RhoC HEK293 H RhoA mediated mitosis 
Neuropsychiatric; 
Myelination;Stroke; Cancer 1 - 12 
DOCK11        [
3  H] GDP release    Cos1 M Activated Cdc42  13, 14 
FGD3             HeLa Tet-off M   15,16 
SOS2            HRas*      
ARHGEF6        
GTPγS binding, 
[3  H] GDP release    Cos1 H Integrin clustering; Hippocampal neuron morphogenesis; Apoptosis 
X-linked mental retardation; 
Cancer 17-27 
TUBA        
GTPγS binding; 
MANT-GTP     Caco-2; U2-OS H Epithelial junction formation; Centrosome organisation 
Alzheimer's Disease; L. 
monocytogenes infection 28 - 34 
TRIO       RhoG [3  H] GDP release   RhoG CCL39; HeLa H Neuronal pathfinding; Galphaq11; Myoblast fusion Cancer Reviewed in 35 
DOCK2        [
3  H] GDP release    
293T, 
Jurkat H Lymphocyte migration and adhesion; neutrophil motility and polarity Alzheimer’s Disease 36 - 48 
AKAP13       RhoB; RhoC 
GTPγS binding, 
[3  H] GDP release    Swiss 3T3 H 
Rho  mediated NFĸB signalling; TLR2 mediated NFĸB; integrin; Galpha 
12/13; glucocorticoid Oncogenic; Cardio hypertrophy 49 - 54 
DEPDC2             
HEK293T, 
PAE, Sf9 H Purkinje cell morphology and signalling Tumourigenesis 55 - 59 
DOCK3             Cos7; A375M2 H 
Cell-cell adhesion via N-cadherin; Neurite outgrowth; Wnt signalling; tumour 
cell movement; ADHD; Alzheimer's Disease 60 - 64 
DOCK6        [
3  H] GDP release    Cos7 H Mouse neurite outgrowth Adams-Oliver Syndrome 65 - 66 
OBSCN            RhoQ Cos7 H Myofibrillogenesis; localised to sarcomere in skeletal muscle L. Pneumonila infection 67 - 77 
VAV1        GTPγS binding, [3  H] GDP release    Cos7; Cos1  
T-call signalling; Cytoskeletal organisation; B-cell signalling; Integrin 
Signalling Malignancy Reviewed in 78 
ALS2            Rab5A sf9 , CHO H 
Endothelial dynamics; membrane dynamics; neuronal development and 
degeneration 
ALS; JLS; infantile onset 
ascending spastic paralysis 79 - 81 
DOCK8        MANT-GTP     DOCK8
-/- M  DCs T- and B- cell function; NK cytotoxicity; DC migration DOCK8 deficiency; HPV infection 82 - 90  
FGD4        [
3  H] GDP release    
FGD4-/- R  sciatic nerve Microspike formation; Endocytosis Schwann cells Charcot-Marie Tooth 91 - 94 
ARHGEF2       RhoB; RhoC 
GDP release, 
GTPγS binding     
Cos7;  MDCK; 
Cos1; NIH3T3  H 
Tight junctions; cytokinesis; cell cycle; paracellular permeability; cell 
migration; microtubule binding; trafficking; dendritic spine morphology; Cancer Review in 95 
NET1        
GTPγS binding, 
[3  H] GDP release     HELA H 
TGF-β signalling; Gastric cancer cell invasion; Upregulated in HCC cells; 
DNA damage response Breast cancer: 96 - 107 
FGD1        
GTPγS binding, 
[3  H] GDP release     Swiss 3T3 H 
Invadopodia; Export form Golgi; Translocation to leading edge on EGF 
stimulation and wound healing; integrin adhesion 
Faciogenital dysplasia 
(Aarskog-Scott syndrom); ADHD 108 - 113 
Table 4.1 Rho GEF Hit Proteins. Table showing Rho GEF Hit proteins organised by screen phenotype. Green and red shading indicate positive or 
negative Z-scores, respectively, on parameter after siRNA depletion. Both in vitro and in vivo GTPase specificities are noted for Rho (purple), Rac 
(yellow) and Cdc42 (orange). Other known GTPase substrates are also noted. Where possible studies refer to the earliest evidence of GEF activity 
using human sequences (H), other species are shown if no human data is available (M, mouse; R, rat). This is not a comprehensive list of all cell 
types tested in the literature for substrate specificity. Key molecular and cellular functions are given along with disease associations. Where 
appropriate reviews are cited, otherwise primary research papers are referenced. 1Bibliography in Appendix 1.* Inferred from sequence homology. 
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Figure 4.11 Molecular and cellular processes gene ontology annotations of GEF Hits. Bar 
graph representing the molecular and cellular properties of the GEF Hits. Annotations were derived 
using gene ontology searches for biological and molecular functions (www.GOterms.org).  
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Figure 4.12 Representative images of GEF Hit selected for further characterisation. 
Confluent wells of keratinocytes cultured in the absence of cell-cell contacts were induced to form 
junctions after treatment with control-scrambled (Scr) or with one of two single target 
oligonucleotides (ARHGEF10#1 or #4). Cells were fixed and stained for E-cadherin and with 
Phalloidin to visualise F-actin. Top panels show merge images for Control-treated and 
ARHGEF10- depleted cells. E-cadherin and F-actin are shown below as single channel images. 
Arrows indicate E-cadherin localised at cell-cell contacts. E-cadherin images were processed 
using intensity-thresholding (see section 2.4.6). 
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4.4 Conclusions 
In conclusion, our studies find that cell number is not an appropriate measure of 
confluence but Total F-actin Area could be used to assess confluence in large automated 
analyses. We also show that E-cad and Jun-A Area are not influenced by the number of 
cells in a sample, whereas Cyt-A Area is very weakly negatively correlated. We show that 
the distribution of Area values within plates is generally normal, implying that the targeted 
siRNA library induces a dynamic range of E-cadherin and F-actin perturbations.  
 After normalisation of Area values using Z-score analysis, we find that the parameters E-
cad and Jun-A are highly positively correlated in the primary screen. Following selection of 
candidate proteins and further validation of GEF candidates, the E-cad and Jun-A 
relationship remained strong. In contrast, the correlation of Cyt-A with E-cad or Jun-A is 
always negative and, as stringency increased from proteins tested in the primary screen to 
validated GEF hits, the strength of correlation weakens.  
The phenotypic analyses of All candidates, GEF candidates and GEF Hits show that the 
majority of candidate proteins and GEF candidates tend to affect all three experimental 
parameters, whereas the GEF Hits show perturbation of one or two parameters rather than 
all three. This implies that GEF proteins might regulate specific cellular processes rather 
than influence global cytoskeletal rearrangements during junction assembly.    
Finally, the GEF Hits separate into nine distinct groups based on their screen phenotypes 
and consist of proteins that are known regulators of RhoA, Rac and Cdc42 in vivo.  There 
are no clear relationships between a particular screen phenotype and the substrate 
specificity or molecular and cellular functions of a GEF Hit. However, GO annotations 
reveal that many of the GEF Hits proteins have known roles in development of the PNS 
and CNS, in cell survival and in adhesion signalling. These observations underscore the 
current thinking that aberrant activation of developmental processes in adult tissue can 
contribute to cancer progression.  
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4.5 Discussion 
Automated quantitative screening techniques are valuable tools to enable assimilation of 
information from large data sets in a short period of time. Here I used this methodology to 
examine the contribution of Rho GTPases and their regulators and effectors in governing 
epithelial biogenesis.  
4.5.1 Rho GTPases, their regulators and interactors tend to act as positive 
regulators of epithelial biogenesis 
The raw Area measurements for the output parameters E-cad, Jun-A and Cyt-A are 
generally normally distributed meaning that, even though we tested families of genes 
which share common properties associated with regulating cytoskeletal dynamics, 
silencing of these genes is able to elicit a restricted range of perturbations. We used 
control-based normalisation techniques to evaluate how particular siRNA treatments 
perturb junction formation for two reasons. First, it allows our selection of cut-offs to be 
based on the control phenotype (Birmingham et al, 2009). This contrasts to genome-wide 
functional genetic screens where the majority of siRNAs are ineffectual and can be used 
as negative controls, allowing normalisation-by-plate techniques to be used (Demir & 
Boutros, 2012). Second, several sub-confluent wells were excluded from analysis leading 
to inter-plate variability and lack of normal distribution for some plates. A sub-confluent 
phenotype can occur if genes required for cell growth, proliferation or attachment are 
silenced. However, these samples should be consistently removed in all replicates. 
Rather, additional technical factors can impact on confluence leading to inconsistent 
exclusion of wells between replicates and thus increased variability. Also, the inherent 
properties of RNAi based screening can compound inter-plate variation (Birmingham et al, 
2009) as transfection efficiency of siRNA can vary and RNA interference is itself a 
biological process (Echeverri & Perrimon, 2006).  
Our finding that control-based normalisation gives Z-scores that are negatively skewed for 
E-cad and Jun-A implies that the majority of depletions of the library genes tend to be 
detrimental to junction formation.  It suggests that the endogenous roles of the proteins 
tested are to promote E-cadherin and F-actin junctional localisation, or act to compact the 
underlying F-actin thin bundles and are thus required for proper cell-cell contacts to form. 
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A major part of image-based screening is multidimensional analysis to examine cross-
correlations between assay output parameters (Bakal et al, 2007).  The lack of correlation 
between cell number and E-cad or Jun-A levels shows the range of these parameters is 
related to RNAi depletion and demonstrates their validity as the experimental read-out.  In 
studies using qualitative visual scoring, a large number of phenotypes, not strictly related 
to intensity, can be identified and recorded allowing for additional inferences to be made 
from the data (Bai et al, 2011; Kiger et al, 2003; Liu et al, 2009). The intensity-based 
binary classification of E-cadherin signal used herein is not able to distinguish between 
possibilities such as: increased intensity of E-cad at the junction; wavy junctions that are 
longer than normal junctions and thus incorporate more E-cadherin to the junctional area; 
increased cytoplasmic levels of E-cadherin such as in vesicular or punctate structures, or; 
aberrant rounded cells extruding from the monolayer.  Nevertheless, automated analysis 
of three parameters chosen here is sufficient to allow cross-comparisons to be made. 
Reduction in E-cadherin may be due to perturbations in E-cadherin trafficking or lack of 
stabilisation of E-cadherin once at the AJ (Cavey et al, 2008; Delva & Kowalczyk, 2009; 
Gumbiner, 2005; Nelson, 2008).  Reduction in junctional F-actin might arise from 
perturbations in F-actin reorganisation at junctions (Chhabra & Higgs, 2007). Increased 
Cyt-A may reflect incorporation and stability of F-actin in thin bundles, or delayed thin 
bundle compaction which could be due to perturbed interactions with actin-binding proteins 
such as Myosin VI, α-catenin and vinculin (Michael & Yap, 2013). Negative regulators of 
these processes give the opposite screen phenotype when depleted and increase levels of 
E-cad and Jun-A or decrease Cyt-A. The identification of a small number of negative 
regulatory proteins suggests junction formation requires a balance between junction-
promoting and junction-disassembling processes to fine-tune and refine formation of AJs.  
The findings from the primary screen that show E-cad, Jun-A and Cyt-A Z-scores are all 
highly correlated uncovers the relationships between the perturbations of E-cadherin and 
F-actin and suggests the function of the depleted proteins is to rearrange the actin 
cytoskeleton in order to promote localisation of E-cadherin to the AJ. For the GEF Hits the 
cellular mechanisms that regulate thin bundles (Cyt-A) and junctional F-actin and E-
cadherin appear to be more independent of each other. The specific reduction in 
correlation of E-cad/Jun-A with Cyt-A implies that the GEF Hit subset might modulate 
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distinct processes than those controlled by the other types of proteins tested in the screen. 
For example, individual GEFs may specifically regulate F-actin dynamics to drive 
branching adjacent to the cadherin-catenin complex or bundling of cortical actin, rather 
than act upstream and govern a process that controls the overall balance of F-actin 
rearrangements.    
A large number of proteins from the primary screen (101/202) are identified as candidate 
proteins, as determined by the subjective stringency level of selection (Birmingham et al, 
2009). One caveat associated with selecting candidate proteins with a range of phenotype 
strengths is that the weak phenotypes may be false positives. On the other hand, choosing 
only proteins with strong phenotypes may lead to the selection of false positives alone, 
such as those that have a non-specific effect on cellular homeostasis as opposed to 
junction-specific effects. The performance of a secondary screen to validate the candidate 
proteins can go some way to reducing false positives.  Indeed, during the validation 
screening, the number of GEF candidates is reduced to 20 GEF Hits and the proportion of 
GEF hits that perturbed all three parameters is much lower. Together these findings 
suggest that the validation screen eliminates some false-positives and selects for proteins 
with a more specific phenotype (Echeverri et al, 2006).  
4.5.2 Multiple Rho GEFs are implicated in AJ formation 
The diversity of upstream regulators might account for distinct signalling pathways driven 
by Rho GTPases downstream of cadherin ligation. The candidate proteins were enriched 
for GAPs whilst the proportion of GEF proteins remained the same. The increased number 
of GAP proteins may indicate a wide range of specific functions for the GAPs and 
highlights the general thinking that GAP proteins are often overlooked in the spatio-
temporal control of Rho GTPases (Bernards & Settleman, 2004). Despite a lack of 
enrichment in Rho GEF Hits, from over 70 initial Rho GEF proteins, 20 are identified as 
Rho GEF Hits. These GEF Hits tend to perturb one or two of the output parameters.  
A small pool of GEF proteins may be sufficient to define cellular contexts due to their 
ability to be differentially regulated. For example, in TJ assembly Tiam1 subcellular 
localisation and activation state is tightly regulated (Chen & Macara, 2005; Guillemot et al, 
2008; Mack et al, 2012; Mertens et al, 2005) to establish a basal to apical gradient of Rac 
Natalie Welsh   PhD Thesis 
  176 
activation which is required for proper TJ assembly (Mack et al, 2012).  This is achieved 
through β2-syntrophin-mediated activation of Tiam1 in the basal domain (Mack et al, 2012) 
combined with Par3-mediated inactivation of Tiam-1 more apically (Chen & Macara, 2005; 
Mack et al, 2012) which generates graduated Rac activation. The importance of this 
differential Tiam1 regulation is clear as apical lumen formation is perturbed when the 
active Rac gradient is lost (Mack et al, 2012). 
It is not clear how multiple GEFs can have the same phenotype when depleted (i.e. 
decrease in E-cadherin intensity). One explanation could be that many of the GEFs are in 
the same signalling pathway and act in a linear cascade. If any of the GEFs in this 
cascade are blocked, then the outcome would be similar. For example, Unc-73 (Trio) acts 
as a MIG-2 (RhoG) GEF upstream of CED-2/CED-12/CED-5 (CrkII/ELMO/DOCK180) 
complex to regulate CED-10 (Rac)-mediated engulfment in C. elegans (deBakker et al, 
2004).  Similarly Ect2 activates Cdc42, which in turn stimulates Trio-mediated Rac 
activation to mediate glioma cell responses to extracellular signals (Fortin et al, 2012).  
Alternatively, GEFs may in-fact exhibit different strengths of the same phenotype. Here, 
the potency of phenotype has not been analysed. It could be that there is a degree of 
redundancy amongst the GEFs in a phenotype group and that loss of more than one GEF 
function is required to obtain maximum perturbation.  Indeed, one study showed that 
double knockdowns are required to show signalling interactions (Nir et al, 2010). An siRNA 
screen in HeLa cells using the same library as in my study, shows that knockdown of the 
GEFs Tiam1, Trio, Vav1 and Ect2 are all able to induce the same phenotype to cause 
zigzag stress fiber morphology, multinucleate cells and decreased cell number (Rohn et al, 
2011).  On the other hand, I find there are phenotype groups that have only one GEF Hit, 
strongly suggesting that there is not always redundancy in a system, and that the 
quantitative technique used was sensitive enough to discern this. Moreover, several 
closely related GEFs FGD1, FGD3 and FGD4 segregated into three separate phenotype 
groups, a phenomenon that was seen in a screen of actin regulators in PC3 pancreatic 
cancer cells (Bai et al, 2011). This might indicate the divergent functions of related proteins 
rather than their use as redundant proteins. 
One interesting observation from the phenotypic groupings showed clearly that all the 
GEFs affecting E-cad alone specifically increased the levels of E-cad upon depletion. This 
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was in stark contrast to the GEFs that were able to perturb both E-cad and Jun-A 
simultaneously by having a negative effect on the level of E-cad (table 4.1). For example, 
GEFs that functionally couple F-actin and E-cadherin could play roles in stability of AJs, 
whereas GEFs that regulate E-cadherin trafficking dynamics might define a separate mode 
of cadherin regulation (Baum & Georgiou, 2011; Zaidel-Bar, 2013).   
Some GEF Hits have been identified as regulators of actin-based processes in other 
siRNA screens. For example, DOCK6 knockdown accelerates migration of MCF-7 cells in 
wound healing assays by transiently weakening cell-cell adhesion (Simpson et al, 2008) 
and Vav1 or Trio depletion perturbs F-actin and cell shape in HeLa cells (Rohn et al, 
2011). This might imply that DOCK6, Vav1 and Trio may be wide-spread regulators of cell-
cell adhesion in many cell types. In contrast, ARHGEF11 and p114RhoGEF were 
identified as regulators of migration (Simpson 2008), but not of adherens-based cell-cell 
adhesions herein, which could reflect the known roles of these proteins at TJs but not AJs 
(Itoh et al, 2012; Nakajima & Tanoue, 2011; Terry et al, 2011).  
Many of the GEF Hits have roles in neurological disorders and tumourigenesis. ARHGEF6 
(β-PIX), Trio, DEPDC2, DOCK3, and ALS2 mediate neuronal development including 
pathfinding and neurite outgrowth (Cleveland & Rothstein, 2001; Donald et al, 2008; 
Jackson et al, 2010; Meseke et al, 2013; Namekata et al, 2010; Nodé-Langlois et al, 2006; 
Totaro et al, 2012; van Rijssel & van Buul, 2012). These processes are actin-dependent 
and rely on an integration of extracellular cues to modify cell adhesions. Moreover many 
GEFs (ARHGEF6, A-kinase anchor protein (AKAP) 13, VAV1 and FGD1) have been 
implicated in integrin adhesion (Ayala et al, 2009; Daubon et al, 2011; Rosenberger et al, 
2005; Rosenberger et al, 2003; Tybulewicz, 2005).  How these GEF-specific properties 
impinge on junction assembly is not clear.  Integrin-based and cadherin-based adhesions 
participate in the physiological and pathophysiological regulation of cell death and 
development of tumour invasiveness (Chiarugi & Giannoni, 2008; Epifano & Perez-
Moreno, 2012). Whether or not loss of a particular GEF directly affects AJ-specific cellular 
machinery, or whether there is co-operation between integrin and cadherin signalling to 
bring about the observed phenotypes is a key question to investigate.  
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4.6 Future work 
4.6.1 Compilation of data to form molecular networks of AJ assembly 
Having identified a number of GEF regulators of epithelial biogenesis it is important to 
assemble the data obtained for the validation of the other protein classes performed by 
colleagues in the lab (J. McCormack and S. Bruche, unpublished), along with the 
validation data from the Actin regulator screen (V. Braga, unpublished).  With the large 
validated data set, numerous in-depth bioinformatics analyses can be carried out, 
incorporating information about binding partners and protein structures as well as the 
molecular and cellular properties uncovered so far. This type of analysis enables 
computational construction of large signalling networks and can be central to identifying 
key signalling nodes where cross-talk might occur.  Having this kind of information to hand 
is an invaluable tool to help rationalise experimental design and maximise dissemination of 
knowledge in the wider scientific community.  
4.6.2 In-depth morphological phenotype evaluation 
The image data set can be analysed to identify morphological differences amongst similar 
quantitatively-derived phenotypes, thus providing an extra layer of insight into mechanisms 
governing epithelial biogenesis and maturation. This can be achieved through visual 
analysis and scoring, or by design of further image quantification algorithms. One advance 
could be the use of a segmentation pipeline which first uses a step to segment the cell 
periphery (junctional region) from the rest of the cell (cytoplasm), thus measuring the two 
compartments independently of one another, helping to classify more phenotypes. 
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5 Regulation of cell-cell contact assembly by 
ARHGEF10 
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5.1 Introduction 
5.1.1 Negative regulation of AJ assembly 
Current understanding holds that E-cadherin and F-actin recruitment to newly forming 
junctions is a dynamic and highly regulated process (Green et al, 2010; Yonemura, 2011; 
Zaidel-Bar, 2013). Understanding the spatial and temporal regulation of the localisation of 
the AJ complex proteins is an increasingly popular area of research.  It is well known that 
Rho GTPases and their regulators are important for the proper organisation and function 
of newly formed cell-cell contacts (and indeed the mature, stable contact) (Braga, 2002; 
Braga & Yap, 2005; Citi et al, 2011; McCormack et al, 2013).  However, as with many 
complex signalling networks, there are likely to be a number of positive and negative 
regulators that co-ordinate cellular processes to ensure appropriate assembly of 
intercellular contacts (Dikic & Giordano, 2003; Greenhalgh & Hilton, 2001; Ritter & Hall, 
2009).  Many positive regulatory factors have been previously studied whose loss-of–
function impairs the assembly of proteins into the classical AJ (Citi et al, 2011; McCormack 
et al, 2013; Zaidel-Bar, 2013). Much less focus has been afforded to the negative 
regulatory processes that facilitate flexibility in this highly regulated system.  It is therefore 
important to investigate whether negative regulation of de novo AJ plays an important role 
in establishing functional cell-cell connections. 
I identified the Rho GEF ARHGEF10 as a putative AJ negative regulator (See Chapter 4).  
Depletion of ARHGEF10 leads to more E-cadherin incorporation into cell-cell contacts 
independent of an effect on F-actin rearrangement at the newly formed cell-cell junction. 
This finding implies that endogenous ARHGEF10, as part of a negative regulatory 
pathway, is important for organising the AJ during biogenesis by regulating the dynamics 
of E-cadherin recruitment and/ or turnover.   
5.1.2 ARHGEF10 structure and expression 
A small number of key studies on the functions and disease associations of ARHGEF10 
provide insight into the suitability of ARHGEF10 for my follow-up studies. ARHGEF10 is a 
1344 amino acid protein member of the Dbl family of Rho GEFs.  It contains a DH domain 
followed by an atypical PH domain and a WD40-like protein-protein interaction domain 
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(Fig. 5.1A) (Mohl et al, 2006; Verhoeven et al, 2003). It is a member of a subset of Rho 
GEFs including the closely related Grinch GEF (ARHGEF10-Like) and p167-RhoGEF 
(ARHGEF17) (Mohl et al, 2006; Rümenapp et al, 2002; Winkler et al, 2005).  The human 
gene is found on the 8p chromosome and can be transcribed as two major alternative 
splice variants known as the long (ARHGEF10) and the short (ARHGEF10-s) splice 
variants, with and without exon 8, respectively (Mohl et al, 2006). 
ARHGEF10 is expressed during development of the mouse nervous system, where it is 
found in the brain, dorsal root ganglia and the ventral horn (Verhoeven et al, 2003; 
Yoshizawa et al, 2003). Expression is ubiquitous in the adult mouse and human (colon, 
small intestine, lung, heart, failing heart, skeletal muscle, kidney and liver) (Mohl et al, 
2006; Verhoeven et al, 2003; Yoshizawa et al, 2003), and levels are increased in the adult 
mouse brain (Yoshizawa et al, 2003). Overexpressed full-length ARHGEF10 is largely 
cytoplasmic (Mohl et al, 2006). Endogenous ARHGEF10 co-localises with RhoA in 
centrosomes of HeLa cells in the G1/S and M phases of the cell cycle (Aoki et al, 2009).   
5.1.3 Signalling properties of ARHGEF10 
Recombinant GST-ARHGEF10-DH acts as a nucleotide exchange factor on recombinant 
GST-tagged RhoA, but not Rac or Cdc42 in in vitro assays (Mohl et al, 2006).  In vivo GEF 
activity has also been demonstrated for full-length ARHGEF10 on endogenous RhoA, 
exogenous HA-tagged-RhoB and HA-RhoC, but not endogenous Rac or Cdc42 (Mohl et 
al, 2006). As shown for other GEFs, the substrate specificity of ARHGEF10 is likely to be 
cell type-dependent.  Expression of a truncated ARHGEF10 construct containing the DH 
and PH domains increases GTP-bound HA-RhoA; however, no increase in RhoB activity is 
shown (Aoki et al, 2009). 
 
It is thought that ARHGEF10 is negatively regulated by its N-terminus, since removal of 
the amino acids N-terminal to the DH domain (ARHGEF10ΔN) induces activation of 
ARHGEF10 and increases active levels of exogenous RhoA, RhoB and RhoC in HEK293 
cells. Regulation of ARHGEF10 activation is thought to be specifically mediated by 
Threonine 332: when mutated to Isoleucine (T332I) leads to an increase in SRF activity 
compared with wild-type ARHGEF10 in HEK293 cells (Chaya et al, 2011). This increase in 
activity upon T332I mutation is GEF-activity dependent as deletion of the DH domain, or 
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mutation of Leucine 547 to Alanine in the DH domain (rendering the protein inactive), 
abolishes GTP-loading of RhoA in vivo (Chaya et al, 2011).  
Consistent with the in vivo substrate specificity, ARHGEF10 regulates a number of RhoA-
mediated cellular processes. Full-length ARHGEF10 enhances SRF activity induced by 
overexpression of wild-type RhoA, RhoB and RhoC in HEK293 cells with a seemingly 
increased efficacy for RhoB (Mohl et al, 2006). Interestingly, when co-expressed with 
RhoA, RhoB or RhoC, a truncated ARHGEF10 mutant containing the DH domain alone, is 
not able to increase SRF activity above the levels of GTPase alone (Mohl et al, 2006), 
indicating that unlike a number of Dbl GEFs ARHGEF10-DH is not a constitutively active 
protein and that additional regions of the protein are required for GEF activity (Rossman et 
al, 2005; Schmidt & Hall, 2002a).  
Overexpression of ARHGEF10 induces stress fibre formation in NIH3T3 fibroblasts, 
supporting a role in RhoA signalling (Mohl et al, 2006). Further evidence of an 
ARHGEF10-RhoA signalling pathway has been demonstrated during mitotic spindle 
formation (Aoki et al, 2009). Depletion of either ARHGEF10 or RhoA results in multipolar 
spindle formation in HeLa cells during M phase.  Moreover, constitutively active RhoA 
rescues the ARHGEF10 phenotype (Aoki et al, 2009). Interestingly, cytokinesis is not 
perturbed by ARHGEF10 depletion, suggesting a role for the protein in the regulation of 
centrosome duplication, rather than the regulation of contractile machinery classically 
associated with RhoA function in cell division (Aoki et al, 2009; Piekny et al, 2005). This 
demonstrates the ability for GEFs to direct specific signalling processes. More recently, 
over-activation of ARHGEF10, by removal of the N-terminus or the T332I mutation, has 
been shown to drive Rho-ROCK-dependent contraction in HEK293T, HeLa and Schwann 
cells, independently of external stimuli (Chaya et al, 2011). Taken together, these recent 
studies support the hypothesis that ARHGEF10 can act as a RhoA GEF to regulate 
intracellular processes.  
5.1.4 Clinical significance of ARHGEF10 mis-regulation 
The clinical implication of ARHGEF10 over-activation has been demonstrated in human 
diseases. The constitutively active T332I mutation completely co-segregates with a slowed 
nerve conduction velocity and myelination defect in all 12 affected members of a family of 
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39 (Verhoeven et al, 2003).  Interestingly, the mutation is associated with a non-
progressive, non-clinical pathology, implying instead, that the over-activation of 
ARHGEF10 during embryogenesis is important for development of the peripheral nervous 
system (Verhoeven et al, 2003).  As recapitulation of developmental processes in adult 
tissues are key triggers of epithelial tumourigenesis (Berx et al, 2007), a 
pathophysiological activation of ARHGEF10 would be consistent with the evidence that 
other members of the Dbl family of GEFs are known oncoproteins when their constitutively 
active mutants are expressed (Rossman et al, 2005; Schmidt & Hall, 2002a).  
On the other hand, several studies have identified aberrant ARHGEF10 expression in a 
number of epithelial primary tumours and cell lines (Cooke et al, 2008; Williams et al, 
2010; Wood et al, 2007). These studies assessed expression levels in a variety of tumours 
and cancer cell lines and mutations associated with oncogenic chromosomal aberrations 
in cancer. Loss of heterozygosity, coupled with a mutation in the remaining copy of 
ARHGEF10 is found in the DU4475 breast cancer cell line, whilst 15 out of 18 breast 
cancer cell lines tested have over 50% reduced expression of ARHGEF10 (Cooke et al, 
2008). ARHGEF10 expression is also reduced in some (eight out of 33) but increased in 
other (two out of 33) urothelial cancer cell lines by more than four-fold (Williams et al, 
2010).  Additionally, mutations in ARHGEF10 have been found in three urothelial cancer 
cell lines. Two of these are in close proximity to the T332I previously identified (Verhoeven 
et al, 2003; Williams et al, 2010).  Other mutations are found in two out of 11 colon 
tumours tested (Wood et al, 2007). Of the cancer related mutations found to date in 
ARHGEF10, none are in the DH domain. It is not known whether the functional 
consequences of the amino acids substitutions are activating or inactivating. Nonetheless, 
these findings indicate the possibility that ARHGEF10 may act as a tumour suppressor in 
some cancer types, whereas it may function as an oncoprotein in others (Cooke et al, 
2008; Williams et al, 2010; Wood et al, 2007).  
5.2 Hypothesis and Aims 
From my data showing that ARHGEF10 depletion increases E-cadherin levels during cell-
cell contact formation and from earlier studies showing ARHGEF10 acts upstream of 
RhoA, I hypothesise that ARHGEF10 is a negative regulator of epithelial biogenesis and 
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that over-activation of ARHGEF10 would be detrimental to junction formation. I predict that 
ARHGEF10 is required for the appropriate turnover of E-cadherin molecules at the cell 
surface allowing for dynamic re-distribution of E-cadherin to the nascent AJ. 
I aim to establish the cellular process and signalling pathway mediated by ARHGEF10 
which leads to the regulation of E-cadherin incorporation into nascent AJs. I also aim to 
determine whether ARHGEF10 spatially and temporally regulates RhoA activity to drive 
epithelial biogenesis. 
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5.3 Results 
5.3.1 Activated ARHGEF10 disrupts junction formation 
A number of Dbl family Rho GEFs have been described as oncoproteins, whereby over-
activation of the GEF activity is implicated in cancer progression (Rossman et al, 2005; 
Schmidt & Hall, 2002a). I hypothesise that, because in the screen (see Chapter 4) 
depletion of ARHGEF10 increased E-cadherin levels at junctions, over-expression of an 
activated form of ARHGEF10 (ARHGEF10T332I
I overexpressed GFP-vector (control), wild-type ARHGEF10 (GFP-ARHGEF10-WT), the 
constitutively active ARHGEF10 (GFP-ARHGEF10
) (Chaya et al, 2011) may reduce junctional 
E-cadherin levels at nascent contacts. Moreover, if GEF activity per se is required then 
removal of the DH domain, to render the protein inactive, will abolish any effects driven by 
over-activation (Chaya et al, 2011). 
T332I) or a mutant of the constitutively 
active protein lacking the DH domain (GFP-ARHGEF10ΔDHT332I) (Fig. 5.1A). I measured 
the levels of junctional E-cadherin by immunofluorescence after 30 minutes calcium-
switch, as a percentage of a pre-defined, constant junctional region (See segmentation 
method in section 2.4.4). Cells over-expressing GFP-ARHGEF10-WT displayed no 
noticeable differences in junctional E-cadherin staining compared with control transfected 
cells (Fig. 5.1B and Fig. 5.1C). In contrast, overexpression of GFP-ARHGEF10T332I 
significantly reduced the area of junctional E-cadherin per cell by 0.74 fold, compared with 
controls (p=0.0061) (Fig. 5.1B and Fig. 5.1C). This reduction was not apparent in GFP-
ARHGEF10ΔDHT332I
5.3.2 ARHGEF10 is required for RhoA activation upon junction assembly 
 transfected cells (Fig. 5.1B and Fig. 5.1C). Overall, these data 
suggest that activation of ARHGEF10 is detrimental for junction formation, a process 
specifically dependent on the presence of the DH domain.  
In control experiments, I found that loss of ARHGEF10 (individual siRNA oligonucleotides 
ARHGEF10#1 or ARHGEF10#5) did not affect total levels of E-cadherin, α-catenin and β-
catenin compared with control-treated cells (Fig. 5.2A). Similarly, total levels of the Rho 
family GTPases RhoA, RhoC, Rac and Cdc42 were not changed in cells lacking 
ARHGEF10 (Fig. 5.2B). Total levels of RhoB are not shown as expression levels were 
Natalie Welsh   PhD Thesis 
  186 
 
Figure 5.1 Activated ARHGEF10 disrupts junction formation. A) ARHGEF10 cDNAs used in 
this study: wild-type (ARHGEF10-WT), constitutively active ARHGEF10 (ARHGEF10T332I) and 
GEF-deficient ARHGEF10 (ARHGEF10ΔDHT332I). B-C) Confluent monolayers of keratinocytes 
cultured in the absence of cell-cell contacts were transfected with pEGFP vector control (GFP 
vector) or with the above cDNAs. Eight hours post-transfection, cells were induced to form contacts 
for 30 minutes and immediately fixed and stained for E-cadherin. B) Epifluorescence images of 
GFP-expressing cells (left panels) and corresponding E-cadherin shown as inverted images 
(middle panels). Right-hand panels show merged images. Arrows and arrowheads indicate 
junctions with normal or reduced levels of E-cadherin, respectively. C) Quantification of the area of 
junctional E-cadherin (Junc. E-cad) expressed as a percentage of a pre-defined junctional region 
per cell (See section 2.4.4; Fig. 2.4 for quantification). Values are normalised to the mean of the 
control condition within a replicate.  Replicate values from three independent experiments are 
shown. Five or more cells per experiment. Graphs show mean of pooled data. Conditions were 
compared using Unpaired Students T-test (multiple comparison adjusted significance level α = 
0.016). * = p<0.016. Scale bar in B = 10µm. 
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Figure 5.2 ARHGEF10 is dispensable for maintenance of total protein levels of adherens 
junctions components and tested Rho GTPases. Keratinocytes depleted of ARHGEF10 for 48 
hours using one of two siRNA oligonucleotides (ARHGEF10#1 or ARHGEF10#5), or control (Con) 
scrambled siRNA-treated (Scr) cells were grown to confluence. Following junction induction for 30 
minutes, equal amounts of total cell lysate were analysed by Western blot for total protein levels of 
A) adherens junction complex proteins and B) Rho family GTPases.  
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very low and therefore blots were inconclusive. Overall, ARHGEF10 is not required for 
maintenance of total levels of junctional proteins or the Rho family GTPases tested.  
ARHGEF10 is a GEF for RhoA and RhoA is activated by junction formation. I therefore 
asked whether junction-dependent RhoA activation involves ARHGEF10. ARHGEF10 
depletion (Fig. 5.3A) did not significantly change basal levels of active RhoA in 
unstimulated cells (Fig. 5.3B and C). Following calcium addition, active RhoA levels 
increased 3.56 fold from 0 to 5 minutes in control cells (Fig. 5.3B and D). Due to variability 
between replicate experiments this change tended towards significance but did not reach 
the α=0.05 level of confidence (Fig. 5.3D). In contrast, the increase seen in control-treated 
cells was abolished after ARHGEF10 depletion: active RhoA levels only increased 1.44 
fold with high reproducibility between experiments (Fig. 5.3B and D). Taken together, 
these results suggest that ARHGEF10 is not required to maintain basal levels of active 
RhoA in unstimulated cells, but is necessary for the peak of RhoA activation after 5 
minutes junction induction. 
5.3.3 ARHGEF10 may be required for junction-induced phosphorylation of MLC 
RhoA is known to govern myosin-II activation via a number of mechanisms to drive 
remodeling of the cytoskeleton (Ito et al, 2004; Vicente-Manzanares et al, 2009). Myosin II 
is localised at junctions where it is organised in peripheral bundles (Ivanov et al, 2007; 
Shewan et al, 2005; Watanabe et al, 2007) and functions to stabilise junctions (Hildebrand, 
2005; Ivanov et al, 2007; Smutny et al, 2010). Its phosphorylation is induced by cadherin 
ligation (Kalaji et al, 2012; Shewan et al, 2005; Zhang et al, 2005) and its activation is 
important for driving morphological changes during maturation of cell-cell contacts (Ivanov 
et al, 2007; Kalaji et al, 2012; Zhang et al, 2005). ARHGEF10 may also be important for 
directing specific-RhoA signaling responses to activate myosin-II.  
To address this possibility, I induced junctions to form for 15 minutes and measured 
phosphorylation of the myosin light chain (MLC) regulatory unit at residue Serine 19 
(pMLCS19). Basal levels of pMLCS19 in unstimulated cells (0 minutes) were not significantly 
increased after ARHGEF10 depletion (ARHGEF10#1 or ARHGEF10#5) compared with 
controls (Fig. 5.4A-C). In control cells after 15 minutes calcium stimulation pMLCS19 levels 
increased 1.89 fold. However, this was not a significant change from basal levels. On the 
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Figure 5.3 ARHGEF10 is required for RhoA activation upon junction assembly. Following 
junction induction for 5 minutes cell lysates were subjected to effector pull-down using GST-RTK 
(Rhotekin-Rho Binding Domain recombinant protein). A) Representative Western blot of 
ARHGEF10 depletion (GEF10). Beta-tubulin was used as a loading control. B) Cells were 
analysed for RhoA•GTP and total RhoA levels. Amido black membrane stain of GST-RTK protein 
is also shown. C) Densitometric quantification of basal (unstimulated) levels of RhoA activation.  
Active levels of RhoA in cells without junctions where normalised to total levels of RhoA protein 
found in each sample and expressed as fold-change from siRNA control. D) Quantification of 
normalised RhoA•GTP levels shown as fold change from 0 minutes for each siRNA condition. 
Graphs show means with SEM error bars. N=3.  One-sample T-Tests were performed on 
ARHGEF10 in C and on 5 minute values for Con and ARHGEF10 treated samples in D. 
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Figure 5.4 ARHGEF10 may be required for junction-induced phosphorylation of MLC. 
Keratinocytes grown in the absence of cell-cell adhesion were treated with ARHGEF10 siRNA 
oligos#1 and #5 or control-scrambled (Con, Scr) siRNA. Cells were induced to form junctions for 
15 minutes then lysates were analysed for levels of phosphorylated myosin-II regulatory light chain 
(MLC) (pMLCS19) by Western blot using an antibody against phosphorylated MLC at Serine 19. A) 
Western blot of ARHGEF10 depletion of samples used in B. GAPDH is shown as a loading control. 
B) Representative Western blots of pMLCS19 and GAPDH loading. C) Densitometric quantification 
of basal levels of pMLCS19 levels at 0 minutes, relative to control-treated cells. D) Quantification of 
the fold-change in levels from 0 minutes to 15 minutes for each siRNA condition. N=3. Graphs 
show mean and error bars are SEM.  One-sample T-tests were used to analyse relative basal 
levels of pMLCS19 for ARHGEF10#1 and #5 in B and relative levels at 15 minutes for all conditions 
in C. 
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other hand, the absence of ARHGEF10 tended to inhibit the response to junction-
induction. In ARHGEF10-depleted cells, pMLCS19 levels only increased by 1.59 fold with 
ARHGEF10#1 and was reduced 0.72 fold by ARHGEF10#5 (Fig. 5.4D). The difference in 
results given by the two ARHGEF10 oligonucleotides, despite a similar level of 
knockdown, is due to variable pMLCS19 
5.3.4 ARHGEF10 is required for proper distribution of RhoA to nascent cell-cell 
contacts. 
western blots for ARHGEF10#1. The results from 
this preliminary experiment indicate that ARHGEF10 may be required for junction-induced 
MLC phosphorylation on residue Serine 19. Future experiments will test this hypothesis by 
further repeating this current assay and using additional assays ensuring robust control 
conditions.  
To complement the above experiments, the spatial distribution of RhoA activity would 
provide further information about the regulatory signaling pathways downstream of AJ 
formation. As RhoA is activated by junction assembly, I hypothesise that RhoA is in the 
vicinity of cell-cell contacts as junctions mature. To assess RhoA localisation to junctions I 
performed a calcium switch assay and fixed cells in TCA, a method established to allow 
detection of membrane-bound proteins (Godsel et al, 2010; Hayashi et al, 1999; Piekny et 
al, 2005; Takaishi et al, 1995; Yonemura et al, 2004). When geranylgeranylated RhoA is 
membrane-bound, it is not bound to Rho GDI and is able to bind Rho GEF or Rho GAP 
proteins (Cherfils & Zeghouf, 2013).  
Images taken at the plane of E-cadherin signal showed that neither RhoA nor E-cadherin 
were present at cell boundaries in unstimulated cells (Fig. 5.5 top row). At 5 minutes 
calcium stimulation, RhoA accumulated at cell-cell contact regions, which corresponded to 
E-cadherin signal (Fig. 5.5). As junctions assembled and expanded (see E-cadherin 
localisation), RhoA signal area and intensity increased along junctions (Fig. 5.5; 15 – 30 
minutes). Interestingly, RhoA was not observed along the entire length of the junction (as 
defined by E-cadherin staining) and was absent from the lateral-most sites, or junction 
vertices (Fig 5.5; 30 minutes). RhoA signal was absent from junctions of cells stained with 
conjugated secondary antibody alone (control for non-specific binding, Fig. 5.5 bottom 
row). These findings show that RhoA is enriched at nascent AJ, as early as 5 minutes 
following calcium addition.  
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Figure 5.5 RhoA is recruited to AJs during early contact formation. Monolayers of confluent 
keratinocytes were maintained in low calcium conditions (0 minutes) or induced to form contacts 
for 5, 15 or 30 minutes. Cells were fixed using TCA and permeabilised before immunofluorescence 
detection of endogenous RhoA and E-cadherin. Confocal micrographs of RhoA (left panel) at the 
plane of adherens junctions as indicated by the presence of E-cadherin shown as inverted images 
(middle panel). Red and black arrows indicate junctions enriched for RhoA or E-cadherin 
respectively. Red arrowhead indicates absence of RhoA signal in the conjugate only stained 
control at 30 minutes (30 (-anti-RhoA)). Right panel images are merges. Images are representative 
of three independent experiments. Scale bar = 10µm. 
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These data, together with the participation of ARHGEF10 in RhoA activation, led me to 
hypothesise that ARHGEF10 is important for RhoA recruitment to cell-cell contacts upon 
junction induction. To address this hypothesis, I performed an initial experiment to look at 
RhoA localisation over time in ARHGEF10-depleted cells (data not shown). I observed 
reduced levels of RhoA recruitment to junctions compared with control cells at all time-
points (5, 15 and 30 minutes), with the clearest difference seen at 15 minutes post-
induction (data not shown). I therefore performed subsequent quantitative experiments 
after 15 minutes calcium switch.  
Following ARHGEF10 depletion (ARHGEF10#1 or ARHGEF10#5; Fig. 5.6A), levels of 
TCA-insoluble RhoA staining at junctions were reduced compared with controls (Fig. 
5.6B). Whilst in control cells RhoA appeared to localise to most E-cadherin-positive 
junctions, after ARHGEF10 depletion RhoA signal was either reduced or absent in some, 
but not all junctions (Fig. 5.6B). Quantification of the number of junctions labelled with 
RhoA per condition showed that overall, RhoA-positive junctions in control-treated cells 
proportionally outweighed RhoA-negative junctions (Fig. 5.6C). In contrast, ARHGEF10-
depleted cells had equal amounts of RhoA-positive and -negative junctions (Fig. 5.6C).  
Statistical analysis of the three siRNA conditions (control, ARHGEF10#1 and 
ARHGEF10#5) showed that the ARHGEF10 siRNA had a significant effect on the 
proportion of RhoA- positive junctions (p=0.0004). These data show that ARHGEF10 is 
important for the efficient re-distribution of RhoA from a cytoplasmic localisation to cell-cell 
contacts. 
In summary, I have shown that, when ARHGEF10 is constitutively active, junctions were 
not able to assemble properly. The spatial localisation of RhoA to the assembling junction 
is partially perturbed when ARHGEF10 is lost. The transient peak of RhoA activation seen 
after 5 minutes of junction induction required ARHGEF10, and the subsequent junction-
induced phosphorylation of MLC may be attenuated in cells with reduced levels of 
ARHGEF10. Overall, these results suggest that ARHGEF10 may govern RhoA activity 
during junction assembly. 
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Figure 5.6 ARHGEF10 is required for proper distribution of RhoA to nascent cell-cell 
contacts. Keratinocytes depleted of ARHGEF10 using one of two siRNA oligos (ARHGEF10#1 or 
#5), or treated with scrambled controls siRNA (Con Scr), were cultured to confluence without cell-
cell contacts then  stimulated to form junctions for 15 minutes.  Cells were stained for endogenous 
RhoA and E-cadherin after TCA fixation. A) Western blot showing ARHGEF10 depletion for the 
images shown in B. GAPDH is shown as loading control. B) Epifluorescence micrographs of RhoA 
(top panel and merge), E-cadherin (middle panel and merge) and merged images (bottom panel). 
Presence or absence of labelling is indicated by arrows or arrowheads respectively. C) 
Quantification of junctional enrichment of RhoA above cytoplasmic background levels. Histograms 
show the total number of RhoA-positive (pos) and negative (neg) junctions per condition, for 
pooled junctions from three independent experiments. (n=>100 junctions, N=3 experiments). Chi-
square analysis in C gives p=0.0004. Scale bar = 10µm. 
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5.3.5 ARHGEF10 depletion does not significantly affect total levels of surface E-
cadherin 
Activation of ARHGEF10 is detrimental to E-cadherin levels at AJ. Therefore, I next 
investigated which cellular process is regulated by ARHGEF10.  As the screen phenotype 
of ARHGEF10 depletion showed increased levels of E-cadherin at junctions (Fig. 4.11), I 
hypothesised that, ARHGEF10 depletion can drive an upregulation of total surface E-
cadherin by modulating intracellular trafficking events.  It could be that more E-cadherin is 
incorporated into AJ due to increased availability of E-cadherin on the cell surface.  I used 
biotinylation assays to pull-down surface E-cadherin in unstimulated cells (0 minutes) or 
after a calcium switch. Following ARHGEF10 depletion (Fig. 5.7A), basal levels of surface 
E-cadherin did not significantly increase in unstimulated cells (Fig. 5.7B and C).  
Furthermore, surface E-cadherin levels were not clearly altered during junction assembly 
in cells treated with Scramble (control) or ARHGEF10 oligos (Fig. 5.7B and D).   
These results suggest that the absence of ARHGEF10 does not lead to global 
upregulation of total surface levels of E-cadherin.  However, the technique employed to 
measure total surface levels may not be sensitive enough to resolve the small changes in 
levels that occur upon ARHGEF10 depletion.  To address this issue, I measured total 
surface levels of E-cadherin using fluorescence activated cell sorting (FACS). I first 
established whether a difference in surface E-cadherin could be detected between 
unstimulated cells and cells stimulated for 30 minutes with calcium (data not shown). I 
encountered a number of technical difficulties that meant I could not reproduce quantitative 
data between multiple experiments. Due to time constraints, I went on to investigate the 
implications of ARHGEF10 depletion on junction function.   
5.3.6 ARHGEF10 depletion increases junctional E-cadherin but does not alter its 
detergent solubility 
As loss of ARHGEF10 upregulates junctional E-cadherin levels, it is possible that the role 
of endogenous ARHGEF10 is to negatively regulate the amount of E-cadherin 
incorporated into junctions. One way to achieve this is to destabilise junctional E-cadherin 
allowing for recycling events to occur (Green et al, 2010). I hypothesise that depletion of 
ARHGEF10 may lead to an increase in stability of E-cadherin 
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Figure 5.7 ARHGEF10 depletion does not significantly affect total levels of surface E-
cadherin. SiRNA-treated keratinocytes grown to confluence in the absence of cell-cell contacts 
were induced to form cell-cell junctions and then subjected to surface biotinylation assays. A) 
Western blot showing ARHGEF10 and HSP90 loading control after ARHGEF10 depletion for 
experiment shown in B. B) Western blot of surface (biotinylated) and total E-cadherin levels during 
calcium-induced junction formation. C) Quantification of surface E-cadherin as a percent of total E-
cadherin at time 0 (% total) relative to Scrambled siRNA-treated control cells (Con). D) Changes in 
E-cadherin surface levels during junction assembly. Surface E-cadherin levels (% total) were 
quantified during junction induction and expressed relative to 0 minutes for each siRNA condition. 
N=4. Graphs show mean and error bars are SEM.  One-sample T-tests applied to GEF10 data in 
C. 
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at junctions. To analyze stability, I used pre-fixation detergent extraction techniques to 
detect Triton-insoluble, stabilised proteins such as membrane-bound proteins or those 
anchored to the cytoskeleton. I depleted ARHGEF10 and quantified E-cadherin at 30 
minutes post-induction using a different segmentation algorithm than previously used in 
the screen (see section 2.4.4). This methodology measures changes in E-cadherin levels 
in the junctional region in a way that the readout is less sensitive to variations caused by 
out-of-focus cells in the field of view or increased cytoplasmic staining. 
First, I assessed the effect of ARHGEF10 depletion on levels of junctional E-cadherin in 
cells that were not detergent-extracted. The area of E-cadherin in the junctional region was 
increased upon ARHGEF10 depletion (Fig. 5.8A) (ARHGEF10#1 1.14 fold; ARHGEF10#5 
1.21 fold) compared to controls (Fig. 5.8B-C). This increase was statistically significant for 
ARHGEF10#5 (p=0.0174) and tended towards significance for ARHGEF10#1 (p=0.0386; 
multiple comparison adjusted α=0.025). This confirms the validation screen phenotype and 
implies that endogenous ARHGEF10 is required for restricting the level of E-cadherin at 
junctions during contact formation.  
Secondly, I went on to establish the effect of ARHGEF10 depletion on cadherin detergent 
solubility. Following detergent extraction, the area of E-cadherin at junctions after 
ARHGEF10 depletion was unchanged from controls (ARHGEF10#1 1.03 fold; ARHGEF#5 
1.02 fold) (Fig. 5.8D-E). This means that the insoluble fraction of E-cadherin remains the 
same as in control cells. These data suggest that, in the absence of ARHGEF10, the small 
increase in levels of junctional E-cadherin observed (Fig. 5.8B-C) is not accompanied by a 
corresponding stabilisation of the receptors into an insoluble pool (Fig. 5.8D-E). This 
suggests that endogenous ARHGEF10 does not regulate E-cadherin solubility at cell-cell 
contacts but rather the availability of receptors per se. 
5.3.7 ARHGEF10 is required for newly-formed cell-cell contact strength 
Both changes in the availability of E-cadherin at junctions and the ability to connect 
properly to the actin cytoskeleton influence the adhesiveness of cell-cell contacts (Angres 
et al, 1996; Yap et al, 1997).  To investigate the functionality of E-cadherin contacts, I 
examined the susceptibility of newly-formed contacts to mechanical stress in the absence 
of ARHGEF10. Despite an increased availability of E-cadherin in ARHGEF10-depleted 
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Figure 5.8 ARHGEF10 depletion increases junctional E-cadherin but does not alter its 
detergent solubility. Confluent monolayers of keratinocytes cultured in the absence of cell-cell 
contacts were depleted of ARHGEF10 then induced to form junctions for 30 minutes. Cells were 
fixed and stained for E-cadherin. A) Western blot showing ARHGEF10 levels after knockdown for 
the representative images shown in B and D. B) Epifluorescence micrographs of cells fixed with 
PFA. Arrows indicate regions of increased levels of E-cadherin. C) Quantification of the amount of 
junctional E-cadherin per cell, relative to control (Con, Scr) samples. D) Epifluorescence images of 
cells pre-treated with 0.5% Triton-X 100 to extract soluble proteins. E) Quantification of junctional 
E-cadherin levels per cell, relative to control conditions. Graphs show mean and SEM error bars. 
Values are normalised to mean of the control group for each replicate. All data collected over two 
(ARHGEF10#5) or three (ARHGEF10#1) independent experiments (five or more images per 
experiment). Replicate experiments were reproducible as determined by analysis of variance. 
Replicate values were then pooled and analysed with Unpaired T-Tests. Multiple comparison 
adjusted α=0.025. *=p<0.025.  Scale bars in B and D = 10µm. 
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cells, because the fraction of E-cadherin found in an insoluble pool is unchanged I predict 
that the adhesiveness of intercellular connections will not be affected. Monolayers of 
keratinocytes induced to form junctions for 30 minutes were detached from the cell-culture 
dish using dispase. In all conditions detached monolayers remained as intact single-sheets 
(Fig. 5.9A, B; pre-disruption). Cell sheets were then disrupted by application of 
mechanical stress for 10 minutes on an orbital shaker (Fig. 5.9B post-disruption).  
Interestingly, in the absence of ARHGEF10, a significant increase in the number of 
fragments post-disruption was observed relative to the controls (1.6 to 1.9 fold increase; 
Fig. 5.9C).  This result indicates reduced stability of assembled junctions and shows that 
ARHGEF10 is required to maintain the physical integrity of newly-formed cell-cell contacts.  
5.3.8 Role of ARHGEF10 in membrane dynamics and lateral mobility of E-cadherin  
The phenotype of weak junctions observed after ARHGEF10 depletion could indicate that 
a pool of junctional E-cadherin is unable to make proper cis-interactions, which then 
interferes with further stabilisation of cadherin clusters as they coalesce.  If overall stability 
is weaker, then E-cadherin may be more mobile within the plasma membrane in the 
absence of ARHGEF10.  The dynamics of E-cadherin can be measured using 
fluorescence recovery after photobleaching (FRAP) of exogenous EGFP-E-cadherin. I 
predict that, if E-cadherin stability is reduced by ARHGEF10 depletion, the fluorescence 
recovery after photobleaching will be faster.   
EGFP-E-cadherin localised to cell-cell boundaries in both control-treated and ARHGEF10-
depleted cells by 20 minutes of junction induction (pre-bleach) (Fig. 5.10A and 10B). 
Upon bleaching at 20 minutes, recovery of fluorescence signal after photobleaching was 
seen in both control- and siARHGEF10-treated samples (Fig. 5.10B). Recovery curves 
were obtained by non-linear regression analysis (Fig. 5.10C) and used to derive the 
plateau of fluorescence intensity reached during recovery (plateau), the fraction of 
molecules unable to contribute to recovery (immobile fraction), and the half-time to 
recovery (t1/2). Overall, ARHGEF10-depleted cells tended not to recover to the same 
extent as controls, but have an increased rate of recovery. When normalised to control-
treated cells, only small differences were observed in the percentage of recovery obtained 
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Figure 5.9 ARHGEF10 is required for newly-formed cell-cell contact strength. Confluent 
monolayers of keratinocytes treated with scrambled control (Con Scr) siRNA or depleted of 
ARHGEF10 were induced to form junctions for 30 minutes. Monolayers were then subjected to 
dispase treatment for 30 minutes followed by mechanical disruption for 10 minutes. A) Western 
blots showing efficiency of ARHGEF10 depletion for the images shown in B. B) Representative 
brightfield images of dispase-detached monolayers, pre-disruption (top panel), and post-disruption 
fragments (middle and bottom panel – images taken of the same well for each condition). Arrows 
show individual fragments. C) Quantification of the number of fragments produced after 
mechanical disruption. Graphs show all values after mechanical disruption normalised to the mean 
of the controls for each experiment. N=3. Samples were analysed with Unpaired T-Tests. Multiple 
comparison adjusted α=0.025. *=p<0.025, **=p<0.005. 
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Figure 5.10 E-cadherin membrane dynamics during cell-cell contact formation. 
Fluorescence recovery after photobleaching (FRAP) was performed on exogenous EGFP-E-
cadherin transfected into ARHGEF10-depleted keratinocytes or controls treated with scrambled 
oligo. Photobleaching was performed at cell-cell contacts after 20 minutes of junction induction 
and recovery was recorded for the subsequent 8 minutes. A) Representative ARHGEF10 
knockdown with GAPDH loading control. B) Representative confocal images of EGFP-E-
cadherin (EGFP-E-cad) in control-treated and siARHGEF10-treated cells. Image stills show the 
bleach region as indicated by the arrows. Half-time to recovery (t1/2) is shown for each condition 
at the time points shown (seconds). C) Recovery curves for the cells shown in B (Bleach = 0 
seconds) for the 500 seconds measured. Non-linear regression fit is shown in red. Scale bar in 
B = 10µm. 
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(Fig. 5.11A), the proportion of immobile EGFP-E-cadherin (Fig. 5.11B) and the t1/2 (Fig. 
5.11C). These results were derived from two small preliminary experiments as it was not 
possible to undertake further replicates during the time available. As such, statistical 
analysis was not performed. If further experiments are able to substantiate these 
observations, these data suggest that, in the absence of ARHGEF10, E-cadherin is less 
freely able to move laterally within the membrane or recycle to/from bleached regions. This 
implies a lack of functional connections with the cellular machinery that drives clustering 
and/or trafficking. Future experiments of increased sample size are now required.  
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Figure 5.11 Quantification of FRAP recovery parameters. Dynamic properties of EGFP-E-
cadherin were derived from non-linear regression analysis of individual cells during recovery 
periods after photobleaching 20 minutes after calcium addition. A) Plateau values reached during 
recovery. B) Immobile fraction of EGFP-E-cadherin. C) The half-time to recovery (t1/2). Two 
experiments were performed. Each experiment measured recovery in Scrambled (Control; Con) 
and siARHGEF10 (GEF10) treated cells (Exp1: Con=3 cells, GEF10=3 cells; Exp2: Con=1 cell, 
GEF10=2 cells).  For each experiment mean values were calculated and expressed relative to 
control treated cells. The mean relative values of two experiments are shown in the graphs. Error 
bars are standard deviation. 
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5.4 Conclusions 
In summary, I have found that loss of ARHGEF10 can affect the spatial regulation of RhoA 
during junction formation and partially blocks the transient increase in contact-induced 
GTP-bound RhoA.  In cells depleted of ARHGEF10, junction-induced phosphorylation of 
MLCS19
Consistent with a role for ARHGEF10 in regulating E-cadherin localisation to AJ, over-
activation of ARHGEF10 decreases junctional E-cadherin at newly-formed contacts in a 
GEF activity-dependent manner.  Conversely, junctional E-cadherin is enriched in the 
absence of ARHGEF10, due to the presence of a pool of E-cadherin with decreased 
resistance to detergent extraction. This does not appear to be due to an overall increase in 
total surface E-cadherin or a difference in the mobility of E-cadherin in the membrane, 
although further studies to confirm this are required. Functionally, the perturbations in E-
cadherin biochemical and biophysical properties driven by ARHGEF10 depletion lead to a 
reduction in the stability of newly-formed cell-cell junctions. Taken together these data 
indicate that ARHGEF10 may regulate a RhoA-mediated intracellular trafficking event to 
negatively regulate levels of junctional E-cadherin. This process is necessary for the 
dynamic building, refinement and strengthening of AJ during epithelial biogenesis. 
 appears to be attenuated, although further confirmation of this phenotype is 
required.  
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5.5 Discussion 
5.5.1 RhoA is targeted to newly forming AJs 
Calcium-induced cadherin ligation triggers the translocation of cytoplasmic RhoA to 
nascent cell-cell contacts. This is shown by the enrichment of RhoA at newly forming AJs. 
As subcellular localisation is a key aspect to defining signalling cascades, targeting of 
RhoA to AJs suggests that RhoA is well placed to play a role in cadherin signalling. That a 
wave of RhoA activity is seen by 5 minutes in biochemical assays, but RhoA protein 
continues to accumulate at AJ as late as 30 minutes implies that the junction-associated 
RhoA, during the later stages of assembly, may be in the GDP-bound state. Inactivation of 
RhoA at junctions (after initial activation) could provide a way to sequester RhoA in an 
inactive state at junctions if it is (i) no longer required to promote cell-cell contact formation 
and (ii) its activation elsewhere in the cell would be detrimental to generation of the 
epithelial phenotype.  Indeed, sequestration of inactive RhoA at mature cell-cell contacts 
blocks RhoA-mediated disassembly of junctions (Samarin et al, 2007). Furthermore, 
downregulation of RhoA activity at mature junctions is necessary for contact-inhibition of 
cell proliferation in confluent cells (Aijaz et al, 2005).  
Reduced Rho activity at cell-cell contacts could be achieved by activation of GAP proteins 
or inhibition of GEF proteins. Three distinct RhoA regulators have been shown to 
downregulate RhoA activation as junctions form and at steady-state contacts. The Rho 
GAP MyoIXA is required for RhoA inactivation as new contacts form between colliding 
human bronchial epithelial cells (Omelchenko & Hall, 2012), whilst p190RhoGAP-mediated 
inhibition of Rho occurs in mature junctions and is dependent on interaction with p120ctn 
(Ponik et al, 2013; Wildenberg et al, 2006; Wozniak et al, 2003).  Additionally, inhibition of 
RhoA at junctions in MDCKII cells is achieved by inhibition of the Rho GEF protein GEF-
H1 (Aijaz et al, 2005; Guillemot et al, 2008). Although these studies do not directly 
investigate cell-cell contact assembly in confluent cells, they support the hypothesis that 
RhoA is switched off following initial activation during junction assembly by regulation of 
Rho GAP and/or Rho GEF activity.  Further studies will elucidate the spatial regulation of 
RhoA activity during cell-cell contact formation.  
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Proper distribution of RhoA to nascent cell-cell contacts depends on regulated targeting. 
My data shows that when ARHGEF10 is lost, RhoA is not uniformly localised at all cell-cell 
junctions. It is not clear how RhoA is still able to target to some, but not all junctions in the 
absence of ARHGEF10.  Perhaps ARHGEF10 mediates a positive feedback mechanism 
to promote further RhoA recruitment once a pool of active RhoA, associated with initial 
cell-cell contacts, has formed.  This could be achieved via the regulation of a scaffold 
protein which can bind to both active and inactive RhoA such as in the regulation of Rac1 
activity at junctions by Ajuba and missing in metastasis 1 (Mtss1) (Dawson et al, 2012; 
Garcia-Cattaneo & Braga, 2013; Nola et al, 2011). If the initial pool of membrane recruited 
RhoA is not activated by ARHGEF10 then subsequent recruitment of more RhoA to the 
cell-cell contact may be impaired. To date, no conclusive evidence for the localisation of 
ARHGEF10 to junctions has been found, so whether ARHGEF10 directs targeting of RhoA 
from an extra-junctional localisation, or acts as a docking site at membranes remains to be 
elucidated. 
5.5.2 ARHGEF10 may regulate RhoA activity during junction formation 
The promotion of RhoA activation by cell-cell contacts is reduced in the absence of 
ARHGEF10, supporting the hypothesis that cadherin signalling utilises Rho GEF proteins 
to activate Rho GTPases. Furthermore, the disruption of cell-cell contact formation by 
constitutively active ARHGEF10 in a GEF-dependent manner implies that over activation 
of RhoA can perturb E-cadherin incorporation into junctions.  
As overexpression of wild-type ARHGEF10 did not affect junction assembly, it suggests 
that ARHGEF10 may exist in an inhibitory conformation and requires upstream regulation 
in order to promote GDP-GTP exchange. This is supported by previous studies which 
show that deletion of ARHGEF10 N-terminal region results in its constitutive activation 
(Aoki et al, 2009). Many Dbl family Rho GEF proteins such as p115-RhoGEF, Intersectin, 
Vav, Dbl, ASEF, Ect2, Tiam1 and Net1 exist in an autoinhibited conformation where 
deletion of N-terminal regions relieves intramolecular inhibitory interactions allowing DH 
domain function (Rossman et al, 2005; Schmidt & Hall, 2002a).  The phosphorylation state 
of residues in the regulatory N-terminal region is important for control of autoinhibition. For 
example, phosphorylation of Tyr174 in Vav proteins is necessary to induce conformational 
changes leading to relief of autoinhibition (Lazer & Katzav, 2011). Whether inhibition of 
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ARHGEF10 GEF activity is modulated by the phosphorylation state of T332 or by intra- or 
inter- molecular interactions, remains unknown. 
5.5.3 ARHGEF10 negatively regulates E-cadherin localisation to nascent cell-cell 
contacts 
I hypothesise that the role of ARHGEF10 in junction formation is to negatively regulate the 
re-distribution of E-cadherin to nascent contacts to ensure functional AJs can form. There 
is a small but significant increase in E-cadherin at junctions in the absence of ARHGEF10, 
yet junctions are not more stable or resistant to mechanical stress. In the absence of 
ARHGEF10, neither surface nor total E-cadherin levels are changed and no increase in 
insolubility of the accumulated E-cadherin at junctions occurs. These results are intriguing 
and suggest that additional incorporation of E-cadherin into newly forming junctions is 
detrimental to adhesive function. This implies that ARHGEF10 does not regulate 
mechanisms that affect the rate of insolubility of E-cadherin, rather ARHGEF10 might 
regulate the availability of E-cadherin for stabilisation via other mechanisms.   
Two possibilities might explain this hypothesis. Firstly, endogenous ARHGEF10 could be 
responsible for restricting delivery of E-cadherin (either by recycling or lateral movement) 
to junctional regions in a RhoA-dependent manner.   In normal epithelial cells, both stable 
and unstable E-cadherins are present at junctions in optimal amounts to facilitate 
remodelling. Upon depletion of ARHGEF10, this restricted delivery could be lost, allowing 
E-cadherin to accumulate in regions where it cannot be stabilised. The lack of concurrent 
stabilisation of the accumulated E-cadherin could be due to targeting of the extra E-
cadherin to non-lipid raft regions, where the protein is less resistant to detergent extraction 
than its lipid raft-associated counterparts.  Another possibility is that the accumulated E-
cadherin is not stabilised because upregulation of E-cadherin delivery is not accompanied 
by an upregulation in machinery that couples E-cadherin to the cytoskeleton. As cadherin 
clustering depends on its association with lipid rafts (Seveau et al, 2004), and coupling to 
the cytoskeleton network (Hong et al, 2010; Hong et al, 2011; Hong et al, 2013; Kametani 
& Takeichi, 2007), either of these possibilities is plausible. Indeed, RhoA has been 
implicated in the negative regulation of exocytosis in chromaffin cells, whereby activated 
RhoA is thought to block vesicle fusion with the plasma membrane by assembling an actin 
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network to block association. When RhoA is inactive actin structures disassemble allowing 
docking to occur (Gasman et al, 2003; Ory & Gasman, 2011). 
Secondly, ARHGEF10 may be responsible for removal of destabilised E-cadherin from the 
junctional region.  Upon loss of ARHGEF10 the destabilised fraction of E-cadherin may not 
be internalised resulting in accumulation at cell-cell contacts. RhoA could mediate 
internalisation as it has been implicated in clathrin-independent endocytosis of interleukin 
2 receptor in lymphocytes and plasma membrane regions in umbrella bladder cells 
(Khandelwal et al, 2010; Lamaze et al, 2001).  However, in both cases RhoA drives 
dynamin-dependent, lipid-raft associated endocytic events. How these mechanisms would 
contribute to upregulation of unstable E-cadherin is not clear, but perhaps blockade of 
clathrin-independent endocytosis leads to accumulation of protein outside the lipid-raft 
regions.  
From these experiments it is not yet clear whether the accumulated E-cadherin is 
destabilised due to lack of interaction with the cytoskeleton and/or because of the lipid-raft 
context. Nevertheless, accumulation of E-cadherin, in the absence of ARHGEF10, leads to 
global effects on stabilisation of junctions.  When ARHGEF10 is lost, although junctions 
are still able to form, the resulting structures have increased susceptibility to mechanical 
disruption. Two underlying mechanisms could be at play. Firstly, destabilisation could be 
independent of accumulated E-cadherin and rather result from a loss of tension in the 
underlying cytoskeleton in the absence of ARHGEF10. RhoA is a key regulator of the 
development of the contractile forces thought to be critical for proper junction formation 
(Nelson, 2008; Yamada & Nelson, 2007). If ARHGEF10 impairs RhoA signalling leading to 
loss of myosin II activation, this could lead to a loss of contractility and therefore tension at 
junctions (Fig. 5.12). Loss of tension but not loss of cadherin-based junctions is seen 
when Cdc42 is mis-regulated in CaCo2 cells (Otani et al, 2006). This process is regulated 
by the Cdc42 GEF Tuba and results in intact but wavy junctions (Otani et al, 2006). 
ARHGEF10 depletion does not perturb the linearity of junctions, which suggests a milder 
phenotype when RhoA-mediated tension is lost, or cell type-specific phenotypic 
differences.  
A second possible mechanism for destabilisation is that, in the absence of ARHGEF10, 
atypical accumulation of a subset of cadherins might be sufficient to perturb a strong 
Natalie Welsh   PhD Thesis 
  209 
engagement of neighbouring cadherin clusters with the cortical cytoskeleton. A number of 
mechanisms co-operate in a hierarchical fashion to strengthen AJ. Following initial 
cadherin binding in trans, cis-interactions are made which together are sufficient to drive 
clustering of E-cadherin upon contact initiation (Brasch et al, 2012) (Harrison et al, 2011; 
Hong et al, 2010; Hong et al, 2013; Ozaki et al, 2010). Clusters are able to move in the 
plane of the plasma membrane, coalesce and are stabilised by interactions with 
intracellular scaffold proteins and the underlying cytoskeletal network (Hong et al, 2010; 
Hong et al, 2011; Hong et al, 2013; Kametani & Takeichi, 2007).  
Coupling to F-actin is critical for stabilisation and basal-apical movement of E-cadherin 
clusters to form stable AJs (Hong et al, 2010; Hong et al, 2011; Hong et al, 2013; 
Kametani & Takeichi, 2007). Increased stability in this manner confers physical strength to 
newly-formed AJs. However, without coupling to intracellular F-actin, these clusters have a 
high disassembly/reassembly rate, are not stabilised and undergo random movement 
(Hong et al, 2010; Hong et al, 2011; Hong et al, 2013).  Hong and colleagues 
demonstrated that in cells lacking endogenous E-cadherin, the overall stability of E-
cadherin clusters, containing only E-cadherin which is artificially coupled to F-actin, is 
reduced when an uncoupled population of E-cadherin is introduced (Hong et al, 2013). I 
propose that this situation is analogous to the situation in keratinocytes in the absence of 
ARHGEF10. As stabilisation confers strength to newly formed AJs (Angres et al, 1996; 
Yap et al, 1997), it is likely that the atypical accumulation of E-cadherin impairs the ability 
of some E-cadherin in clusters to bind to F-actin which in turn impairs the overall strength 
of the junctions (Hong et al, 2013) (Fig. 5.12). As such, ARHGEF10 acts to negatively 
regulate the accumulation of E- cadherin into AJ which ensures optimum interactions with 
the cytoskeleton are made for maintenance of mechanotransduction. 
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Figure 5.12 Proposed model of ARHGEF10 cellular function during epithelial biogenesis. A) 
Solubility of E-cadherin at the plasma membrane can be modulated by the lipid environment and/or 
interaction with the cortical cytoskeleton. B) Both insoluble and soluble E-cadherin exists at the cell 
surface (i). In the absence of ARHGEF10 the level of soluble E-cadherin is increased via an 
unknown mechanism (ii). 1. Clustering of stable E-cadherin can occur via contractile events in the 
underlying cytoskeleton (iii). Without   ARHGEF10, clustering may be perturbed due to (a) the 
presence of more soluble E-cadherin than normal and/or (b) a lack of contractile forces in the acto-
myosin cytoskeleton (iv). 2. When extracellular forces are applied, normal junctions are able to 
withstand such stresses (v), but when ARHGEF10 is lost the weaker junctions are unable to resist 
the tensional forces and junctions are destabilised (vi). 
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5.5.4 Implication of ARHGEF10 in AJ regulation in cancer 
Increased activity of RhoA due to overexpression has been documented in a number of 
tumour types and correlates with invasive phenotype (Karlsson et al, 2009). Loss of cell-
cell adhesion due to deregulated Rho GTPase activity is a key step in the development of 
tumourigenesis (Lozano et al, 2003). My finding that ARHGEF10 activation results in a 
loss of newly-formed cell-cell contacts raises the possibility that activation of ARHGEF10 
could be an oncogenic process. Constitutive activation of several other RhoA GEFs has 
been observed in human cancers, such as Vav proteins (reviewed by (Lazer & Katzav, 
2011) and the Rho GEF LARG in leukaemia (Reuther et al, 2001). Similarly, elevated 
expression of Myosin-interacting guanine nucleotide exchange factor (MyoGEF), a GEF 
involved in cytokinesis, is found in MDA-MB-231 invasive breast cancer cells (Wu et al, 
2009). The Rho and Cdc42 GEF Ect2 is overexpressed in lung and oesophageal cancer 
and leads to poor prognosis for lung cancer patients (Hirata et al, 2009). Several mutations 
(thus far of unknown consequence) have been found in the N-terminus of ARHGEF10 in a 
small number of colon tumours and urothelial cancer cell lines (Williams et al, 2010; Wood 
et al, 2007).  If these mutations give rise to release of ARHGEF10 autoinhibition, in these 
situations, over-activation of ARHGEF10 would be oncogenic. 
On the other hand, loss of ARHGEF10 upon chromosomal aberrations associated with 
colon, bladder and breast cancers denotes its role as a potential tumour suppressor 
(Cooke et al, 2008; Williams et al, 2010; Wood et al, 2007). My loss of function studies, 
that show reduced strength of newly formed contacts, could be applicable to ARHGEF10 
in cancer cells. As many cancer cells acquire a motile phenotype during epithelial to 
mesenchymal transition, junctions in tumours without ARHGEF10 could be too weak to 
oppose other forces associated with motility. This could lead to the physical breaking of 
cell-cell contacts without necessarily first reducing levels of E-cadherin. For example, the 
functional role of ARHGEF10 could be evaluated during growth factor-induced scattering 
of epithelial cells. As a physical weakening of the junctions has been demonstrated, it 
could be predicted that depletion of ARHGEF10 may lead to increased scattering upon 
growth factor stimulation. Studies to address the role of ARHGEF10 in cells with mature 
junctions are required to demonstrate this hypothesis.   
Natalie Welsh   PhD Thesis 
  212 
5.6 Future Work 
5.6.1 Investigate the relationship between ARHGEF10 localisation and activation 
state downstream of E-cadherin 
There are two broad questions arising from my studies. Firstly, how is ARHGEF10 
regulated by cadherin-mediated adhesion? Secondly, what is the precise molecular 
mechanism governed by ARHGEF10 to negatively regulate AJ assembly? 
To know the subcellular localisation of ARHGEF10, how it is targeted to a particular region 
and whether this is cadherin-mediated is important for understanding the signalling 
properties of ARHGEF10. Additionally, identification of the subcellular context can provide 
information about the upstream and downstream regulation of ARHGEF10 and give clues 
to its functionality. Immunofluorescence labelling of endogenous ARHGEF10, coupled with 
colocalisation studies with E-cadherin by immunofluorescence or by 
coimmunoprecipitation assays, will identify whether ARHGEF10 is associated with E-
cadherin as junctions assemble.  
As ARHGEF10 is thought to be in an autoinhibited conformation experiments to address if 
and how junction induction relieves autoinhibition and whether this leads to junction 
recruitment of ARHGEF10 can be performed.  As an amino acid substitution of the single 
Threonine 332 residue to Isoleucine is sufficient to constitutively activate ARHGEF10, it 
would be important to establish whether T332 is a target for regulation downstream of E-
cadherin ligation. Generation of a T332 phospho-specific antibody would be useful to 
address the phosphorylation state in unstimulated and calcium-induced cells. 
5.6.2 Establish whether ARHGEF10 modulates junction-associated RhoA activity 
and downstream signalling 
As I have found that RhoA localises to newly forming AJs, it is important to now identify 
whether RhoA is active at junctions and whether ARHGEF10 mediates activation of a 
junction-specific pool of RhoA. Using a unimolecular FRET biosensor consisting of RhoA 
and one of its effector proteins coupled to the donor and acceptor fluorophores, 
respectively (see section 3.6.1), spatially defined measurements of RhoA activation can be 
made. RhoA activity can be assessed in the absence of ARHGEF10, or when 
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ARHGEF10T332I
The role of myosin II in ARHGEF10-mediated junction assembly is not clear due to lack of 
definitive data.  To build on the evidence I have gained thus far, it is important to use a 
robust assay to investigate the activation of myosin II.  For example, endogenous staining 
of phosphorylated MLC either after calcium switch or upon α-E-cad bead assays, with and 
without ARHGEF10 would show whether ARHGEF10 drives recruitment/activation of 
myosin II at sites of cadherin-based adhesion.  
 is overexpressed.  If it is found that RhoA is indeed GTP-bound at 
junctions during the early stages of cell-cell contact formation I predict that ARHGEF10 
depletion would reduce the level of RhoA activity in this specific region.  
ARHGEF10 has been shown to activate RhoB and RhoC in addition to RhoA. It is not 
currently known whether RhoB and RhoC are themselves activated by cell-cell contact 
assembly. In preliminary studies, I have found that both RhoB and RhoC are transiently 
activated by 5 minutes junction induction in effector pull-down assays using specific RhoB 
and RhoC antibodies.  If these profiles are confirmed I predict that ARHGEF10 depletion 
may abolish the transient peaks in a similar way to the effect seen on RhoA activity upon 
ARHGEF10 depletion.  It would be interesting to investigate whether ARHGEF10 acts as a 
signalling node to integrate multiple GTPase activities upon junction induction. 
5.6.3 Establish the mechanism of ARHGEF10 negative regulation of E-cadherin 
localisation 
I hypothesise that ARHEF10 is important for the endocytosis and/or intracellular trafficking 
of soluble E-cadherin generated during junction formation to facilitate regulated 
incorporation of E-cadherin at the dynamic AJ. Spatio-temporal studies can be performed 
to further clarify the role of ARHGEF10 and to define precisely which intracellular 
trafficking event is modulated by ARHGEF10.  First, to establish whether ARHGEF10 is 
required for internalisation of E-cadherin, immunofluorescence studies to observe the 
uptake of fluorescent dextran in the plane of the AJ can be performed. If ARHGEF10 is 
required for efficient endocytosis, I predict that upon ARHGEF10 depletion dextran-
containing vesicles will be reduced.  
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Secondly, E-cadherin is thought to travel from basal to apical regions to be incorporated 
into junctions. I predict that endogenous ARHGEF10 could inhibit the translocation of 
soluble E-cadherin from the basal to apical regions. Time-lapse immunofluorescence 
imaging of E-cadherin in the plane of the lateral interface between two neighbouring cells 
would provide insight into whether ARHGEF10 regulates this process. Additional studies 
using photoswitchable E-cadherin could provide information about the turnover of E-
cadherin at the AJ with and without ARHGEF10.  
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6 Final Discussion 
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6.1 EGFR, DOCK180 and Trio: complexities of Rac activation  
E-cadherin ligation appears to modulate EGFR phosphorylation in a non-canonical pattern 
to both dephosphorylate some, but induce phosphorylation of other, tyrosine residues, 
demonstrating a cross-talk between the two transmembrane proteins. This is a 
combination of the varied situations found in integrin-EGFR crosstalk where in some cases 
integrins induce ligand-independent phosphorylation of a subset of tyrosine residues 
compared to EGF treatment (Bill et al, 2004; Moro et al, 2002), whilst other integrins (α1β1
 
) 
mediate dephosphorylation of EGFR (Chen et al, 2007). E-cadherin could therefore act to 
both dampen EGFR activity to avoid excessive Rac activation, which is known to be 
detrimental to junctions (Braga et al, 2000), whilst invoking activation of precise signalling 
pathways downstream of the specific phosphorylated tyrosine residues.  
I have shown that, despite overall dephosphorylation of EGFR, a minimal level of EGFR 
activity is important for remodelling of the F-actin cytoskeleton in response to cadherin 
ligation. EGF treatment of A431 epithelial carcinoma cells stimulates actin polymerisation 
and reorganisation and the association of EGFR with cortical actin structures (Chinkers et 
al, 1979; Peppelenbosch et al, 1993; Rijken et al, 1991; Schlessinger & Geiger, 1981). 
However, EGF stimulation leads to disassembly of AJs (Lu et al, 2003). It is plausible that 
E-cadherin signalling subverts canonical EGFR signalling by regulating the amplitude of 
EGFR activation response to facilitate dynamic actin recruitment to AJs. Yet, the 
mechanisms which mediate the specific phosphorylation of EGFR by E-cadherin or how 
dephosphorylation modulates the function of EGFR in junction assembly are not yet clear.  
 
Downregulation of EGFR activation is a critical step in cell-cell contact-dependent 
inhibition of proliferation (McClatchey & Yap, 2012).  Loss of cell-cell inhibition leads to the 
hyperproliferation of epithelial cells and the onset of tumourigenesis (Hanahan & 
Weinberg, 2011). It is known that E-cadherin-mediated cell-cell contact formation inhibits 
EGFR activation (Takahashi & Suzuki, 1996), but the precise mechanism of crosstalk is 
not well known. E-cadherin-induced association of the cytoskeletal tumour suppressor 
protein Merlin (Li et al, 2012) with EGFR prevents EGFR internalisation and blocks 
intracellular EGFR signalling (Curto et al, 2007). Similarly, Leucine-rich repeats and 
immunoglobulin like-domains (LRIG1), a regulator of stem cell quiescence (Jensen & Watt, 
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2006), associates with E-cadherin and EGFR in a ternary complex to negatively regulate 
EGFR signalling and promote contact-inhibition of growth (Lu et al, 2013). Importantly, 
EGFR signalling from internal compartments is rapidly inhibited by EGFR 
dephosphorylation (Monast et al, 2012; Tarcic et al, 2009). To reduce EGFR 
phosphorylation, E-cadherin could regulate the activity of protein tyrosine phosphatases 
(PTPs), several of which are found at AJs (Bertocchi et al, 2012), such as in the case of 
VE-cadherin-induced dephosphorylation of VEGFR by DEP-1 to prevent proliferation 
promoting signalling (Lampugnani et al, 2006).    
 
Less is known about the consequences of specific tyrosine phosphorylation in response to 
junction formation. One possibility is that phosphorylation of specific amino acids could 
serve to recruit a particular repertoire of proteins to define the molecular environment 
necessary for junctional signalling (Morandell et al, 2008). The precise signalling 
components of this pathway in ligand-independent activation are not clear. The Rac GEF 
DOCK180, which stabilises new cell-cell contacts (J. Erasmus unpublished), localises to 
sites of cadherin ligation in an EGFR-independent manner. However, as both proteins are 
required for cadherin-induced Rac activation (Betson et al, 2002; J. Erasmus unpublished), 
I predict that activation of DOCK180 may be regulated by EGFR.  
Furthermore, the regulation of Rac-dependent cellular processes appears to be complex, 
as EGFR acts to recruit F-actin to newly-forming junctions, whereas the two Rac GEFS, 
DOCK180 and Trio, are dispensable for this process. An alternative possibility is that 
DOCK180 may indeed be downstream of EGFR to promote actin remodelling. As such, I 
propose a model whereby DOCK180 and Trio might co-operate in a redundant fashion to 
govern Rac-dependent actin reorganisation during junction formation (Figure 6.1). I 
speculate that, upon junction induction, the presence of either DOCK180 or Trio is 
sufficient to compensate for the loss of the other GEF, thus accounting for a lack of 
phenotype on actin recruitment when either GEF is depleted. 
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Figure 6.1 Proposed model of GEF regulation of Rho and Rac activation in de novo 
adherens junction assembly. A) Flow diagram depicting the proposed molecular pathways 
governed by the GEFs DOCK180, Trio and ARGEF10 to establish AJs. The mechanism of 
activation of each GEF at junctions is currently unknown, or whether DOCK180 and Trio regulate 
actin dynamics. B) Schematic representation of the spatial regulation of Rho GTPases by 
DOCK180, Trio and ARHGEF10 to mediate distinct cellular processes upon calcium-induced AJ 
assembly. GEFs are represented in their activated form. Black arrows and blunt lines show positive 
and negative regulation, respectively. Blue double-headed arrow represents E-cadherin 
stabilisation and red arrows are intracellular trafficking processes. Dotted lines represent 
processes that are predicted to be driven by DOCK180, Trio and ARHGEF10. In this scenario 
DOCK180 and Trio may redundantly regulate Rac-dependent F-actin remodelling, thus are 
dispensable for this process.  
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EGFR may regulate Rac localisation and activation by distinct mechanisms. Indeed, 
evidence for two-step recruitment and activation of Rho GTPases is found in 
immunoglobulin Fc portion gamma receptor (FcγR)-mediated and the integrin complement 
receptor 3 (CR3)-mediated phagocytosis, where, in the former, inactive Rac is recruited to 
phagosomes but requires activation by Vav to drive phagocytosis (Caron & Hall, 1998; 
Patel et al, 2002), and RhoA recruitment and activation are specified by distinct residues 
within the beta2 integrin cytoplasmic tail of the CR3 receptor (Wiedemann et al, 2006). 
EGFR may therefore promote the translocation of Rac to the molecular environment which 
includes DOCK180 and the actin remodelling machinery, and drive the upstream activation 
of DOCK180 in order to activate the translocated Rac. When EGFR is lost, Rac may 
become mis-localised and therefore cannot be activated by either DOCK180 or the 
compensatory Trio pathway.  Experimental evidence to confirm this scenario is now 
required. 
6.2 RhoA activation and negative regulation of AJ biogenesis 
 
It is known that Rho function is required for the establishment of nascent cell-cell contacts 
(Braga et al, 1997). However, the direct effect of E-cadherin activation on active RhoA 
levels during the initial stages of junction assembly remains poorly understood and 
somewhat controversial (Calautti et al, 2002; Nakagawa et al, 2001; Noren et al, 2001; 
Yamada & Nelson, 2007).  Here, I show for the first time that RhoA is robustly and 
transiently activated by trans-dimerisation of endogenous E-cadherin in response to 
physiological calcium addition, independently of cell migration and serum stimulation.  
 
The molecular processes governed by RhoA activation during de novo junction formation 
have not yet been studied in depth. Here, we propose a model whereby ARHGEF10 and 
Trio (potentially via regulation of RhoA activity) co-operate to restrict the availability and 
stabilisation of E-cadherin at junctions, respectively (Figure 6.1). Although the requirement 
for RhoA activation in these processes has not formally been shown, I speculate that 
firstly, ARHGEF10 facilitates either delivery or removal of E-cadherin to a membrane niche 
or molecular sub-structure that does not support E-cadherin stabilisation, such as into non-
lipid raft regions or where stabilisation via interaction with the actin cytoskeleton does not/ 
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cannot occur.  The role of endogenous ARHGEF10 would be to restrict incorporation of E-
cadherin into junctions, as when ARHGEF10 is lost, increased levels of unstable E-
cadherin appears to interfere with the global strength of newly-formed adhesions. 
Secondly, when Trio is depleted E-cadherin insolubility increases, indicating that the 
function of endogenous Trio may be to maintain an optimised level of interaction of E-
cadherin with stabilising factors to prevent over-stabilisation of E-cadherin during the 
dynamic process of contact assembly. Whether Trio regulates association of E-cadherin 
with lipid raft compartments or the interaction with proteins that mediate actin binding 
remains to be investigated. Together endogenous ARHGEF10 and Trio, by limiting 
availability and stability of E-cadherin, coordinate the negative regulation of AJ formation. 
 
Upon loss of ARHGEF10, abnormal incorporation of soluble E-cadherin and/or a putative 
reduction in MLC phosphorylation is concurrent with a general destabilisation of junctions, 
which could indicate loss of overall tension at newly formed junctions. Coupled with the 
ability of endogenous Trio to regulate E-cadherin stability, it is possible that ARHGEF10 
and Trio co-operate to ensure optimum transduction of tensile strength within the new 
junctions. The cadherin-catenin complex has recently been identified as a tension sensing 
module (Borghi et al, 2012) that regulates cell shape changes to remodel tissues in 
development (Adams et al, 1990; Beloussov et al, 1975; Keller et al, 2008).  
 
Sites of adhesive interactions such as cadherin- and integrin-based adhesions are 
modulated by intracellular forces (Jiang et al, 2003; Liu et al, 2010). Moreover, the 
cadherin-actomyosin physical interactions need to be strong to allow for efficient force 
transmission between cells (Cavey et al, 2008; Lecuit et al, 2011; Yonemura, 2011). This 
mechanical coupling of contractility between neighbouring cells is thought to be crucial for 
coordinating force transmission at the tissue level to allow several tissue morphogenic 
events to occur (Lecuit et al, 2011; Martin et al, 2010). Therefore, a fine balance of 
regulatory events, which may be driven by ARHGEF10 and Trio, must exist to control both 
the availability of cadherins to participate in trans-interactions and the strength of cadherin-
cytoskeletal interactions. Together these processes can allow optimal force transmission 
during tissue remodelling. 
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6.3 Relief of inhibition: a common theme for Rho GEFs in AJ assembly 
 
Spatio-temporal regulation of GEF proteins is key to their regulatory functions on GTPase 
activation (Cherfils & Zeghouf, 2013; Rossman et al, 2005; Schmidt & Hall, 2002a). Here, I 
find evidence that DOCK180, Trio and ARHGEF10 may exist in inhibitory states and 
require relief of inhibition provided by cadherin stimulation. DOCK180 and DOCK2 are 
autoinhibited by interaction of their N-terminal SH3 domains with the DHR2 nucleotide 
exchange domain (Lu et al, 2004; Lu et al, 2005), which is released by binding of ELMO1 
(Hanawa-Suetsugu et al, 2012). DOCK180 junctional localisation does not require EGFR, 
however both proteins mediate Rac activation. This indicates the possibility that EGFR 
may relieve autoinhibition of the junction-associated DOCK180 to allow Rac activation.  
 
Similar indications for constitutive inhibition can be derived from our finding that 
constitutively active, but not wild-type ARHGEF10 is able to disrupt junction formation.  
Trio GEFD1 is also known to be constitutively inhibited by binding to the actin-binding 
protein, TARA at mature AJs (Yano et al, 2011). Moreover, the PH domain in Trio’s 
GEFD2 (RhoA activity) domain is known to inhibit the GEFD2 DH domain (Bellanger et al, 
2003). Whether either of these mechanisms exists to regulate Trio activation at nascent 
contacts remains to be shown.  However, I predict that relief of GEFD2 autoinhibition is 
key to Trio function as contacts form. That over-activation of Trio is detrimental to junction 
formation but inactivation stabilises E-cadherin underscores the necessity for tight 
regulation of GEF proteins to precisely control GTPase activation in response to 
extracellular stimuli. 
 
Our data supports the current thinking that autoinhibition of GEF activity provides a level of 
regulation which allows context-dependent activation of specific GEF-related signalling 
programs at the appropriate time and place (Cherfils & Zeghouf, 2013). This appears to be 
a globally conserved mechanism of cellular regulation as, in addition to other Rho GEFs, 
the Ras GEF Sos1, Rap GEF EPAC and Arf GEF cytohesin proteins are also under this 
tight upstream control (Cherfils & Zeghouf, 2013). Moreover, emerging evidence highlights 
the importance of appropriate GEF activation to maintain the physiological state. Mis-
regulation of several GEFs such as Sos1 (Gureasko et al, 2010; Lepri et al, 2011; Roberts 
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et al, 2007; Tartaglia et al, 2007), DOCK6 (Shaheen et al, 2011) and α-Pix  (Kutsche et al, 
2000), particularly by loss of autoinhibition, is associated with several pathologies, through 
inappropriate regulation of their cognate GTPases.  
6.4 Multiple Rho GEFs allow coordinated spatio-temporal regulation of 
Rho GTPase to govern the signalling diversity necessary for 
epithelial biogenesis 
 
The complexity of Rho-related signalling networks which co-operate to drive junction 
formation and maturation is underscored by the identification of multiple Rho GEFs as 
regulators of cell-cell adhesion, by RNAi screening. The majority of Rho GEF Hits are 
positive regulators of AJ assembly, whereby upon depletion, junctional localisation of E-
cadherin and F-actin are reduced. Two general mechanistic insights arise from the RNAi 
screen results. First, E-cadherin levels can be negatively regulated independently of F-
actin distribution, such that depletion of a GEF can lead to increased E-cadherin 
localisation to junctions without altering F-actin levels. Conversely, positive E-cadherin 
regulation is coupled to F-actin remodelling, whereby GEF depletion results in decreased 
E-cadherin and F-actin levels at junctions. Second, proteins such as GAPs, Rho GTPases 
and their effectors tend to regulate global cytoskeletal reorganisation to drive E-cadherin 
localisation, as demonstrated by their abilities to perturb junctional E-cadherin and F-actin 
levels with a concomitant modulation of cytoplasmic F-actin distrubtion. Rho GEF Hit 
proteins, on the other hand, appear to govern more specific cellular processes as less 
proteins simultaneously perturb E-cadherin and the two F-actin populations.   
 
One interesting observation is the discovery that multiple regulators of the same Rho 
GTPase are able to give a variety of phenotypes on junction stabilisation when depleted. 
This strongly implies that the specificity of downstream signalling pathways attributed to a 
single Rho protein can be determined by the upstream GEF regulator. This concept is 
rapidly gaining favour through evidence showing that spatio-temporal regulation of Rho 
GTPases into specific macromolecular/subcellular environments is the driving force for 
signalling diversity (Cherfils & Zeghouf, 2013; Pertz, 2010; Rossman et al, 2005). 
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Indeed, several RhoA and Rac GEFs have now been identified with various roles in 
establishment of the epithelial phenotype. RhoA GEFs such as Trio and ARHGEF10 
identified here along with Ect2, p114RhoGEF, PDZ-RhoGEF and GEF-H1 and the Rac 
GEFs DOCK180, Trio and Tiam-1 all have distinct roles in either AJ or TJ formation and 
function (McCormack et al, 2013).  These roles include regulation of junctional component 
localisation, biochemical and physical properties; modulation of contractile machinery, and; 
maintenance of strong and tight cell-cell connections (McCormack et al, 2013). The 
overarching observation is that each GEF is able to drive a specific process with little 
overlapping function with other GEFs. This seemingly low redundancy system underscores 
the hypothesis that the Rho GTPase-mediated processes are tightly coupled to the types 
and functions of other proteins that are in complex with the GEF protein in question 
(McCormack et al, 2013; Ratheesh et al, 2012).  
 
Many GEF proteins exist in macromolecular complexes that include specific effector 
proteins for their cognate Rho GTPase (Cherfils & Zeghouf, 2013; Rossman et al, 2005). 
Effector proteins range from scaffold proteins such as Rhotekin and the Dia family 
proteins, to Ser/Thr kinases such as the PAK proteins (Bishop & Hall, 2000). Although the 
Rho effector proteins responsible for driving the differential molecular responses to Rho 
GTPase activation have not been found in all cases above, given the large number of 
effector proteins that are regulated by Rho GTPases (over 100) (Hall, 2012), it seems 
reasonable to suggest that the type of effector protein within these multi-protein complexes 
ultimately directs cellular outcome.  
 
Overall, the identification of multiple Rho GEFs with novel roles in cell-cell adhesion 
assembly and maturation highlights that Rho GTPases are cellular tools that require 
instruction to do their job in regulated molecular environments to achieve a multitude of 
cellular responses (Cherfils & Zeghouf, 2013). Moreover, spatial and temporal interplay of 
these signalling nodes enables co-ordination of a number of cellular processes to drive 
proper and controlled epithelial biogenesis.  
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